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Preface 
Development of nanomaterials opens opportunities for new product types 
with many special technological features. There is, however, also expressed 
concern for nanomaterials health and environmental aspects, where lack of 
concrete knowledge can be a major problem in the regulation of nanomateri-
als. 
The Danish EPA (DEPA) has already initiated several projects which have 
highlighted the nanomaterials that can be found in products on the Danish 
market (Consumer Survey No. 81, 2007 / Forbrugerprojekt nr. 81, 2007 
(Danish version)) and the nanomaterials used in the Danish industry (Envi-
ronmental Project No. 1206, 2007).  
For a number of nanomaterials and products specific knowledge and experi-
ence are lacking and though nanomaterials are covered by the existing chemi-
cal legislation there is an ongoing debate on how risk assessments of nanoma-
terials best can be carried out. Chemical control is predominantly covered by 
common EU legislation, and work is currently carried out in both the EU and 
the OECD to assess whether the methods used for hazard and risk assessment 
are able to handle nanomaterials or if nanomaterials in certain cases possess 
specific properties, such that the methods and technical tools of regulation 
should be adjusted accordingly. 
In principle REACH also covers nanomaterials, as the regulation covers 
chemical substances, but work is carried out in relation to REACH in order to 
clarify various issues concerning the definition, identification, registration and 
assessment of nanomaterials. 
Denmark has taken several initiatives related to research and knowledge gen-
eration concerning the possible environmental and health effects of nanomate-
rials and there are also a number of knowledge institutions in Denmark, work-
ing to examine these effects. Both Danish and foreign knowledge institutions 
have contributed to build up considerable knowledge about potential expo-
sures to nanomaterials and the associated risks. 
For the individual citizen or company a major source of current knowledge on 
nanomaterials is the DEPA website, which provides an overview of both 
nanomaterials, nanomaterials in consumer products, current research related 
to environmental and health effects, and regulation of the materials. Turning 
to the individual applications of nanomaterials, knowledge on exposure and 
possible health and environmental effects is to a large extent missing. 
DEPA has therefore initiated this project to provide an overview of the exist-
ing knowledge about seven of the most common nanomaterials, their envi-
ronmental and health properties, the use of those nanomaterials and the pos-
sibility of exposure of humans and the environment. 
The Danish Environmental Protection Agency has contracted with COWI 
A/S in collaboration with DTU Environment and DTU Food to carry out this 
survey on basic knowledge about exposure and potential environmental and 
health risks for selected nanomaterials. 
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The study has been guided by a steering group consisting of Flemming Inger-
slev, Poul Bo Larsen, Magnus Løfstedt and Katrine Bom, the Danish Envi-
ronmental Protection Agency, Sonja Hagen Mikkelsen, COWI A/S, Anders 
Baun, DTU Environment and Mona-Lise Binderup, DTU Food.  
This report was prepared by Erik Hansen and Sonja Hagen Mikkelsen (Pro-
ject Manager), COWI A/S, Denmark and Anders Baun and Steffen Foss 
Hansen, DTU Environment and Mona-Lise Binderup, DTU Food. Trine 
Boe Christensen, COWI has contributed to the development of input for in-
formation material to be presented on the Danish EPA homepage. The study 
was conducted during a period from September 2010 to March 2011. 
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Executive Summary 
Background and Objective 
Danish Environmental Protection Agency (DEPA) has initiated the study 
"Survey on basic knowledge about exposure and potential environmental and 
health risks for selected nanomaterials". The objective of the study is to pro-
vide an overview of the applications of the most commonly used or wide-
spread nanomaterials and to identify areas most likely to have health or envi-
ronmental problems associated with their use.  
 
 
Characterisation and Selection of nanomaterials 
Nanomaterials are often defined as materials having one or more external di-
mensions in the nanoscale (1 nm to 100 nm) or materials which are nanos-
tructured (possessing a structure comprising contiguous elements with one or 
more dimensions in the nanoscale but excluding any primary atomic or mo-
lecular structure). There is yet no scientific consensus on the more precise 
categorization of nanomaterials. 
Seven nanomaterials have been selected for the study. Focus is on the core 
particles without surface functionalisation. The seven nanomaterials are: 
 Titanium dioxide 
 Cerium dioxide 
 Fullerenes (Carbon balls) 
 Silver 
 Zero-valent iron 
 Silicium dioxide 
 Nanoclay 
Selection was made based on expected application volumes, potential human 
and environmental exposure from consumer products and the expected bio-
logical effects. Carbon nanotubes are covered by another similar study, and 
are therefore not selected here, although they would qualify based on the se-
lection criteria. 
 
 
Use of nanomaterials in Denmark 
There is no single source of information that provides an overview of the use 
of nanomaterials and products in Denmark or in the EU for that matter. 
Pieces of information are, however, available from databases and previous 
studies initiated by DEPA. This information has in this project been reviewed 
together with results from other studies carried out in the Nordic countries 
and including estimates on relevant consumer applications and uses of the 
selected nanomaterials. A considerable part of the nanomaterial-containing 
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products are found to be sold from web shops in Denmark and abroad but an 
increasing part is sold from ordinary shops. 
A limited industry survey on the industrial use of the selected nanomaterials in 
Denmark has been conducted. The objective of this survey was to confirm the 
use of the nanomaterials in question in Denmark, and to develop a rough es-
timate of the consumption. 
The survey was carried out among identified actors dominating the markets 
for the selected nanomaterials and their typical applications. The relevant ac-
tors were asked about the uses and the amounts of the nanomaterials. Focus 
for the survey was on obtaining information for the most dominant field of 
application and not to cover all different use areas. 
The outcome of our survey can be summarized as follows: 
 Titanum dioxide, nanoclay and silicium dioxide are all materials used 
in most significant quantities in Denmark.  
 The use of nanosilver has not been confirmed, but indications exist 
that some products/brands may contain nanosilver.  
 The use of cerium dioxide has not been confirmed either. It is not 
used by leading marked actors in Denmark.  
No information was available on fullerenes and zero-valent iron. 
 
 
Nanomaterial profiles 
A profile for each of the selected materials was then developed. For each ma-
terial the focus has been on the general characteristics and manufacture of the 
nanomaterials, their current uses (mainly focussed at consumer products), 
and hazard profiles (ecotoxicity and human toxicity). Furthermore the pro-
files include sections discussing relevant exposures from consumer products 
and considerations regarding the related risk. 
Each nanomaterial profile is summarised in a 'summary sheet' containing the 
key findings and also emphasising areas where information is lacking. The 
general picture is that the specific knowledge base is limited and that more 
information is needed for sufficient characterisation of the nanomaterials and 
for illustration of the relevant (eco)toxicological endpoints. In addition more 
information is required with regard to fate, behaviour and kinetics of the dif-
ferent nanoparticles and crucial to the assessment of the relevant risks is an 
agreed methodology for risk assessment.  
Conclusive risk assessments were therefore not possible to develop within the 
framework of the present project. Based on the reviewed literature the seven 
selected nanomaterials were not found to exhibit new and completely un-
known risks to the consumer or to the environment in the current application. 
Products in the form of liquids or free particles are expected to give rise to the 
highest exposures in the environment and to humans, particularly those liq-
uids that are intended to come in direct contact with the body, and the poten-
tial risk is likely to increase with increased exposure. However, as the applica-
bility of the existing exposure and risk assessment methodology has been chal-
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lenged in relation to nanomaterials, there are still areas that need to be ex-
plored - especially for engineered nanomaterials.  
A key question in relation to risk and safety assessment of nanomaterials as 
raised in Stone et al. (2010) is to which extent the existing knowledge base 
about toxicity and risk related to the bulk counterparts can be used in the 
evaluation of the nanomaterials. In other words, it is the question of whether 
the risk information can be scaled from bulk substances to the nano-form tak-
ing the size of the nanoparticles into account or whether it is the small size 
that triggers the nano-specific behaviour and effects.  
Based on the reviewed literature there are some indications that scaling of tox-
icity could be relevant for the more chemically intert materials as TiO2 and 
SiO2 whereas e.g. carbon-based materials like fullerenes where surface-
modifications are introduced are more likely to acquire nano-specific proper-
ties. This is an area that needs further clarification before firm conclusions can 
be made. Relevant for this discussion is also the fact that many nanoscale par-
ticles (e.g. silver, nanoclay, TiO2 and SiO2) are naturally occurring particles 
that have been used for decades. However, these materials may also be modi-
fied with different surface coating, which can alter there physical-chemical 
properties and toxicity. 
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Introduction 
1.1 Overview of types of nanomaterials 
Nanoparticles can originate from primary sources (natural), from secondary 
sources (artificial) or they can be engineered nanoparticles. 
Naturally occurring nanoparticles comprise small particles from e.g. volcanic 
ashes, particles formed during combustion processes and also some biological 
molecules like RNA and DNA. Artificial nanoparticles comprise particles 
from e.g. diesel exhaust or by-products from industrial production whereas 
engineered or manufactured particles are designed with a specific purpose. 
Nanomaterials are often defined as materials having one or more external di-
mensions in the nanoscale (1 nm to 100 nm) or materials which are nanos-
tructured (possessing a structure comprising contiguous elements with one or 
more dimensions in the nanoscale but excluding any primary atomic or mo-
lecular structure). 
There is yet no scientific consensus on the more precise categorization of 
nanomaterials. Hansen et al. (2007) have suggested a categorisation based on 
the location of the nanoscale structure in the system, leading to a division of 
nanomaterials into three main categories: 
I. Materials that are nanostructured in the bulk; 
II. Materials that have nanostructure on the surface; and 
III. Materials that contain nanostructured particles. 
The three main categories can be further divided into subcategories as illus-
trated in Figure 1. 
In category I, the materials are nanostructured in three dimensions. This cate-
gory is further subdivided into materials consisting of one or of two or more 
different materials. 
In category II the nanostructure is on the surface and the subcategories in-
clude materials where the surface is structured but surface and bulk consist of 
the same material, another subgroup is un-patterened nanoscale film on a dif-
ferent substrate and the third subgroup is patterned film on a substrate where 
the film is in nanoscale thickness or the pattern is in nanoscale dimensions 
along the surface. 
Category III contains nanoparticles defined as free structures that are 
nanosized in two dimensions.  The division into subcategories depends on the 
environment around the nanoparticles, i.e. nanoparticles bound to the surface 
of a solid structure, nanoparticles suspended in a liquid, nanoparticles sus-
pended in a solid and airborne nanoparticles. 
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Figure 1 The categorization framework for nanomaterials as suggested by Hansen et 
al. (2007) 
 
This categorisation closely corresponds to the classification of nanomaterials 
according to dimensions which are not confined to the nanoscale range, where 
nanomaterials can be classified as zero-dimensional (0-D), one-dimensional 
(1-D), two-dimensional (2-D) and three-dimensional (3-D). 
0-D nanomaterials are those materials where all dimensions are nanoscale, 
most commonly nanoparticles; 1-D nanomaterials have one dimension out-
side the nanoscale, e.g. nanotubes, -rods and -wires; 2-D nanomaterials have 
two dimensions outside the nanoscale, e.g. nanofilms and graphene-based 
composites; and 3-D nanomaterials have three dimensions outside the nano-
scale, e.g. heterogeneous nanostructures like mesoporous carbonbased com-
posites and nanostructured networks. 
The DEPA report (Environmental Project No. 1206, 2007) distinguishes be-
tween six types of nanomaterials based on the shape characteristics of the ma-
terials: 
• Nanoparticles  with all three dimensions in the nanoscale range (e.g. TiO2 
nanoparticles); 
• Nanofibres and tubes with at least two dimensions in the nanoscale range 
and an aspect ratio of more than 3 (primarily carbon nanotubes); 
• Nanostructured surfaces (protrusions or grooves in the nanoscale range); 
• Nanofilm (coatings with layers thinner than 100 nm e.g. cured film on 
glass); 
• Nano Flakes with at least one dimension in the nanoscale range (e.g. 
nano-clay (silicate) and the materials used in semiconductor elements); 
• Nanoporous structures with pore sizes in the nanoscale range (such as 
ceramic materials used as catalysts). 
The most commonly available engineered nanomaterials can be organised into 
four types (EPA, 2007): 
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Carbonbased materials 
Carbonbased materials are composed mainly of carbon and commonly 
shaped as hollow spheres, ellipsoids, or tubes. Spherical and ellipsoidal carbon 
nanomaterials are referred to as fullerenes, while cylindrical ones are called 
nanotubes. These particles have many potential applications, including im-
proved films and coatings, stronger and lighter materials, and applications in 
electronics. 
Metal-based materials 
These nanomaterials include quantum dots, nanogold, nanosilver, zero valent 
iron and metal oxides, such as titanium dioxide, and cerium oxide. A quan-
tum dot is a closely packed semiconductor crystal comprised of hundreds or 
thousands of atoms, and whose size is on the order of a few nanometers to a 
few hundred nanometers. Changing the size of quantum dots changes their 
optical properties. 
Dendrimers 
These nanomaterials are nanosized polymers built from branched units. The 
surface of a dendrimer has numerous chain ends, which can be tailored to 
perform specific chemical functions. This property could also be useful for 
catalysis. Also, because three-dimensional dendrimers contain interior cavities 
into which other molecules could be placed, they may be useful for drug de-
livery. 
Composites 
Composites combine nanoparticles with other nanoparticles or with larger, 
bulk-type materials. Nanoparticles, such as nanosized clays, are already being 
added to products ranging from auto parts to packaging materials, to enhance 
mechanical, thermal, barrier and flame-retardant properties. 
 
1.2 Nanomaterials in consumer products 
Nanomaterials which are already widely used in various consumer products 
and therefore also are focus for research into environmental, health and safety 
aspects of the materials include: 
 Carbon tubes and fullerenes. Carbon materials have a wide range of uses, 
ranging from composites for use in vehicles and sports equipment, to in-
tegrated circuits for electronic components.  
 Cerium dioxide. Nano cerium is being investigated for uses ranging from 
drug delivery to automobile catalytic converters. Currently a major use in 
some countries is as a diesel fuel additive to reduce exhaust particulates 
and increase fuel mileage.  
 Titanium dioxide. Nano titanium dioxide is currently used in many 
products. Depending on the type of particle, it may be found in sun-
screens, cosmetics, food additives and paints and coatings. It is also being 
investigated for use in removing contaminants from drinking water. 
 Silicium dioxide. Silicium dioxide is like titanium dioxide used in many 
products including sunscreens, cosmetics, paints and cement. Silicium 
dioxide is also used in the food industry. 
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 Silver. Nanosilver has long been known for its antimicrobial properties. 
Nanosilver is being incorporated into textiles and other materials to 
eliminate bacteria and odour from clothing, food packaging and other 
items where antimicrobial properties are desirable.  
 Iron. While nano-scale iron is being investigated for many uses, including 
“smart fluids” for uses such as optics polishing and as better-absorbed 
iron nutrient supplement, one of its more-prominent current applications 
is for remediation of polluted groundwater and soil.  
 Zinc oxide. Zinc oxide is very UV-stable and is used as sunscreen in 
cosmetic products and UV-stabiliser in plastics. Zinc oxide also exhibits 
anti-bacterial properties which are utilised in pharmaceutical applications.  
 Nanoclay. Nanoclay (aluminium silicon oxide) is used as additive for re-
inforced plastics improving both mechanical and thermal properties as 
well as barrier characteristics. It is used in food packaging where it re-
duces the permeation rate of oxygen through the packaging material and 
more recently it has also been used as synergist flame retardant to substi-
tute the halogen-containing flame retardants. 
Other types of nanomaterials are gold nanoparticles and dendrimers, but they 
are mainly explored in relation to medical and other more specialised applica-
tions, although patents are already filed for the application of dendrimers in 
various cosmetic products. 
Examples of consumer products (PEN, 2011) that use nanomaterials are: 
 Health and Fitness: toothpaste, toothbrush, tennis racket, air filter, 
sunscreen, antibacterial socks, cosmetics, waste and stain resistant 
pants, golf clubs, wound dressings, pregnancy tests, bath and sports 
towels 
 Electronics and Computers: computer displays, computer hardware, 
games 
 Home and Garden: paint, antimicrobial pillows, stain resistant cush-
ions, humidifiers, cleaners, fabric softeners 
 Food and Beverage: non-stick coatings, antimicrobial refrigerator, ca-
nola oil, food storage containers, packaging 
 Other: coatings, lubricants 
 
1.3 Special characteristics of nanomaterials vs. bulk materials 
The special characteristics and properties of nanomaterials are largely attrib-
uted to the small size and the very large surface area to volume ratio. This 
makes a large fraction of the atoms available on the surface and results in 
more surface-dependent material properties which again may enhance or 
modify the properties of the bulk material.  
It should, however, be stressed that many conventional bulk chemicals with 
various applications in e.g. consumer products, foodstuffs and construction 
materials also contain a naturally occurring nanosized fraction. This is the 
case for titanium dioxide, silicium dioxide and clays. Other examples include 
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products containing nanosilver particles, which have been commercially avail-
able for over 100 years, and have been used in applications as pigments, pho-
tographics, wound treatment, conductive/antistatic composites, catalysts and 
as biocides (Nowack et al., 2011). 
Nanomaterials in general are known to have many novel properties that are 
already utilised or explored for use in different products and technologies and 
that allow new areas of application of these materials. These properties in-
clude mechanical, thermal, biological, optical and chemical properties, which 
may also affect the potential exposure to the materials, as well as the health 
end environmental effects from that exposure. Information on potential haz-
ards to health and environment is therefore urgently needed. 
A key challenge in relation to characterisation of the materials is that the dif-
ferent nanomaterials exist in various forms, sizes and shapes and cannot be 
described by a unique set of parameters. Their small sizes, complex struc-
tures, potential property changes during synthesis and use, sensitivity to and 
interaction with the surrounding environment also add to the challenge of 
characterization and providing sufficient information for assessing potential 
risks of the nanomaterials. Furthermore, information available in the literature 
is often very scarce and not always reported in a form relevant for risk assess-
ment. 
Key physical-chemical parameters (list of endpoints) to take into account, 
when testing specific manufactured nanomaterials for human health and envi-
ronmental safety within phase one of the OECD testing program include 
(OECD, 2010): 
 Agglomeration and/or aggregation 
 Water solubility / Dispersability 
 Crystalline phase 
 Dustiness 
 Crystallite size 
 Particle size distribution - dry and in relevant media 
 Specific surface area 
 Zeta potential (surface charge) 
 Surface chemistry (where appropriate) 
 Photocatalytic activity 
 Pour density 
 Porosity 
 Octanol-water partition coefficient, where relevant 
 Redox potential 
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 Radical formation potential 
 Other relevant physical-chemical properties and material characterisa-
tion information (where available) 
Further studies investigating the relation between these parameters and 
the toxicity of nanomaterials are needed, and will need to be addressed at 
some point in the evaluation and risk assessment of nanomaterials. 
The current EU legislative framework for chemicals covers in principle 
the potential health, safety and environmental risks posed by nanomateri-
als. However, there is also a recognised need to modify this legislation, in 
order to reflect the specific properties of nanomaterials, and the need for 
more elaborate characterisation of the nanomaterials compared to the 
conventional bulk form to include e.g. the specific surface properties. The 
existing testing requirements for bulk chemicals may also not be adequate 
in all areas of toxicity, and the same is the situation with regard to classifi-
cation and labelling of substances and mixtures and thereby also toxicity-
based thresholds based on these criteria. 
REACH provides the overarching legislation applying to the manufacture, 
placing on the market, and use of substances on their own, in preparations 
or in articles. The current view from the Commission is that the legislation 
in place to a large extent covers risks in relation to nanomaterials, and that 
the risks can be dealt with under the current legislative framework includ-
ing REACH. However, modification is expected for example with regard 
to thresholds used in some legislation and with regard to testing methods, 
test guidelines and risk assessment of nanomaterials. 
 
1.4 Use of nanomaterials in Denmark 
1.4.1 Industry and products 
There is no single source of information that provides an overview of the use 
of nanomaterials and products in Denmark or in the EU for that matter. 
Pieces of information are, however, available.  
Recently, the Nanowerk published an online Company & Labs directory1 with 
4,196 links to labs, associations, networks and companies. This directory in-
cludes only companies and labs that work with and/or commercialise 
nanotechnology and/or nanomaterials and does not include entities that only 
have “nano” in their name.  
According to Nanowerk there are 18 commercial companies in Denmark in-
volved in various fields of nanotechnology. The majority are relatively new 
and very specialised companies and some have emerged from university re-
search. One or two do not seem to be operational anymore in December 2010 
based on their homepage information. The list of companies is presented in 
Annex 1. 
                                                          
1 http://www.nanowerk.com/nanotechnology/research/nanotechnology_links.php 
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1.4.2 Results from selected Nordic surveys 
Conclusions regarding consumer products from three recent surveys from 
Denmark and Norway on products containing nanomaterials or based on 
nanotechnology are presented in this section.  
Survey on production and application of nanomaterials in Danish industry 
In 2007 DEPA published a survey of the nanomaterials being applied and 
produced within Danish industry, how these materials are handled in proc-
esses and how the waste from these processes and products is disposed (Envi-
ronmental Project No. 1206, 2007). It was found that a total of 24 companies 
worked with nanomaterials of which 16 companies worked with nanoparticles, 
nanofibres or nanoflakes within nine different industrial areas: Paints & inks, 
coatings, cosmetics, pharma & biotech, optics, sensors, catalysts, concrete and 
textile. More than half of the companies (i.e. 9) worked on a R&D level or 
used nanomaterials in their processes on a very small scale (<1 kg per year), 
whereas a few companies (i.e. 7) within the field of paint & ink, concrete, tex-
tile or cosmetics industries worked with >100 kg nanoparticles per year. Most 
used nanomaterials were metal oxides, polymers, silica and carbon black 
nanoparticles which had been obtained from foreign suppliers in powder or 
suspended form. Only one company reported the nanomaterial to be the end-
product, and this product was produced on a very small scale (<1 kg per 
year). 
Based on the survey and responses from 24 Danish companies working with 
nanomaterials, it was concluded, that with the exception of textiles, all prod-
ucts (made in Denmark) on the market containing nanomaterials have a con-
tent of nanomaterials above 0.1%. The nanoparticle content was 0.1 - 10 % in 
sunscreen and coatings and more than 1 % in paint and concrete. It was fur-
ther concluded that the pace for new industrial applications of nanomaterials 
seemed less rapid than previously predicted and that new applications of 
nanomaterials are restricted to small scale or R&D use, and have not yet 
reached a scale of production requiring the use of more than 1 kg of nanoma-
terial per year.  
Table 1 summarizes the nanoparticulate materials for which the specific 
chemistry was identified (Environmental Project No. 1206, 2007). 
Table 1 Specifically identified nanparticulate materials 
Nanoparticulate 
material 
Cas No Industrial area (sizes) Scale 
TiO2 (rutil + anatase) 13463-67-
7 
Cosmetics (10-20 nm) 
Paints & inks (nano/microparticles) 
> 1 ton per year 
> 100 tons per year 
TiO2 (anatase) 1317-70-0 Coatings (9-25 nm) < 1 kg per year 
Fe2O3 1309-37-1 Paints & inks (nano/microparticles) > 100 tons per year 
Carbon black 7440-44-0 Paints & inks (nanoparticles) 
Textiles (nanoparticles) 
> 1 ton per year 
> 10 tons per year 
Silica (amorphous) 7631-86-9 Paints & inks (10-20 nm) 
Coatings (10-25 nm) 
Concrete (100-200 nm) 
> 1 ton per year 
kg per year 
Not reported 
ZnO 1314-13-2 Cosmetics (nano/microparticles) Not reported 
Ag 7440-22-4 Coatings (nanoparticles) 
Textiles (nanoparticles) 
< 1 kg per year 
< 1 kg per year 
Cu 7440-50-8 Coatings (nanoparticles) < 1 kg per year 
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The particle size of the used materials varies from approximately 10 nm and 
more and in the case of metaloxide (pigments in the paints & ink industry), 
silica (concrete industry) and zinc oxide (cosmetics) the medium particulate 
particle size is >> 100 nm. The companies estimated particle size distribution 
of the used materials is so broad that an unknown fraction of the particles falls 
within the usual definition of nanoparticles.  
Commercialised nanoproducts in Denmark 
In 2007, DEPA initiated a survey in order to identify consumer products 
available to the Danish consumer (Consumer Survey No. 81, 2007). The sur-
vey was based on interviews and questionnaires submitted to stakeholders in 
Denmark, internet searches and follow-up on search results of consumer 
products in the Consumer Product Inventory maintained by the Project of 
Emerging Nanotechnologies at the Woodrow Wilson Centre in Washington, 
DC, USA.  
As there is no legal requirement for producers or importers of products to de-
clare the content of nanomaterials, it is not possible to be certain, that a pro-
ducer or importer who uses the prefix ‘nano’ in association with a product are 
referring to a content of nanoparticles, or if a nanomaterial is formed during 
use or whether it is the technology behind the product that is ‘nano’ (Con-
sumer Survey No. 81, 2007).  
The survey found that 243 products based on a nanomaterial were available 
on the Danish consumer market. The searches for Danish importers and dis-
tributors of products in the Woodrow Wilson database and Danish web shops 
selling these articles showed that two out of three products registered in the 
U.S.A. in general are for sale in Denmark (Consumer Survey No. 81, 2007). 
The report further concludes, that more than two thirds of the products on 
the Danish market (i.e. 154 products) – are various liquid products, partly for 
surface treatment of a great number of materials such as glass, concrete, metal 
(especially car maintenance) glass fibres and textiles, and partly for skin pro-
tection products, especially sun lotions. The remaining products are in par-
ticular sporting goods- and clothing, which account for 60 out of the 99 re-
maining products (Consumer Survey No. 81, 2007). 
More than half of the consumer products on the Danish market are products 
from Europe. Out of the 135 European products on the Danish market, al-
most 100 come from Germany. The remaining products originate from 
United Kingdom, Finland and France. Three products are sun lotions formu-
lated in Denmark. In 202 out of the 243 products it was not possible to iden-
tify the nanomaterial in the product. Of the 41 known nanomaterials, half of 
them were found in cosmetic products (six products with zinc oxide and 13 
with titanium dioxide), 10 with antibacterial silver in textiles and home appli-
ances, and 12 with carbon tubes or balls (seven with carbon tubes in sporting 
goods and five with fullerenes in cosmetics) (Consumer Survey No. 81, 
2007). 
As part of the survey it was found, that a considerable part of the consumer 
products are sold in web shops in Denmark and abroad, especially products 
for surface treatment within the product types `Car care products and acces-
sories’, ‘Home and gardening’ and ‘Personal care and sports equipment’, but 
a smaller and increasing part is found in ordinary shops. A group of paints 
contain ‘carbon black’ (20-100 nm) as colouring agent or silica (down to 
 
21
approx. 10 nm) as thickening agent. Both these materials have been used for a 
number of years, but are only now recognized as nanomaterials. In the Danish 
Product Register a great number of individual products are registered with 
carbon black (approx. 9,500) or silicium dioxide (approx. 15,500). The regis-
trations do, however, not include information about whether these substances 
include particles in the nanoscale. The registered amounts used in paints are 
483 tons carbon black and 622 tons silicium dioxide. The individual products 
containing these materials have not been further analysed (Consumer Survey 
No. 81, 2007). 
With regard to potential exposure of consumers the survey concludes that in 
most products containing nanomaterials on the Danish market the nanomate-
rials are suspended in liquid and that these products constitute the greatest 
likelihood of exposure of the consumer. These products include products for 
surface treatment and cosmetics. No products with free nanoparticles were 
identified (Consumer Survey No. 81, 2007). 
Survey on production, import and use of nanomaterials in Norway 
In the survey carried out in 2010 based on questionnaires sent to companies 
expected to produce, import or use nanomaterials, 27 out of 162 responded 
positively. Nanomaterials were primarily titanium dioxide, polymers, carbon 
nanotubes and carbon nanofibres mostly in powder form. Other forms in-
cluded suspensions, composite materials and films. Particle size was reported 
to be in the range of 20 to 100 nm for all types of powder (Norwegian Labour 
Inspection Authority, 2010). 
The Norwegian Product Register has in mid 2009 started voluntary registra-
tion of products containing nanomaterials. Registration covers in general all 
products with a hazard classification and produced or imported in volumes of 
100 kg or more. Cosmetics are not included. By 20 June 2010 19 products 
containing nanomaterials were registered of which 13 were consumer prod-
ucts. Typical products were paints and lacquers, car care products, products 
for impregnation and windscreen wash (Norwegian Labour Inspection Au-
thority, 2010). 
Use of nanomaterials in Sweden in 2008 - analysis and prognosis 
The Swedish Chemicals Agency has published a survey on the use of nano-
materials in Sweden in 2008 (KemI, 2009). According to this survey, the 
nanomaterials in Swedish nanoproducts can be categorised as 7 % ceramic 
materials, 13 % carbon-based, 7 % metals, and 5 % polymers in terms of 
the number of products. It is also stated in the report that it is difficult to 
get a true picture of nanoproducts that are on the market. This is partly 
due to the fact, that in most cases it is not obvious from the product in-
formation, that the product contains a nanomaterial, nor what material it 
is, if they do. Another problem is that consumers are purchasing the nano-
products directly on the Internet. 
An overview from an English summary of the report of examples of 
nanomaterials in products on the Swedish market is shown in Table 2. 
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Table 2 Examples of nanomaterials contained in articles on the Swedish market 
ARTICLE ON SWEDISH MARKET PROBABLE NANOMATERIAL  
Coatings for protection and self-cleaning effect 
on cars, tiles, stone, glass, textiles 
titanium dioxide, silicon dioxide/glass, 
polymers  
Paints and plastic  hyperbranched polymers 
Rackets carbon nanotubes, silicon dioxide composite 
Bicycles carbon nanotube composite, aluminium  
Skis and ice-hockey sticks epoxy carbon nanotube composite  
Tennis balls  nanoclay composite  
Car components  polymer-clay composites  
Filler in car tyres, black ink carbon black  
Filter for treatment of intake air to engines nanofibres of polymers 
Socks, soles, dressings  silver nanofilament  
Clothing fluorinated fibres  
Water repellent on textiles dendrimers, hydrophobic 
Sunscreen  titanium dioxide, zinc oxide 
Toothpaste  hydroxyapatite  
Paper chemicals  silicon dioxide  
Electron microscopy  gold particles  
 
The report estimates, that few new nanoproducts will be introduced in 
Sweden during the next five years or so, while further testing and devel-
opment of legislation takes place.  
Other reports 
A number of other reports from the Nordic countries discussing more general 
aspects and effects of nanomaterials in e.g. the work environment are avail-
able, but are not referred to here, as they do not include market surveys. 
 
1.5 Industry survey 
For the nanomaterials selected for this investigation (Chapter 2, Table 3), a 
limited survey on the industrial use in Denmark has been conducted. The ob-
jective of this survey was - if possible - to confirm the use of the nanomaterials 
in question in Denmark, and to develop a rough estimate of the consumption. 
The survey was carried out among identified actors dominating the markets 
for the selected nanomaterials and their typical applications. The relevant ac-
tors were asked about the use of the nanomaterials. The focus has been on 
obtaining information for the most dominant field of application and not to 
cover all different use areas. 
The outcome of the survey can be summarized as follows: 
 Titanium dioxide, nanoclay and silicium dioxide are all materials used 
in most significant quantities in Denmark.  
 The use of nanosilver has not been confirmed, but indications exist 
that some product/brands may contain nanosilver.  
 The use of cerium dioxide has not been confirmed either. It is not 
used by leading marked actors in Denmark.  
No information was available on fullerenes and zero-valent iron.   
 
23
2 Nanomaterials survey 
2.1 Selection of nanomaterials for the survey 
The nanomaterials selected for review in this project are shown in Table 3. 
The selected materials are all used in consumer products and are relevant to 
international discussions on the exposure and effects for humans and the en-
vironment. Furthermore it was important, that different application scenarios 
were involved. In addition, the following criteria were used for selection of 
individual materials: 
1. Application Volumes 
2. Potential human exposure 
3. Potential direct discharge to the environment 
4. Expected biological effect (human and / or environment), persistence 
or bioaccumulation 
 
Table 3  Selected nanomaterials, use and criteria for selection 
Materials Application –examples of products 
and function 
Basis for selec-
tion(criteria as shown 
above) 
Titanium dioxide Sunscreen, paint (catalyst, self-
cleaning surfaces) 
1, 2, 3, 4 
Cerium dioxide Fuel additive (catalyst) 1, 2, 3 
Fullerenes(carbon balls) Motor oil, cosmetics (lubricant, anti-
oxidant) 
2, 3 
Silver Textiles, electrical appliances (bio-
cide) 
1, 2, 3, 4 
Zero-valent iron Remediation of soil and groundwa-
ter contaminations  (reactant, cata-
lyst) 
3, 4 
Silicium dioxide Surface treatments, paints, 
(hydrophobic surfaces) 
1, 2, 3, 4 
Nano-clay Plastic materials  (lower oxygen dif-
fusion), cement 
1, 2 
 
Nanotubes are not considered, as they are already covered by another project 
with a similar focus.  
With the material selection shown in Table 3, it is expected, that the major 
health and environmental problems specific for nanomaterials can be identi-
fied in relation to the intended application and the environmental fate of the 
nanomaterials. 
The aim is to provide an overview of the existing knowledge, to identify areas 
in which the knowledge can be generalized, and to summarize the present 
state-of-knowledge in short and focused human health and environment pro-
files for each material. 
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To focus the characterisation, it is the pure form of the nanomaterials that is 
discussed in the following, thereby ignoring that various kinds of doping and 
coatings might exists. Furthermore, the overview of the key characteristics is 
primarily based on the form of the nanomaterials that is commercially avail-
able. 
 
2.2 Nanomaterials profiles 
In chapter 2-7 a profile for each of the selected materials will be developed. 
For each material the focus has been on the general characteristics and manu-
facturing of the nanomaterials, their current uses (mainly focussed at con-
sumer products), and hazard profiles (ecotoxicity and human toxicity).  
2.2.1 Manufacturing and applications 
The manufacturing processes and applications are described based on a litera-
ture review, and the available information from the small industry survey is 
also included. Furthermore, an updated review of the commercially available 
consumer products in Denmark containing the selected nanomaterials is in-
cluded in this report based on the methodology described in Consumer Pro-
ject No. 81 (2007). Outset is taken in the online “Nanotechnology Consumer 
Products Inventory” maintained by the Project of Emerging Nanotechnolo-
gies at the Woodrow Wilson International Center for Scholars. The 
Nanotechnology Consumer Products Inventory was launched in 2005 with 
the inclusion of 54 products – a number that one year later had increased to 
356 products. In the years 2007-2009, the number of products listed in the 
inventory continued to increase (580 products in 2007, 803 products in 2008, 
and 1015 products in 2009). In the most recent update in March 2011, a total 
of 1317 products were listed as commercially available worldwide from a wide 
variety of producers and countries (Woodrow Wilson Inventory, 2011). For 
products to be included in the inventory it has to fulfil mainly the following 
conditions: The products can be purchased directly by the consumers or iden-
tified by the producer or another source as based on nanotechnology and the 
information about nanomaterials in the product seems probable. 
The database divides the products in a number of categories: Appliances 
(heating, cooling and air; large kitchen appliances, air cleaners and air condi-
tion devices, domestic appliances, bio-up and textile protection products), 
Automotive (exterior) maintenance and accessories, Goods for children (ba-
sics; toys and games), Electronics and computers (audio; cameras and film, 
computer hardware; display; mobile devices and communications, television; 
video), Foodstuffs (cooking, foodstuffs, storage, dietary supplement), Health 
and fitness (clothing, cosmetics, filtration, personal care, sporting goods, sun 
screen), Home and garden (cleaning, construction materials, home furnish-
ings; luxury products; paint), and Surface treatment (overlapping several 
groups). 
In order to identify products that contain nanomaterials, and which are com-
mercially available in Denmark, it was investigated if the products registered 
in the database, are also marketed in Denmark or may be available through a 
web shop. This was done for the 2009 data since the most recent update co-
incide with the termination of the present project. 
It should be noted, however, that as there is no legal requirement to producers 
or importers of products to declare the content of nanomaterials, it is not pos-
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sible to be certain that a producer or importer, who uses the prefix ‘nano’ in 
association with a product, is referring to a content of nanoparticles, a nano-
meter thin surface layer that is formed upon use, a nanotechnological function 
expressed when used, or whether it is the technology behind the product that 
is ‘nano’. The term ‘nano’ may also be used in advertisement without a back-
ground in real nanotechnology and this is also a factor that may bias attempts 
to make inventories of nano-based products. It should be emphasised that the 
information in the inventory is based only on information that can be found 
on the internet and therefore products solely sold by non-internet retailers are 
not included.  
Using the same methodology as in Consumer Project No. 81 (2007), we iden-
tified a total of 612 products to be available in Denmark (of the 1015 prod-
ucts included in the database in 2009) primarily through various webshops 
compared to 243 products in 2007 as identified in Consumer Project No. 81 
(2007). It is unknown, which nanomaterials are used in more than half of the 
products identified. For each of the selected nanomaterials, the results of this 
survey are included in the nanomaterials profiles in Chapter 2-7. It should be 
noted, that the methodology used, may for some product types lead to an un-
derestimation of the actual number of products on the market and for others 
the number of “real” nano-based products may be overestimated. 
2.2.2 Ecotoxicological and toxicological profiles 
The sections on ecotoxicolgical and toxicological profiles are short summaries 
primarily of results of literature reviews published in the open peer-reviewed 
literature. In this respect the ENRHES review (Stone et al., 2010) proved to 
be an especially valuable source of information. Therefore, a number of sec-
tions are extracted from the ENRHES review and updated to the state-of-
knowledge by the end of 2010.  
As nanospecific standard procedures for ecotoxicological and toxicological 
testing as well as nanospecific control of assays and assay conditions are not 
yet developed it can be difficult to compare and conclude about the available 
results. This is further complicated by the fact that characterisation of the par-
ticles in biological systems is often insufficient and sometimes leads to con-
flicting evidence in the literature. 
2.2.3 Relevant exposures 
With regard to the exposure, focus is on nanomaterials from consumer prod-
ucts that can end up in the environment and the potential exposure routes 
relevant for consumers via direct exposure to the products containing the ma-
terials or indirectly via the environment. 
An illustration of the plausible exposure routes for nanomaterials from the 
ENRHES study is presented in Figure 2. It must be emphasized that at pre-
sent the level of knowledge on actual environmental or human exposures to 
nanomaterials originating from consumer products is extremely limited. Even 
though it is likely that the methods for exposure assessment for “ordinary” 
chemicals can be transferred to nanomaterials in consumer products (Hansen 
et al., 2008), the pronounced lack of data hampers quantitative exposure as-
sessments. The actual content of nanomaterials used in consumer products is 
often unknown and realistic human exposure scenarios are therefore difficult 
to evaluate in a quantitative way. For more generic overviews and model pre-
dictions, it is a major limiting factor that the production volumes of specific 
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nanomaterials cannot be estimated with reasonable certainty. This is even 
valid for materials like titanium dioxide, which is a high-production volume 
chemical (i.e. produced in more than 1000 tons/year) mainly used as a pig-
ment in its bulk form. However, data on how much of the total amount of ti-
tanium dioxide produced is in the nano-scale range are not publically avail-
able. This is due to the fact that no specific inventories for nanomaterials ex-
ist. 
For the environment, less than 15 scientific studies have been published on 
modeling approaches to quantify environmental concentrations (e.g. Arvids-
son et al., 2011; Blaser et al., 2008; Gotteschalk et al., 2010a,b; Mueller & 
Nowack, 2008). None of these have been validated by actual monitoring data. 
Less than 10 scientific studies report on measured concentrations of nanoma-
terials in environmental matrices and in most cases the studies are carried out 
under controlled conditions simulating environmental exposures (e.g. Kaegi et 
al., 2008; Kaegi et al., 2010; Farré et al., 2010) 
Figure 2  Plausible exposure routes for nanomaterials (from Stone et al, 2010) 
 
2.2.4 Risk profiles  
The findings with regard to ecotoxicity and human toxicity, and information 
about relevant exposures are used to develop risk profiles for each of the se-
lected nanomaterials. A summary sheet at the end of each chapter describing a 
nanomaterial, summarises the findings and are intended to form the basis for 
information material in the form of short data sheets in Danish for each 
nanomaterial. 
As evidenced by the ecotoxicological and toxicological profiles, large data 
gaps can be found within effects assessment, however, it may be claimed that 
even data gaps can be found within exposure assessment at present. These 
uncertainties do for most nanomaterials hamper quantitative risk assessments 
like those traditionally made for industrial chemicals. Therefore, this report 
does not attempt to make these kinds of risk estimations, but merely provide 
data for information purposes. 
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3 Fullerenes - C60 
3.1 General characteristics 
Fullerenes consist of a family of soccer-ball shaped molecules with 60 or more 
carbon atoms arranged in closed spherical and elliptic structures as each car-
bon atom bonded to three others in pentagonal and hexagonal rings. The size 
of a fullerene is approximately 1 nm. C60 has long been regarded as the poster 
child of nanotechnology, but the fullerenes furthermore consists of the C70, C76 
and C84 (Health and Safety Executive, 2004). Fullerenes can furthermore con-
sist of a number of layers which are called onions (Terrones & Terrones, 
2003). C60-fullerenes are extremely stable and are extremely temperature and 
pressure resistant. Fullerenes have a tendency to agglomerate and form clus-
ters of crystals, termed nanoC60 or nC60. Although normally considered to be 
an insoluble material, C60 can be surface modified making it more water solu-
ble and thereby provide them with a great variation in their physico-chemical 
properties as well as biological activity (Stone et al. 2010). Modification can 
be through the attachment of e.g. hydrophilic groups, peptides, or carbonhy-
drates which changes the properties of C60 (Sayes et al. 2004, European 
Commission, 2005).  
 
3.2 Manufacturing processes 
Different methods exists to produce fullerenes, but most large scale manufac-
turers use a combustion process, which uses hydrocarbons as a raw material 
to produce C60. Toluene is fed together with oxygen to a low-pressure com-
bustion chamber. The flame produces fullerene-enriched soot, which is ex-
tracted and filtered (Takeara et al., 2004). Fullerenes are then extracted from 
the soot by solvents (e.g. chlorobenzene and toluene) in a tank where the in-
soluble soot settle to the bottom while C60 are dissolved in the solution. Puri-
fied fullerenes are collected after the solvent has evaporated and appear as a 
black powder. The separation of single size fullerenes (C60, C70) and the de-
gree of purity determine the price of the final product.   
 
3.3 Uses 
3.3.1 Main applications 
C60 has been applied in a number of different consumer products such as 
sports gear (badminton- and tennis rackets), cosmetics and personal care 
products (anti-aging, eyeliner, skin creams, etc.) and also lubricants (motor 
oil) (Franco et al., 2007, Consumer Survey No. 81, 2007). Other current uses 
include energy applications (such as fuel cells, solar cells and batteries), cata-
lysts, polymer modifications and targeted drug delivery systems (Aschberger 
et al., 2010). In total five products have been identified to be commercially 
available on the Danish marked. While C60-containing cosmetics and personal 
care products can be bought online (Franco et al., 2007, Consumer Survey 
No. 81, 2007), only products related to sports gear have been identified on 
the Danish market. In these products C60 is added to strengthen the structure 
of e.g. tennis rackets where the C60-fullerenes are dispersed in a resin between 
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carbon fibers. The C60 content of e.g. sports gear and lubricants is unknown. 
For patents filed in US in regard to cosmetics, concentrations between 0.05 
and 6 % are reported. Concentrations used are the highest in eyeliner and 
mascara with 6% and 5%, respectively (Boxall et al., 2008). In lubricants, 
fullerene soot containing approximately 3.2 % fullerenes is added to improve 
sliding between metal surfaces. With a soot content of 9.4 %, the concentra-
tion of C60 is estimated at about 3 g/kg. The fullerene molecules are expected 
to be partly free during use and unintended release should therefore be con-
sidered in an exposure assessment (Franco et al., 2007). 
The production and use of fullerenes is assumed to be limited at present, but 
expected to grow significantly over the next decade. In Japan a large scale 
production plant has been opened recently with a production capacity of 40 
tons per year (Aitken et al., 2006 and Fujitani et al., 2008 in Aschberger et al., 
2009).  
 
3.3.2 Results from industry survey 
No information on fullerenes has been obtained. 
 
3.4 Eco-toxicological profile 
For the following overview of the ecotoxicological profile of C60-fullerenes it 
should be stressed that only a few ecotoxicological studies exist and only a 
part of these are aimed at the base-set organisms (fish, crustacean and algae) 
required for doing effects assessment according to REACH. Even fewer stud-
ies report the results in terms of the endpoints and values listed in Information 
Requirements of the REACH (e.g., LC50, EC50, NOEC, LOEC) (ECHA, 
2008).  
The testing of C60 in ecotoxicological tests is difficult due to the very low wa-
ter solubility of the compound. This has lead to the use of organic solvents, 
which has been shown to influence the ecotoxic response. Thus, studies have 
demonstrated that the degradation of tetrahydrofuran (THF), used as a sol-
vent in many of the early ecotoxicity studies on C60, may in fact be the cause 
of the toxicity observed (Stone et al., 2010). In general, less adverse effects are 
observed when using water-stirred or sonicated C60 compared to C60 tested in 
the presence of tetrahydrofuran or dimethylsulfoxide as solvents. For instance, 
a number of studies observed no effect on the survival of larval zebrafish and 
fathead minnow after exposure to stirred and sonicated C60, whereas increased 
mortality and elevated lipid peroxidation was found after exposure to THF- 
C60 (Henry et al., 2007; Zhu et al., 2006a; Oberdörster et al., 2006). Evidence 
from studies on Daphnia magna also shows a large difference between the 
ecotoxicity of water-stirred and THF- C60 (Lovern and Klaper 2006; Lovern 
et al., 2007; Zhu et al., 2006). These interactions lead Stone et al. (2010) to 
the conclusions that ecotoxicological studies carried out with tetrahydrofuran 
do not have a high credibility.  
In C60-suspensions prepared by long-term stirring, Zhu et al. (2008) observed 
no mortality or unusual behaviours of juvenile carp (Carassius auratus) after 
32 days of exposure to between 0.04–1.0 mg/L. However, a significantly re-
duction in the mean total length was observed after 32 d exposure to 0.2 mg/L 
of C60 and a significantly reduced body weight at 1.0 mg/ L. No detectable 
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effects were observed after exposure to 0.04 mg/L for 32 days. This might 
correspond to a NOEC of 0.04 mg/L and a LOEC of 0.2 mg/L for the length 
of juvenile carp and a LOEC of 1.0 mg/L for the body weight after exposure 
to C60 in water for 32 days.  
For crustaceans, the 48 h lethality study by Lovern and Klaper (2006) re-
ported on a great variation in mortality in Daphnia magna, but a LC50, 48h of 
7.9 mg/L for water-sonicated C60 could be established. LOEC and NOEC 
were reported to be 0.5 mg/L and 0.2 mg/L, respectively.  
In regard to survival and reproductive endpoints a significant reduction in the 
number of offspring after 21 days and delays in moulting of the carapace was 
observed by Oberdörster et al. (2006) after exposing Daphnia magna to 2.5 
mg/L water-stirred C60. An increased cumulative mortality and significant de-
lay in moulting and reduced offspring was reported as well after exposure to 
1-5 mg/L for 21 days (Oberdörster et al. 2006).  
For earthworms no significant mortality was found after consuming dry food 
spiked with 99.5% C60 concentrations of 1 g/kg dry food for up to 28 days 
(Scott-Fordsmand et al., 2008). Johansen et al. (2008) found that exposure to 
50 mg/kg to 99.5% C60 aggregates caused a 60% inhibition of the number of 
bacterial colony-forming units CFUs in clay loam soil 3 hours after incorpora-
tion.  
No studies on bioaccumulation of fullerenes have been reported in the litera-
ture. No studies on the degradability of fullerenes have been found in the lit-
erature. The cage-like structure of C60 suggests very low biological degradabil-
ity, however functionalisation (e.g. hydroxylation) may alter the degradability 
behaviour significantly.  It has been suggested that C60 can be oxidised to 
C60fullerol through both abiotic- and biotic-mediated means (Schreiner et al., 
2009). Two white rot basidiomycete fungi (Phlebia tremellosa and Trametes 
versicolor) has again been demonstrated by Schreiner et al. (2009) to metabo-
lize and degrade C60-fullerol to CO2 after 32 weeks of decay, with minor 
amounts of the fullerol carbon incorporated into lipid biomass.  
Finally, it should be mentioned that Baun et al. (2008) found that the pres-
ence of C60 in toxicity tests increase the toxicity of phenanthrene. It was fur-
thermore found that the uptake of phenanthrene in D. magna was faster in the 
presence of C60. A 1.7 times higher steady-state concentration was reached in 
the animals. However, a very fast clearance took place when animals were 
transferred to clean water resulting in no accumulation of phenanthrene 
(Baun et al., 2008). 
 
3.5 Toxicological profile 
Both in vitro and in vivo studies have been performed on fullerenes, but most 
of the studies have some limitations. A number of the toxicological studies 
with fullerenes are relatively old, and therefore they do not focus on the 
“nano” dimension of fullerenes. None of the studies are performed according 
to guidelines (e.g. OECD). Different dispersants used to enhance dispersion 
and to minimise cluster/crystal size can also influence the toxicity. The fact 
that a number of fullerene derivates are available, with different number of 
carbon atoms (e.g. C60 or C70), and different surface modifications used to 
render fullerenes water soluble can also complicate the toxicological evalua-
tion of fullerenes. 
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A particular focus of the more recent studies has been to determine the anti-
oxidant properties of fullerenes, and how to improve their dispersion within 
aqueous suspensions. The most relevant of the studies for risk assessment are 
summarised below and quoted from Stone et al. (2010) and Aschberger et al. 
(2009). 
 
3.5.1 ADME studies 
Determining the kinetics of fullerenes within the body, subsequent to expo-
sure (via the lungs, gut and skin) is necessary to identify potential targets of 
fullerene toxicity, and thereby direct relevant in vitro assessments of their tox-
icity at particular target sites. However, only few studies provide evidence for 
the absorption of fullerenes into the blood from their exposure site. 
Absorption 
Inhalation 
In a study by Baker et al. (2008) nano and microparticulete forms of fullere-
nes were not detected in blood following inhalation by rats, suggesting that 
they do not translocate from their exposure site.  A half life of 26 days for 
fullerenes nanoparticles was determined which is similar to microparticles (29 
days) suggesting that similar elimination processes are involved during the 
removal from the lungs.  However, the pulmonary deposition fraction was 50 
% higher for the nano form compared to the non-nano form. It is necessary to 
note that the preparation method and therefore the form of the fullerene dis-
persion could influence this data and therefore additional studies are required 
before this finding can be considered universal. 
In a rat study no translocation of C60 to other organs was observed after intra-
tracheal installation (3.3 mg/kg bw) or inhalation exposure (0.12 mg/m3), 
supporting that there is no absorption after inhalation (Shinohara et al., 2009) 
In contrast Naota et al. (2009) suggested that nano C60 may be absorbed after 
installation. However, it is unclear whether the suspension induced oedema 
could have influenced the result.   
Oral: 
After oral administration to rats and mice, C60 was not effectively absorbed, 
but instead the majority was excreted in the faeces within 48 hours.  However, 
trace amounts of fullerene were observed in the urine, indicating that some 
fullerenes were able to pass through the gut wall (Yamago et al., 1995). 
In a study by Folkmann et al. (2009) oxidative DNA damage was observed in 
liver and lung after oral exposure via gavage to C60 suspended in either saline 
or corn oil, indicating absorption via the oral route. 
Dermal: 
In a study by Xia et al. (2010) it was shown that pristine nanoC60 can pene-
trate  deep into the stratum corneum both in vivo (tape stripping an tissue bi-
opsies in weanling pigs) and in vitro (diffusion cell experiment). The absorp-
tion was modulated by the solvent, in which C60 was dispersed. This observa-
tion underlines the importance of taken the effect of the dispersion medium 
into account in risk assessment of C60. 
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After administration of C60 dissolved in squalane (Lipo-fullerene, LF-SQ) to 
human skin biopsies at concentrations as high as 223 ppm C60 in LF-SQ, C60 
permeated into the epidermis but into the dermis, indicating that this prepara-
tion of C60 will not be systemically available after dermal administration (Kato 
et al., 2009).  
Other studies: 
Several in vitro studies have shown that fullerenes are taken up by different 
cell types often with oxidative and lethal consequences. Computer simulation 
has also been used to simulate uptake, but the relevance of these studies is still 
unknown (Stone et al., 2010).  
Distribution 
Inhalation, oral, dermal 
There is limited information on distribution to secondary organs, probably 
because there is no or low absorption. 
Other routes - injection 
Following intraperitoneal injection into rats water soluble, polyalkylsulfonated 
C60 were transported via blood, accumulating in liver, spleen and kidney, 
with evidence of toxicity at sites of accumulation (Chen et al., 1998b).   
After intravenous injection water soluble fullerenes were rapidly removed from 
the blood and accumulated primarily in liver, but also, presumably depending 
on their water solubility in kidney, lungs, spleen, heart and brain (Yamago et 
al., 1995). 
Yamago et al. (1995) investigated the distribution of 14C labelled, water solu-
ble C60 within rats, after intravenous injection. Subsequent to exposure, the 
fullerenes were rapidly removed from the blood (only 1.6% of the adminis-
tered dose remained in the blood after an hour) and accumulated within the 
liver, which was the primary site of localisation, although some localisation 
was also evident within, for example the kidney, lungs spleen, heart and brain.  
In a similar study, Bullard-Dillard et al. (1996) also exposed rats via intrave-
nous exposure to pristine (unmodified) and a water soluble quaternary am-
monium salt-derivatised C60. Clearance of C60 from the blood was again rapid. 
However, the clearance of quaternary ammonium salt-derivatised C60, was 
slower than of pristine C60 due to its water soluble character. Again the major-
ity of the unmodified particles were contained within the liver (over 90%) at 
120 minutes post exposure, with minimal accumulation within the spleen, 
lung and muscle. The water-soluble C60 had a wider tissue distribution, with 
only 50% of the administered dose evident within the liver, with the remaining 
dose contained in the spleen, lungs, muscle and cellular component of blood. 
After 120 hours, it was apparent that the majority (95%) of unmodified C60 
still remained within the liver, with no evidence of elimination within urine or 
faeces, highlighting that the liver is a potential target for fullerene accumula-
tion and toxicity.  
Metabolism 
The metabolism of fullerenes has been suggested to occur, following their ac-
cumulation within Kupffer cells in the liver of rats (Gharbi et al., 2005). The 
metabolites have not yet been identified.  
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Elimination 
The elimination of fullerenes in urine (Yamago et al., 1995) and faeces (Mori 
et al., 2006; Yamago et al., 1995) has been demonstrated in rat and mouse, 
suggesting that they may be eliminated, in part, from the body following ex-
posure via a number of routes.   
3.5.2 Short term toxicity 
Oral 
Two studies were identified that show a very low toxicity of fullerenes subse-
quent to oral exposure.  
No lethality or other signs of toxicity in terms of behaviour or body weight 
were evident in rats after oral exposure at a dose of 2000 mg/kg of fullerite (a 
mixture of C60  and C70), during the observation period (up to 14 days) (Mori 
et al., 2006). Based on this study a NOAEL of 2000 mg/kg bw/day is sug-
gested. 
Chen et al. (1998b) demonstrated that polyalkylsulfonated (water soluble) C60 
showed no effects subsequent to oral exposure of rats in acute (2500 mg/kg, 
single administration) and as a consequence it was considered to be not 
acutely toxic. A NOAEL of 2500 mg/kg bw/day is suggested. 
In both studies only one dose was used without effect, and therefore the true 
oral acute NOAEL may be higher.  
Inhalation/intracheal installaion 
A range of nanoparticles has been shown to induce pro-inflammatory effects 
in the lung. However, this does not seem to be the case with fullerenes.   
In a study by (Baker et al., 2008) no inflammatory potential was observed in 
rats exposed to fullerenes following nasal inhalation at concentrations of  2.22 
mg/m3 (nanoparticle, 55 nm diameter) and 2.35 mg/m3 (microparticle, 0.93 
µm diameter) for 3 hours per day for 10 consecutive days,  and following a 
single intratracheal instillation at concentrations between 0.2 and 3 mg/kg C60  
or C60 (OH)24, for a period of up to 3 months following exposure (Sayes et 
al., 2007).  
In a study by Roursgaard et al. (2008) where mice were exposed via intratra-
cheal instillation to doses of 0.02 to 200 µg per mouse for 24 hours it was 
shown that at low concentrations (20 μg per mouse), fullerols (i.e. hydroxy-
lated fullerenes) may have protective, anti-inflammatory properties probably 
due to the ability of fullerols to reduce ROS mediated inflammation, but at 
higher concentrations (200 μg/mouse) they exhibit a pro-inflammatory re-
sponse.   
Dermal 
Only one study on the potential skin effects of fullerenes was found. In a hu-
man study Huczko et al. (1999) used patch testing to assess the skin irritant 
potential of fullerene soot within 30 volunteers (who reported irritation and 
allergic susceptibilities) for a 96 hour exposure time. No skin irritation was 
found.  
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Other routes 
Intraperitoneal exposure 
Following intraperitoneal injection in mice and rats fullerenes induced anti-
genic behaviour by stimulating the generation of antibodies (Chen et al., 
1998) which were also able to interact with SWCNT (Erlanger et al., 2001).  
An LD50 of 600 mg/kg was determined via intraperitoneal injection to rats 
with water soluble, polyalkylsulfonated C60, in an acute (up to 1000 mg/kg, for 
24 hours) or subacute setting (up to 60 mg/kg, with daily exposures for 12 
consecutive days).  The kidney was recognised as a primary site of fullerene 
elimination and toxicity (nephropathy) (Chen et al., 1998). Subsequent to 
intraperitoneal administration fullerenes have also been observed to accumu-
late within Kupffer cells in the liver (Gharbi et al., 2005).   
3.5.3 Irritation and corrosion 
Skin 
The only identified investigation was a patch test model on humans by 
(Huczko et al., 1999) mentioned above  
Eye 
A Draize rabbit eye irritation test was performed to reveal the potential toxic-
ity of fullerenes to the eye. Instillation of a fullerene soot suspension (for up to 
72 hours) was observed to have no toxicity within the eye (Huczko et al., 
1999).  
Inhalation 
No information has been identified on respiratory irritation.  
3.5.4 Skin and respiratory sensitisation 
No effects were seen in a human patch testing to assess the skin irritant poten-
tial (Huczko et al., 1999). No other information on skin and respiratory tract 
sensitisation is identified. There are indications that C60 derivatives may act as 
sensitising agents following intraperitoneal exposure (Erlanger et al., 2001).  
The relevance of these findings to the skin and respiratory tract has to be in-
vestigated. 
3.5.5 Repeated dose toxicity 
Oral 
No effects were observed after subacute (50 mg/kg daily for 12 days) oral ex-
posure to polyalkylsulfonated (water soluble) C60 (Chen et al., 1998b).  No 
information on effects after subchronic or chronic exposure has been identi-
fied. 
Inhalation 
In a subacute inhalation study 0.12 mg/m3 fullerenes did not induce signifi-
cant inflammation and tissue injury during the inhalation exposure period (28 
days) and after 3 months observation period. However, some genes associated 
with the immune system were up-regulated by C60 fullerene particles. It was 
concluded that fullerenes might not have severe pulmonary toxicity (Fujita et 
al., 2009). A LOAEC of 0.12 mg/m3 is proposed. 
No inflammation was seen after 10 days nasal inhalation of 2.22 mg/m3 for 3 
hours per day (Baker et al., 2008) and 3 months after a single intratracheal 
instillation of 3 mg/kg C60 or C60(OH)24 (Sayes et al., 2007). No information 
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after subchronic or chronic exposure has been identified. An acute NOAEC 
of 2.22 mg/m3 is proposed. 
Dermal 
No information after repeated dermal exposure is identified.  
3.5.6 Mutagenotoxicity/genotoxicity  
In vitro data 
Several in vitro genotoxicity studies have been performed during recent years 
in different cell lines and also a few in vivo studies. Different fullerene types 
have been tested as indicated in the text below. 
Gene mutation in bacteria 
Mutagenicity was observed in the Salmonella typhimurium strains TA102, 
T104 and YG3003 (a repair deficient strain of TA102) but only after irradia-
tion with visible light, and the effect was reduced in the presence of oxygen 
scavengers like β-carotene, indicating the formation of ROS by photo activa-
tion of fullerenes  (Sera et al., 1996). Highest tested concentration was 30 µg 
per plate. 
No mutagenic effect was induced within a variety of Salmonella typhimurium 
and Escherichia Coli strains by a C60/C70 mixture (fullerite); up to 5000 µg per 
plate (Mori et al., 2006). 
In a study performed according to OECD guideline 471 (Shinohara et al., 
2009) with a well characterised stable suspension of C60  in 0.1% carboxy-
methylcellulose sodium (CMC-Na) no mutagenic effect was observed in any 
strains either with or without metabolic activation and regardless of irradia-
tion. The highest tested concentration was 1000 µg per plate which was the 
highest achievable. Diameters of the majority of particles were < 100 nm. 
Lipo-fullerene (squalane and C60 ) was tested in 4 Salmonella strains and one 
E. Coli strain according to OECD guideline 471 up to 5000 µg per plate. No 
mutagenic effect was observed in this study either with or without metabolic 
activation. 
Chromosomal aberration in mammalian cells 
No numerical or structural chromosomal aberrations were induced in 
CHL/IU hamster lung cells (Mori et al., 2006). 
A dispersion of pristine C60 in saline containing 0.05% Tween 80 induced a 
concentration related increase of micronuclei in A549 human lung cells at 
concentrations from 0.02 to 200 µg/ml. The tested suspension contained 
mainly agglomerates with a wide distribution range (10.5 to 12914 nm) (Tot-
suka et al., 2009). 
A dispersion of pristine C60  in CMC-Na did not induce structural chromoso-
mal aberrations in CHL/IL cells either with or without metabolic activation 
and irrespective of irradiation at concentration up to 200 µg/ml (Shinohara et 
al., 2009). The assay was claimed to be performed according to Japanese and 
OECD testing guidelines.  
Genotoxic effect in mammalian cells 
Fullerenes have shown to induce DNA damage within human lymphocytes in 
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a Comet assay when exposed at concentrations ranging from 0.42 to 2100 
µg/L for up to 6 hours (Dhawan et al.,. 2006).   
C60 (0-200 µg/ml, 24 or 576 hours) did not increase the level of DNA strand 
breaks, but there was a slight induction of FPG sensitive sites/oxidised 
purines, using the Comet assay, which could be explained by a slight induc-
tion of ROS both within cells and in a cell free medium that were observed 
(Jacobsen et al., 2008). 
Mrdanovic et al. (2009) investigated the genotoxic and antigenotoxic effect of 
fullerenol (C60(OH24) on Chinese hamster ovary cells (CHO-K1). Fullerenol 
did not induce micronuclei (MN) or chromosomal aberrations (CA) at a wide 
range of concentrations (11 – 221 µM). Fullerenol had a protective effect (an-
tigenotoxic) on both non damaged (control) and mitomycin C (MMC) dam-
aged cells. A dose dependent decrease in MN frequency in non damaged cells 
was found after 24 h exposure after 3 h this effect was only observed at lower 
concentrations, but MN was lower at all concentrations and time points com-
pared to controls. CA frequency was lowered after both short (3h) and long 
(24h) treatment, but lowest after 3h (all concentrations) and at low concentra-
tions after 24 h. Fullerenol had antigenotoxic effect on MMC induced MN 
and CA at all concentrations and time points and most pronounced on MN 
after 24h treatment at low concentrations. These findings suggest an anti-
oxidative effect at low fullerenol concentrations which may turn into a pro-
oxidative effect at higher concentrations.    
In vivo data 
A single intragastric administration to rats of C60 suspended in either saline or 
corn oil induced oxidative damage measured as 8-oxodG in the liver and lung 
but not in colon. There was a significant effect of corn oil itself but there was 
no indication of interaction between the type of vehicle used and particle ex-
posure. These data indicate that C60 is absorbed from the gastrointestinal tract 
to blood and circulated to secondary organs resulting in oxidative DNA dam-
age (Folkmann et al., 2009).  
C60 suspended in saline containing 0.05% Tween 80 single or multiple doses 
of 0.2 mg/kg was installed intratracheally to male C57BL/6 mice or gpt delta 
transgenic mice. After 3 hours, DNA damage was observed in the lung of 
male C57BL/6 mice in the alkaline comet assay. After 24 hour this effect was 
decreased, indicating DNA repair. C60 also induced gpt mutations in the lung 
but not in the kidney of transgenic mice the effect increased after multiple 
(x4) exposures. From the mutation spectrum obtained it is suggested that 
oxidative DNA damage may be involved in the mutagenic effect (Totsuka et 
al., 2009). 
A bone marrow micronucleus assay using a stable suspension in 0.1% aque-
ous Tween 80 of nanosized C60 was performed in ICR mice. Three doses (22, 
45 and 88 mg/kg) were administered twice by gavage. There was no induction 
of micronuclei at any doses tested. However, there was also no indication that 
the substance did reach the bone marrow (no toxicity on bone marrow or 
general toxicity). The test was claimed to be performed according to OECD 
guideline 487 (Shinohara et al., 2009).  
3.5.7 Carcinogenicity 
No information on carcinogenic effects of fullerenes has been identified.  
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Some studies have reported anti-tumour effects of fullerenes in vivo and in 
vitro, depending on derivatisation, dispersion and light irradiation (Chen et al., 
2005; Tabata et al., 1997; Zhu et al., 2008). It would appear that fullerenes 
can accumulate in tumours due to hyper permeability of tumour vasculature 
with very low toxicity to other organs. Light irradiation seems to be essential 
for tumour destructive effect to manifest.  
Gd@C82(OH)22 following intraperitoneal administration has been demon-
strated to inhibit the growth of malignant tumours within mice, and that this 
was due to their ROS scavenging activity (Yin et al., 2008). 
3.5.8 Reproductive toxicity 
Effect on fertility 
No in vivo studies have been identified 
Developmental toxicity 
Only one in vivo mammalian study on the effects of fullerenes on the develop-
ing embryo has been identified. Following intraperitoneal administration of 
polyvinylpyrrolidone solubilised C60 (up to 137 mg/kg) to pregnant mice, ef-
fects like abnormal enlargement of the head, tail abnormalities and dead em-
bryos at the higher doses were seen as well as shrunken membrane and nar-
row blood vessels of the yolk sack (Tsuchiya et al., 1996). The NOAEL was 
16.7 mg/kg. This study is of limited relevance due to low number of animals 
per exposure group and the unusual route of administration, using a relatively 
high exposure dose and covering only a small part of the pregnancy period. 
3.5.9 In vitro toxicity studies 
Some in vitro toxicity studies has been performed. However, since they are 
not relevant for the risk assessment they will not be mentioned here.  
3.5.10 Summary 
Fullerenes exist in a variety of forms (carbon atom number, surface modifica-
tions, aggregations states, etc) and it is difficult to make generalisation about 
their toxic behaviour.    
So far it has been shown that one of the main factors for differences in 
fullerene toxicity seems to be the water solubility with fullerenes of greater wa-
ter solubility being less toxic.   
Fullerenes are assumed not to be effectively absorbed and to remain at the 
deposition site (mainly lung and gut). A small amount may be absorbed 
through the gut wall. No information is available for possible dermal absorp-
tion. 
Fullerenes seem to have a very low toxicity after oral exposure and an acute 
NOAEL of 2000 mg/kg bw/day for fullerites and a sub-acute NOAEL of 50 
mg/kg bw/day for polyalkylsulfonated C60 from a subacute toxicity study (12 
days) are suggested. 
Following exposure via the pulmonary route fullerenes were able to induce 
pro- or anti-inflammatory responses with the factors driving these effects still 
unknown. An acute NOAEC of 2.22 mg/m3 for acute inhalation is suggested 
as no inflammatory potential was seen at this concentration. In addition a 
LOAEC of 0.12 mg/m3 from a 28 day whole body inhalation study where 
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weak inflammation was observed (Fujita et al., 2009) is suggested for deriving 
a DNEL for chronic exposure. 
Identified studies suggest that fullerenes may not have an irritating potential to 
skin and eyes.  No conclusions can be made on the sensitising properties of 
fullerenes.  Further clarification concerning an irritating and sensitising poten-
tial of fullerenes is needed. 
No sub-chronic or chronic studies with fullerenes for any of the exposure 
routes have been identified. The main effects associated with fullerene toxicity 
as shown by in vitro and acute toxicity studies are inflammatory and oxidative 
responses as well as anti-inflammatory and anti-oxidant properties. Further 
studies should focus on the sublethal effects following subchronic/chronic ex-
posure via relevant exposure routes. For humans, relevant concentrations 
have to be determined based on a better operational exposure database. These 
studies should investigate the chronic effects of the observed inflammation. 
These effects could become more severe with prolonged period, there could, 
however, also be recovery of the organism. Prolonged inflammation could also 
lead to the release of factors which could induce systemic effects – however, 
there is no indication of that yet. 
Identified in vitro and in vivo mutagenicity /genotoxicity tests have reported 
contradicting results. Appropriate in vitro and in vivo studies should confirm 
the presence or absence of a mutagenic effect and the conditions influencing 
the test results. 
No information on carcinogenic effects of fullerenes has been identified and 
there are indications that fullerenes may have anti-tumorigenic effects which 
could be an indication that carcinogenicity is not an endpoint of concern for 
fullerenes. However, the identified information is not sufficient to reach this 
conclusion. The conclusion on whether carcinogenicity studies are needed is 
dependent on more information on toxicokinetic and mutagenicity. 
Effects on female reproductive organs and embryos have been shown under 
quite artificial conditions. This endpoint should be re-evaluated once more 
information on the absorption and subchronic/chronic effects become avail-
able.  
One important issue to be solved is the question regarding what drives the 
pro- and anti-oxidative and inflammatory properties of fullerenes, to estimate 
the hazard of different fullerene types and maybe allow for a grouping of them 
with regard to their toxicity.  
Full physicochemical characterisation is essential to allow comparisons be-
tween fullerene toxicity and a risk assessment should focus on the fullerene 
type and concentrations to which humans are exposed. 
 
3.6 Exposure scenarios 
For the use of C60 in sports gear (e.g. badminton and tennis rackets) the po-
tential exposure for both humans and the environment is expected to be very 
low during the use phase of the products. This is due to the fact the fullerenes 
are embedded in the products e.g. in a polymer. After disposal of the prod-
ucts, fullerenes may be released, but since nothing is known today about re-
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lease of nanomaterials during waste management operations (e.g. recycling, 
land filling, or incineration), exposure estimations cannot be made. 
The highest concentrations of C60 in cosmetics have been reported for eyeliner 
and mascara (5-6%), but C60 is also used in day and night creams due to its 
acclaimed effectiveness as an antioxidant (Boxall et al., 2008). In the case of 
facial creams used both night and day, Hansen et al. (2008) estimated a 
worst-case exposure of 26 µg/kg bw/d assuming a content of 0.1% of nanopar-
ticles, e.g. fullerenes. Though the concentrations in eyeliner and mascara are 
much higher than this, the amounts used are far lower. After use the facial 
creams etc. will be washed off and the content of fullerenes will be emitted to 
the wastewater treatment plant. Although the resulting concentrations are ex-
pected to be very low indeed, it should be noted that fullerenes are not readily 
biodegradable (Hartman et al., 2010 – submitted), but may end up in the 
sludges from the wastewater treatment plant after agglomeration and settling. 
Fullerenes may also be stabilized by the presence of natural organic matter 
and stay as colloids in the water phase (Stone et al., 2010). 
The use of C60 in motor oil makes exposure to both professionals and con-
sumers possible. Environmental emissions of C60 from motor oil can mainly be 
anticipated during filling and change of the oil. C60 may also adhere to metallic 
components of the car and may therefore have to be taken into account when 
the car is disposed of.  
Exposure to fullerenes will mainly occur via inhalation and the dermal route at 
the work place. 
The main exposure route for consumers is expected to be the dermal route via 
cosmetics and personal care products and chronic exposure might be ex-
pected. Oral exposure is expected to be low (except for potential usage for the 
treatment of cancer).   
The exposure via sports gear (badminton- and tennis rackets) is expected to 
be negligible.   
Based on current use levels, the human exposure via the environment is 
unlikely to be at detectable levels. However, this might increase in the future. 
For all exposure scenarios, quantitative assessment is hampered by the lack of 
data on amounts, sources, and purity of fullerenes. 
 
3.7 Risk profile 
3.7.1 Environment 
The ecotoxicity of bulk C60 fullerenes is at present very poorly documented. 
Only a few of the ecotoxicity studies have reported the results in terms of the 
endpoints and values listed in Information Requirements of REACH (ECHA, 
2008). 
In general, the acute toxicity of C60 seems to be low. However, a LC50, 48h-
value of 7.9 mg/L for water-sonicated C60 has been reported. This would lead 
to a classification of C60 as “Aquatic Chronic 2”. In longer-term exposure 
studies (32 d) with fish a NOEC of 0.04 mg/L and a LOEC of 0.2 mg/L for 
the length of juvenile carp has been found. 
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It must be stressed, that the ecotoxicological testing of C60 is difficult, due to 
the very low water solubility of the compound and further method develop-
ment may be needed. At present it seems clear, that ecotoxicological studies 
carried out with tetrahydrofuran as a solvent, do not have a high credibility 
and should not be used for hazard identification or risk assessment purposes. 
Based on a number of assumptions, Boxall et al. (2008) estimated regional 
concentrations of fullerenes in water to be in the order of 0.3 µg/L. While this 
might be used as a first estimation of PEC, it must be stressed that this esti-
mate is highly uncertain due to lack of data about the sources for fullerenes, 
amounts used, and the environmental transport and fate of fullerenes. 
As concluded by Stone et al. (2010) the poor ecotoxicity database for fullere-
nes implies that no reliable estimation of PNEC can be made. Given the qual-
ity of the present PEC estimates and the lack of suitable ecotoxicity data for 
PNEC estimation, a quantitative risk characterization of fullerenes cannot be 
made at present. 
3.7.2 Human health 
After oral exposure fullerenes showed very low toxicity and an acute NOAEL 
> 2000 mg/kg bw/d for fullerites and > 2500 mg/kg bw/d for polyalkylsul-
fonated C60 was suggested.  
There is limited absorption of pristine fullerenes from the gut, and therefore 
no toxicity may be expected after oral exposure. However, functionalised 
fullerenes with a higher solubility may behave differently. 
Since no oral exposure estimates are known no quantitative risk estimates can 
be performed but qualitatively very low risk via this exposure route is ex-
pected. 
A potential risk for consumers could arise from dermal exposure to skin 
creams due to their direct application and potential widespread use. However, 
no toxicity data on dermal effects has been identified, that could be used to 
derive a human NOAEL. Therefore no quantitative risk assessment is possi-
ble. However, based on the current available information the risk is expected 
to be rather low.  
Based on the assumption that the toxic effect of fullerenes is thresholded, a 
human indicative no-effect level (INEL) was derived (Stone et al., 2010 and 
Aschberger et al., 2010) for inhalation. The key study used for this assump-
tion (Baker et al., 2008) is not a guideline study and was not performed for 
the purpose of risk assessment; therefore a proper DNEL cannot be derived.  
A NOAC of 2.22 mg/m3 C60 was derived based on absence of inflammation in 
rats. This NOAC was modified according to ECHA (2008). A corrected 
NOAC for the general public (24 h exposure via inhalation from air pollu-
tion) and an INELchronic general public= 1.9 µ/m
3 was derived.  
No data have been found, that have shown adverse health effects towards 
fullerenes in consumer products. Although data from the present use in con-
sumer products indicate a low potential for risk towards human health the 
data gaps with regard to toxicological properties as well as to exposure have to 
be acknowledged. Thus complete toxiciolgical data sets on 'pure' fullerenes as 
well as on the various functionalised fullerenes are still lacking. Furthermore, 
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more precise knowledge about consumer exposure is necessary in order to be 
able to make a more detailed risk assessment of fullerenes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.8 Summary sheet for C60 
Nanomaterial characteristics  
Name Fullerene 
CAS number 99685-96-8 
Chemical composition C60 
Appearance Black powder 
 
(Source: Wikipedia) 
Manufacturing proc-
esses 
Controlled combustion of hydrocarbons (e.g. toluene) followed by sol-
vent extraction.   
Nanomaterial description  
C60-fullerene is soccer-ball shaped molecule with 60 carbon atoms arranged in a cage closed struc-
ture. The size of a fullerene is approximately 1 nm. C60-fullerenes are extremely stable and have a 
tendency to agglomerate and form clusters of crystals when dispersed in water (nC60). C60 can be 
surface modified making it more water soluble and thereby provide them with a great variation in 
their physico-chemical properties as well as biological activity (Stone et al., 2010). 
Applications   
C60 has been applied in a number of different consumer products such as sports gear (badminton- 
and tennis rackets), cosmetics and personal care products (anti-aging, eyeliner, skin creams, etc.) 
and even lubricants (motor oil). The C60 content of e.g. sports gear is unknown. The content in 
motor oil is estimated at 3 g/kg (Franco et al., 2007). For cosmetics contents between 0.05 and 
6% are reported. Concentrations used are the highest for eyeliner and mascara with 6% and 5%, 
respectively (Boxall et al., 2008). The world-wide scale of use and production of C60 is unknown at 
this point in time.  
Human health risk profile   
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Fullerenes exist in a variety of forms (carbon atom number, surface modifications, aggregations 
states, etc) and it is difficult to make generalisation about their toxic behaviour.    
So far it has been shown that one of the main factors for differences in fullerene toxicity seems to 
be the water solubility with fullerenes of greater water solubility being less toxic.   
Fullerenes are assumed not to be effectively absorbed and to remain at the deposition site (mainly 
lung and gut).  A small amount may be absorbed through the gut wall.  The absorption via the skin 
is dependent on the fullerene type (functionallisation), the solvent/dispersant used and on skin 
properties, but the dermal absorption is generally assumed to be low. Fullerenes seem to have a 
very low toxicity after oral exposure and an acute NOAEL of 2000 mg/kg bw/day. 
Following exposure via the pulmonary route fullerenes were able to induce pro- or anti-
inflammatory responses with the factors driving these effects still unknown.  An acute NOAEC of 
2.22 mg/m3 for acute inhalation is suggested as no inflammatory potential was seen at this con-
centration.  
Identified studies suggest that fullerenes may not have an irritating potential to skin and eyes.  No 
conclusions can be made on the sensitising properties of fullerenes.  Further clarification concern-
ing an irritating and sensitising potential of fullerenes is needed. 
No sub-chronic or chronic studies with fullerenes for any of the exposure routes have been identi-
fied.  The main effects associated with fullerene toxicity as shown by in vitro and acute toxicity 
studies are inflammatory and oxidative responses as well as anti-inflammatory and anti-oxidant 
properties. 
Identified in vitro and in vivo mutagenicity /genotoxicity tests have reported contradicting results.  
Appropriate in vitro and in vivo studies should confirm the presence or absence of a mutagenic 
effect and the conditions influencing the test results. 
No information on carcinogenic effects of fullerenes has been identified and there are indications 
that fullerenes may have anti-tumorigenic effects which could be an indication that carcinogenicity 
is not an endpoint of concern for fullerenes.  However, the identified information is not sufficient 
to reach this conclusion. The conclusion on whether carcinogenicity studies are needed is depend-
ent on more information on toxicokinetic and mutagenicity  
Effects on female reproductive organs and embryos have been shown under quite artificial condi-
tions.  This endpoint should be re-evaluated once more information on the absorption and sub-
chronic/chronic effects become available.  
Full physicochemical characterisation is essential to allow comparisons between fullerene toxicity 
and a risk assessment should focus on the fullerene type and concentrations to which humans are 
exposed. 
With regard to the human health risk there is little information available with regard to the 
amounts of nano C60  used in different product types and thereby the extent of the exposure. 
Environmental risk profile   
In general the acute ecotoxicity of C60  seems to be low, however, a LC50, 48h-value of 7.9 mg/L 
has been reported. This would rank C60  as “Aquatic Chronic 2”. In longer-term exposure studies 
(32 d) with fish a NOEC of 0.04 mg/L and a LOEC of 0.2 mg/L for the length of juvenile carp has 
been found. Ecotoxicological testing of C60 is difficult due to the very low water solubility of the 
compound and further method development may be needed. Tests performed using organic sol-
vents do not have a high credibility and should not be used for hazard identification or risk as-
sessment purposes. 
Boxall et al. (2008) estimated regional concentrations of fullerenes in water to be in the order of 
0.3 µg/L. This estimate of the predicted environmental concentration (PEC) is highly uncertain due 
to lack of data about the sources for fullerenes, amounts used, and the environmental transport 
and fate of fullerenes. 
As concluded by Stone et al. (2010) the poor ecotoxicity database for fullerenes implies that no 
reliable estimation of predicted no-effect concentration (PNEC) can be made. Given the quality of 
the present PEC estimates and the lack of suitable ecotoxicity data for PNEC estimation, a quanti-
tative risk characterization of fullerenes cannot be made at present. 
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4 Titanium dioxide - TiO2 
4.1 General characteristics 
Titanium dioxide is the naturally occurring oxide of titanium. Often a distinc-
tion is made by TiO2 manufacturers between pigmentary grade and ultrafine 
grade. The primary crystal size typically range from 150 to 300 nm for TiO2 
of a pigmentary grade and the surface area typically ranges from 6 to 60 m2/g 
(coated and uncoated). The ultrafine grade typically has a primary crystal size 
from 10 to 150 nm, and a surface area of between 50 to 200 m2/g (coated and 
uncoated). The pigmentary TiO2 has a white colour and is therefore widely 
used in paints etc. The ultrafine TiO2 including nano-sized TiO2 is transpar-
ent. A number of different crystal structures of TiO2 exist of which the rutile 
and anatase forms of TiO2 are the most important in relation to the use of 
TiO2 in consumer products. Nano-scale TiO2 particles have various forms 
and shapes and may be cicular (non-spherical) or approaching spherical 
forms. Nano-scale TiO2 may furthermore display complex and various ag-
glomeration structures. In contrast to the bulk TiO2 (>100 nm) that is consid-
ered chemically inert, nano-scale TiO2 can act as a photo-catalyst, that can 
generate reactive oxygen species upon illumination. Both UV-light and visible 
light can induce the catalytic activity of TiO2 and the anatase crystal form is a 
more efficient photocatalyst than the rutile form. The fotocatalytic effects can 
be avoided by surface treatment e.g. doping with other metals. Although nor-
mally considered to be insoluble material, it can be made water dispersible by 
applying certain surface treatments. In dry form, TiO2 nanomaterials will 
tend to agglomerate due to interaction of the particle surfaces, but the degree 
of agglomeration is depending on the specific surface treatment, relative hu-
midity, sample aging, etc. (ED & DuPont, 2007). 
 
4.2  Manufacturing processes 
A large number of manufacturing processes exist for the ultrafine grade, many 
of which use either titanium tetrachloride or titanyl sulfate as starting material. 
These processes include precipitation, thermal hydrolysis and flame hydroly-
sis. For the ultrafine grade, the crystal may be further processed involving 
milling, then coating and milling again.  Depending on the medium relevant 
to the application for marketing, a possible last dispersion step (with water / 
cosmetic oils) can be applied, for example for UV attenuation dispersion 
grades. If no further dispersion is carried out, the products obtained are UV 
attenuation powder grades. Both fine and ultrafine TiO2 may be surface 
treated to increase their applicability in products, e.g. to ensure a uniform dis-
tribution in sunscreens or to optimize UV-absorption properties.  
 
4.3 Uses 
4.3.1 Main applications 
TiO2 is one of the most widely used chemicals in the world. As the bulk form 
of the substance often contains a nano-sized fraction, nano- TiO2 has been 
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used for many years for different applications, without being identified as 
nano.  
A wide range of applications exists, exploiting the various properties of TiO2 
nanomaterials. The ability to scatter light can be manipulated by changing the 
size of TiO2 nanomaterials. Hence pigmentary TiO2 has been optimised for 
visible light, which is applicable in white opaque paints, whereas ultrafine 
TiO2 has been optimised for UV absorption and used in sunscreens. The abil-
ity of TiO2 to absorb UV radiation can be manipulated through surface treat-
ment which is applicable to degradation of pollutants (NOx or dirt) or protec-
tion of paint films and polymers from degradation from other chemical spe-
cies (ED & DuPont, 2007). Thus, nano-scale TiO2 is widely used in sun-
screens and cosmetics due to the UV-absorption of the material. 
In paints and for water treatment, nano-scale TiO2 is used as a photo-catalyst 
producing reactive oxygen that may degrade other organics. According to ED 
& DuPont (2007) the rutile form of nano-TiO2 is most often used in applica-
tions where low interaction with the surrounding matrix is desired, whereas 
untreated anatase nano-TiO2 is most often used in photocatalyst applications.  
A number of other and very diverse areas of application exist, such as oint-
ments, toothpaste, catalysts, catalyst supports, adsorbents, delustrants, semi-
conductors, etc. In total 21 products have been identified to be commercially 
available on the Danish marked through searches in the Woodrow Wilson In-
stitute database. Most of these products fall into the category of 'Health and 
fitness'. In the category of 'Health and fitness' nano-TiO2 is mostly used in 
sunscreens (5), personal care products (4) and sporting goods (2), however, it 
must be stressed that these numbers are expected to underestimate the actual 
number of products in use in Denmark, since non-internet retailers are not 
included in the Woodrow Wilson Institute database. Thus, the number of 
sunscreen products and paints containing nano-TiO2 is expected to be higher 
than what the searches in the Woodrow Wilson Institute data base suggests. 
However, this can not be quantified, since the producers are not obliged to 
declare whether or not their products contain nanoparticles. 
While TiO2 rank as one of the most used chemicals world-wide (mainly as a 
pigment), the tonnages of nano-scale TiO2 used nationally, in the EU or 
worldwide can at present not be estimated. This is due to the fact that no spe-
cific inventories for nanomaterials exist. However, it should be mentioned, 
that in some consumer products, e.g. sunscreens, the percentage of nano-
TiO2 may constitute several percent of the product (Barker & Branch, 2008; 
Hansen et al., 2008). TiO2 (E171), which may contain nano-scale TiO2, is 
used for whitening and brightening food, especially for confectionary, white 
sauces and dressings and certain powdered foods. TiO2 is also used in the 
pharmaceutical industry as and opacity agent. 
It has been estimated, that in UK the dietary intake of TiO2 (non-nano + 
nano) is 5 mg/person per day (Powell et al, 2010).Given the range of possible 
applications of nano-scale TiO2 especially within photocatalysis (e.g. for self-
cleaning surfaces and water treatment), the use of nanoTiO2 is anticipated to 
increase significantly in the near future.  
4.3.2 Results from industry survey 
The survey on TiO2 has been focused on the use of TiO2 as a pigment. TiO2 
is known to be widely used as a white pigment in paint, plastics, mortar, ce-
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ment, toothpaste, cosmetics and in most other cases, where a white pigment is 
needed. TiO2 is, however, also used in combination with other pigments to 
obtain different shades of e.g. grey, green etc.   
The concentration of TiO2 differs depending on the material in question and 
the colour strength required. In paint the concentration of pigments will typi-
cally be in the range of 0.1-10% (Environmental project No. 1206, 2007).  
The consumption of TiO2 in Denmark may be roughly estimated to be above 
1000 tons/year. An import of pigments and preparations containing TiO2 of 
about 1800 tonnes to Denmark was registered for 2009 2.  
 
4.4 Eco-toxicological profile 
While bulk-scale TiO2 is generally believed to be inert and not expected to be 
hazardous to the environment, nano-scale TiO2 concerns have been raised, 
since novel properties at the nano-scale, e.g. photo-catalytic activity, may 
change the hazard profile of TiO2. 
The ecotoxicological profile of nano-scale titaniumdioxide (TiO2NP) is build 
upon original research papers, but it should be stressed that only a few 
ecotoxicological studies exist and that none of these have been aimed at verifi-
cation/reproducing the effects found. Thus, it is still unknown whether the 
patterns observed for the ecotoxicity of TiO2NP later on will be proven to be 
single events.  
For fish there are strong indications that even though the acute toxicity of 
TiO2 nanoparticles is low, effects are observed in the more detailed studies 
focussed at gills, brain, and intestine (Federici et al., 2007; Ramsden et al., 
2009). This implies that other endpoints than the traditionally used ones may 
be relevant for nanoparticles.  
For crustaceans, TiO2NP has been found to show both acute and long-term 
toxicity as indicated by the values reported by Zhu et al. (2010): LC50, 72h, of 
2.02 mg/L and EC50, 21d (survival of offspring) of 0.46 mg/L. This would 
correspond to a classification in the hazard class “hazardous to the aquatic 
environment” according to the CLP3. However, it should be emphasized that 
the results of Zhu et al. (2010) are in contrast to other studies that have found 
LC50 values of around 2000 mg/L (Heinlaan et al., 2008) and >10 mg/L 
(Griffitt et al., 2008) and a 40% mortality at the 20 mg/L (Adams et al., 
2006). In a 21-day study using Daphnia magna and 40 nm TiO2NP, Kim et 
al. (2010) found a significantly increased mortality at concentrations of 5 and 
10 mg/L, but no reduction of the reproduction ability was observed. Kim et al. 
(2010) suggest that oxidative stress in D. magna due to reactive oxygen spe-
cies may explain the TiO2NP toxicity. At present the large spread in the re-
ported data makes it impossible to make a definitive conclusion on the toxicity 
of TiO2NP on crustaceans. 
For algae, the lowest EC50, 72h, for TiO2 nanoparticles is 5.83 mg/L (Arouja 
et al., 2008) and this study also found that TiO2NP were more toxic than the 
                                                          
2 Danmarks Statistik, 2010 
3 REGULATION (EC) No 1272/2008 OF THE EUROPEAN PARLIAMENT 
AND OF THE COUNCIL of 16 December 2008 on classification, labelling and 
packaging of substances and mixtures, amending and repealing Directives 
67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 
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corresponding bulk particles (EC50, 72h, estimated to 35.9 mg/L). NOEC of 
the bulk materials was found to be 10.1 mg/L for bulk TiO2as compared to 
0.98 mg/L for TiO2NP (Aruoja et al. 2008). However, the low effect values 
found by Arouja et al. (2008) and Wang et al. (2008) may not be reliable, 
considering the experimental challenges in the algal test as described by 
Hartmann et al. (2010). It seems unlikely that Arouja et al. (2008) did not en-
counter the same kind of problems with reproducibility and agglomeration 
during testing using uncoated TiO2 particles. Therefore, it is recommended 
that the lowest of the values found by Hartmann et al. (2010) is used in haz-
ard assessment of TiO2NP, i.e. the EC50, 72h of 71.1 mg/L. 
So far only three studies of bioaccumulation of TiO2 has been published. Zhu 
et al. (2010) found that 21 nm TiO2 nanoparticles were accumulating in D. 
magna and that it was increasing exposure time. Due to a relatively slow 
elimination of TiO2 from D. magna the authors report very high BCF values 
(>10,000) based on concentrations in daphnids versus water phase concen-
trations (Zhu et al., 2010). However, by calculating BCF values from the up-
take and depuration rates, BCF values <100 can be estimated. In fish, Ram-
den et al. (2010) found Ti-accumulation in the gill, gut, liver, brain and spleen 
of rainbow trout (Oncorhynchus mykiss) after 8 weeks of dietary exposure to 
10 or 100 mg/kg bw TiO2 nanoparticles. In some of these organs, especially 
the brain, no clearance of Ti occurred after exposure. No estimations of BCF 
were made in this study. After intravenous injection of TiO2 nanoparticles in 
Rainbow trout (Oncorhynchus mykiss), Scown et al. (2010) found increased 
levels of Ti in the kidneys and the Ti remained there for up to 21 days. Evi-
dence of clearance was, however, noted after 90 days. Ti accumulation in the 
liver was 15 times lower than in the kidney, but no apparent clearance took 
place in the liver. 
By definition metal oxide nanoparticles are not degradable and speciation of 
TiO2 (e.g. dissociation or complexation) is not likely to occur in aquatic media 
under normal conditions. Therefore, TiO2 particles (both bulk and NP) can 
be regarded as persistent in the sense that the particles will remain TiO2-
particles, however a number of factors may influence the particle size and also 
the resulting bioavailability in aquatic media (Hartmann et al., 2010).  
 
4.5 Toxicological profile 
Due to its widespread exploitation, a great number of studies have focussed 
on revealing the toxicity of titanium dioxide (TiO2). Such studies have ad-
dressed the consequences of exposure via a number of routes. TiO2 (bulk 
form) exposure via the pulmonary route has included the use as a control par-
ticulate compared to pathogenic materials such as alpha-quartz, but has also 
been studied in relation to occupational exposures. Dermal penetration and 
toxicity of TiO2 particles have also formed the focus of a number of studies 
due to their inclusion within sunscreens and cosmetic products. In a few stud-
ies toxicity was investigated after intraperitoneal and oral exposure. Humans 
are exposed orally to high concentrations of TiO2 particles via food. The 
toxicological evaluation of TiO2 is mainly quoted from ENHRES (Stone et al., 
2010). In addition the following reviews were used; IARC, NIOSH (2005) 
and Jelnes et al., (1997). 
As mentioned earlier, bulk TiO2 is considered chemically inert and of low tox-
icity. Adverse lung effects associated with TiO2 are primarily a result of a gen-
eral particle overload more than a specific toxic effect of TiO2. In relation to 
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nano-scale TiO2 it is therefore of particular interest to evaluate if the nano-
forms have specific toxic properties.  
4.5.1 ADME studies 
It is necessary to consider the potential for particle absorption from the site of 
exposure into the blood, as this will dictate their systemic availability and dis-
tribution within the body.   
Absorption and distribution 
No studies were identified investigating systemic absorption after exposure via 
inhalation of TiO2 nanoparticles. Many studies were performed on toxicity 
after inhalation, but the issue on systemic absorption has not been reported. 
There is evidence of pulmonary retention of TiO2 nanoparticles after expo-
sure via inhalation (Ferin et al., 1992 and Bermudez et al., 2004). Wang et al. 
(2008a and 2008b) illustrated the transfer of TiO2 nanoparticles to the brain, 
following intranasal exposure, which occurred via their transport within neu-
rones.   
TiO2 nanoparticles were observed to translocate into the blood, following oral 
exposure, and thereafter distribute to secondary targets, including the liver, 
spleen, lungs, and kidneys (Wang et al., 2007, 2008).  However, it is not pos-
sible to evaluate the degree of absorption based on the data available. 
Studies investigating dermal exposure of TiO2 in vivo (humans) and in vitro 
(porcine and human skin) suggest that penetration of nanoparticles past the 
stratum corneum is negligible, and therefore it is unlikely that the particles will 
access the circulation via this route for intact skin, whereas more knowledge 
has to be gained on damaged skin (Stone et al., 2010).    
Metabolism and elimination 
No evidence of TiO2 metabolism or elimination from the body could be iden-
tified in the literature at this time. 
4.5.2 Short term toxicity 
Acute inhalation toxicity  
In several studies there is clear evidence that nano-sized TiO2 is considerably 
more toxic than microsized TiO2 ( Ferin et al., 1992; Renwick et al., 2004; 
Chen et al. 2006; Inooue et al. 2008).  In addition, it was found that the crys-
tallinity (or the specific crystal form) of TiO2 nanoparticles is thought to influ-
ence the toxicity, with the anatase form expected to be more toxic than the 
rutile form (Warheit et al., 2007). The pulmonary response to TiO2 is in-
flammation (Ferin et al., 1992; Chen et al., 2006; Warheit et al., 2005; War-
heit et al., 2007; Inoue et al., 2008; Renwick et al., 2004; Grassian et al., 
2007), epithelial damage, increased permeability of the lung epithelium, oxi-
dative stress and cytotoxicity (Renwick et al., 2004), and morphological al-
teration within the lung (Chen et al., 2006). In the Renwick et al. study (2004) 
no toxicity was observed at 125 µg per rat corresponding to 0.5 µg/kg bw, as-
suming a rat body weight of 250 g whereas toxicity (inflammation and histo-
logical changes in the lung) was seen at 500 µg per rat (particle size 29 nm). A 
NOAEL for toxicity of 0.5 µg/kg bw was proposed by Stone et al. (2010). 
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Chen et al. (2006) exposed mice, via intratracheal instillation (0.1 and 0.5 mg 
per mouse), to nano (19-21 nm) and micro (180-250 nm) forms of TiO2 and 
determined their pulmonary toxicity 3 days, 1 week or 2 weeks post exposure. 
In mice exposed to TiO2 particles (size 19-21 nm) toxicity (inflammation and 
histological changes in the lung) was observed at the lowest dose of 100 μg 
per mouse (Chen et al., 2006). Despite the huge doses used, no pathological 
lesions were found in response to microparticulate TiO2. 
Acute dermal toxicity 
The impact of TiO2 exposure on the skin is especially relevant due to the in-
clusion of such particles within sunscreens and cosmetics that are directly ap-
plied to skin.   
In relation to acute dermal toxicity, no in vivo studies have been identified. 
However, Kiss et al. (2008) and Jin et al. (2008) (as cited by Stone et al., 
2010) have shown that TiO2 nanoparticles may affect different cell lines in 
vitro.  
The findings from the available studies demonstrated that the penetration of 
microsized-TiO2 is negligible within the “healthy” skin.  However, sunscreens 
are often applied to burnt, damaged and diseased skin, where the barrier func-
tion of the stratum corneum will inevitably be impaired (Borm et al., 2006; 
Kiss et al., 2008) (as cited by Stone et al., 2010), which should be taken into 
consideration in future studies. 
Acute oral toxicity 
Although high human exposure via the oral route has been estimated (Powell 
et al., 2010) only one study could be identified that investigated acute oral ex-
posure to TiO2. Wang et al. (2007) investigated the distribution and acute 
toxicity of nanoparticulate (25 and 80 nm) and microparticulate (155 nm) 
forms of TiO2 following the oral exposure (5 g/kg bw) in mice. TiO2 particles 
of all sizes were distributed to the liver, spleen, lungs, kidneys, thus providing 
evidence that they could be transported to other sites subsequent to exposure, 
due to their translocation into the blood. The primary target organ for 
nanoparticles was the liver (an inflammatory response was detected). Markers 
of cardiac damage were also observed to be elevated by TiO2 nanoparticles. 
Microparticulate TiO2 induced limited toxicity.  
Acute intraperitoneally toxicity  
The only study that used intraperitoneal injection (Chen et al., 2008) investi-
gated the acute toxicity of TiO2 nanoparticles (80-100 nm) subsequent to in-
traperitoneal injection in mice. The doses used were exceptionally high (rang-
ing from 324 to 2592 mg/kg), and it is therefore not surprising that mortality 
was associated with exposure. Furthermore, TiO2 was observed to block pul-
monary vessels, leading to thrombosis, with pathology also evident within the 
liver, spleen and kidneys. This study highlights the need to consider the use of 
relevant doses of particles, as the observed effects derived from the high dose 
and not the inherent toxicity of particles.   
4.5.3 Irritation and corrosion 
No studies specifically investigating irritation (dermal, eye and inhalation) 
have been identified. However, as TiO2 nanoparticles are used widely in sun 
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creams, they are not expected to be irritating to the skin. It is also not ex-
pected that these nanoparticles are irritating following inhalation. 
 
4.5.4 Skin and respiratory sensitization (in vitro and in vivo) 
No studies specifically investigating sensitization (dermal, eye and inhalation) 
have been identified. However, as TiO2 nanoparticles are used widely in sun 
creams, they are not expected to be sensitizing to the skin. It is also not ex-
pected that these nanoparticles are sensitizing following inhalation. 
 
4.5.5 Repeated dose toxicity, short term, sub-chronic and long term 
Repeated dose: inhalation 
The greatest number of studies on TiO2 by far address the consequences of 
the exposure of the lungs, and in particular the size dependence of any effects. 
The studies performed on pulmonary exposure of TiO2 shows that the toxic-
ity primarily was dictated by particle size, and crystal structure; whereby de-
creasing particle size, and anatase forms of TiO2 enhanced particle toxicity.  
In a 12 week inhalation study Ferin et al. (1992) (as cited by Stone et al, 
2010) showed that  TiO2 nanoparticles caused a pulmonary inflammation in 
rats, which micro-TiO2 (250 nm) did not at the same dose levels (thus con-
firming the potency of TiO2 nanoparticles as discussed within the short term 
toxicity section). 
In addition, it is suggested that the exposure scenario (including species used, 
exposure method and dose administered) can impact on the toxicity of TiO2 
and other metal oxides. It has been shown in a 13 weeks (6 hours per day, 5 
days per week, 21 nm particles) inhalation study that rats are more sensitive 
than mice and much more sensitive than hamsters Bermudez et al. (2004). As 
the rat is the most sensitive species it was used for risk assessment in the EN-
RESH report. From this study a No Observed Adverse Effect Concentration 
(NOAEC) of 0.5 mg/m3 (500 μg/m3) was identified. 
It has been shown in a 30 days study that both rutile and anatase TiO2 
nanoparticles after nasal installation of 500 µg/mouse every other day for a 
total of 30 days can bypass the blood brain barrier and be translocated (via the 
olfactory nerve) to the brain, where they accumulated within the cerebral cor-
tex, thalamus and hippocampus (main target). This resulted in morphological 
alterations and loss of neurones in the hippocampus, induction of oxidative 
stress and initiation of inflammation (Wang et al., 2008a, 2008b). 
After chronic exposure (2 years) of rats to TiO2 nanoparticles, at an average 
exposure concentration of 10 mg/ m3, lung tumours were observed. However, 
the relevance of these data for risk assessment purposes are dubious due to the 
very high doses used (average exposure concentration of 10 mg/m3), and the 
high mortality: 60% after 24 months (control 40%) and 90% after 130 weeks 
(control 85%) (Heinrich et al., 1995).  
Repeated dermal dose 
No studies related to repeated dose toxicity via the dermal route were avail-
able 
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Repeated oral dose 
No studies related to repeated dose toxicity via the oral route were available 
4.5.6  Mutagenicity/genotoxicity 
There is little information available concerning in vivo genotoxicity of nano 
TiO2. Driscoll et al. (1997) investigated the mutagenic effect at the hprt locus 
in rat alveolar epithelial cells after intratracheal installation of anatase TiO2 
(median diameter = 180 nm). TiO2 induced mutations at 100 mg/kg bw but 
not at 10 mg/kg bw. The potency of TiO2 was compared with α-quarts par-
ticles (mean diameter = 900 nm) and carbon (mean diameter = 15 nm). Α-
quarts was the most potent followed by cabon black and TiO2 being the less 
potent. All particles induced a neutrophilic inflammatory respond which cor-
related with the relative genotoxic potency of the different materials. These 
findings indicate that inflammation may play a key role of the in vivo 
genotoxic effect of insoluble particles, supporting a non-linear (thresholded) 
relationship between particle exposure and mutagenicity. 
In a recent paper Trouiller et al. (2009) investigated the genotoxicity, oxida-
tive DNA damage and inflammation of nano-TiO2 in an in vivo study in mice. 
The crystal structure was a mixture of 75% anatase and 25% rutile TiO2 with 
a particle size of 21 nm. Male mice were dosed for 5 days in the drinking wa-
ter with doses corresponding to 0, 50, 100 250 and 500 mg/kg bw. Pregnant 
dams were dosed in drinking water with 500 mg/kg bw for 10 days at gesta-
tion days 8.5 to 18.5 post-coitum. In male mice, nano-TiO2 induced DNA 
single strand breaks measured by the comet assay at the highest dose tested 
(500 mg/kg/bw) and micronuclei in peripheral blood. DNA double strand 
breaks (DBS) was measures by λ-H2AX immunostaining assay in bone mar-
row, which was the most sensitive of the assays involved, and showed an in-
crease in DBS in a dose dependent manner. Oxidative DNA damage (8-
OHdG) was measured in the liver at the highest dose tested, and a proin-
flammatory response, measured as changes in cytokine expression, was seen 
in peripheral blood. In utero exposure of fetuses via the mother caused an in-
crease in large deletions in offspring.  
This in vivo study show that the investigated nano-TiO2 administrated orally 
is systemically distributed to different tissues such as blood, bone marrow, 
liver and even the embryo, where it can induce genotoxicity at relatively high 
exposure levels. The inflammatory response and oxidative damage in liver 
indicate that the mechanism behind the observed genotoxicty may be due to a 
secondary response following inflammation and oxidative stress. 
Although the genotoxic effect observed after oral exposure might be thresh-
olded, concern is raised due to its carcinogenic potential following chronic 
exposure (Heinrich et al., 1995), and because of the potential to induce ge-
netic disorders in the offspring as indicated by Trouiller et al. (2009). 
No in vitro genotoxicity/mutagenicity studies were identified using the classi-
cal tests used in regulatory settings. However, some evidence of genotoxicity 
has been encountered within a number of in vitro studies. 
Rahman et al. (2002) (as cited by Stone et al., 2010) investigated the potential 
for TiO2 to elicit chromosomal aberrations in SHE fibroblasts. Micronuclei 
were evident within cells exposed to nano (<20 nm), but not micro (>200 
nm) TiO2 particles (up to 10 µg/cm
2, for up to 72 hours). The nanoparticles 
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also triggered the induction of apoptosis within cells, which is recognised as a 
common response to DNA damage.  
It was shown by Karlsson et al. (2008) (as cited by Stone et al., 2010) that 
TiO2 nanoparticles were able to elicit DNA damage, as determined by the 
Comet assay in A549 lung epithelial cells.   
Nakagawa et al. (1997) investigated the genotoxicity of TiO2 nanoparticles (in 
rutile and anatase forms) in the absence or presence of UV light. Without UV 
light, TiO2 nanoparticles induced no, or very limited genotoxicity. However, 
in the presence of UV light, TiO2 elicited DNA damage and chromosome ab-
errations (but no gene mutations). The type of cells used for the test is not 
mentioned. The genotoxic effect of TiO2 seems to be influenced by the crys-
talline form with the anatase form being more potent that the rutile form.   
The UV dependence of the genotoxic potential of TiO2 nanoparticles (in 
rutile and anatase forms) was also investigated by Theogaraj et al. (2007). In 
contrast to the previously discussed investigations, no chromosomal altera-
tions were observed within CHO cells, either in the presence or absence of 
UV light.   
The genotoxicty of TiO2 nanoparticles is thought to be driven by particle me-
diated ROS production. The particles themselves are not thought to be inher-
ently genotoxic, but may trigger genotoxicity via an indirect threshold driven 
inflammatory mechanism involving oxidative stress and in particular neutro-
phil presence (Driscoll et al., 1997). 
4.5.7 Carcinogenicity 
Only one study on carcinogenicity was identified (Heinrich et al., 1995) and is 
described under repeated dose toxicity above. In this chronic inhalation study 
very high doses were used, and the study had a long duration, resulting in 
high death, also in the control group.   
 
Based on this data, NIOSH (2005) concluded, that TiO2 is carcinogenic in 
rats and that it cannot be excluded as carcinogenic in humans. It is expected 
that carcinogenicity occurs following pulmonary particle overload and thus 
has a threshold and that the effects are considered to be caused by the particle 
exposure rather than the specific chemical substance. The International 
Agency for Research on Cancer have assessed TiO2 (even the microform – if 
exposure is high enough) to be a Class 2B carcinogen (Possibly carcinogenic 
to humans) (IARC 2006).  
 
4.5.8 Reproductive toxicity, developmental toxicity and teratogenicity 
Evaluation of metal oxide nanoparticle effects on the reproductive system is 
limited to a small number of in vitro studies.  
Komatsu et al. (2008) determined the potential for TiO2 nanoparticles, diesel 
exhaust particles and ultrafine carbon black to impair the male mouse repro-
ductive system. This study evaluated the direct effect of nanoparticles on tes-
tis-constituent cells, and examined the effect of TiO2 on mouse Leydig TM3 
cells, the testosterone-producing cells of the testis. TiO2 was more cytotoxic to 
Leydig cells than the other carbon based particles used in the study.  The pro-
liferation of Leydig cells was suppressed transiently by treatment with TiO2. 
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TiO2 nanoparticles were taken up by Leydig cells, and in turn affected cell 
viability, proliferation and gene expression. 
No literature examining nanoparticle effects on organs or cell types in the fe-
male reproductive system were found.  
4.5.9 Summary  
The bulk (microsized) form of TiO2 is generally regarded as relatively inert, 
with a low toxic potential (Jelnes, 1997). 
However, in several studies there is clear evidence that nano-sized TiO2 is 
more toxic than micro-sized TiO2. First of all nano-sized TiO2 is absorbed 
from the gastrointestinal tract and distributed to secondary target organs, 
whereas microsized TiO2 is not absorbed via this exposure route (Jelnes, 
1997). It has been consistent within a wide range of investigations that the 
acute toxicity increases as particle size decreases. In addition the toxicity is 
dependent on the structure of the particles, with the anatase form being most 
toxic. The toxicity of TiO2 nano-particles has been demonstrated to be in-
flammation, induction of oxidative stress, and histological changes in the tar-
get organs. The primary target organ after inhalation is the lung. It is assumed 
(Stone et al., 2010) that the NOAEC is somewhere between 0.5 to 2 mg/m3. A 
few studies indicate the liver is the primary target organ after oral exposure, 
and that TiO2 exposure also may be related to cardiac damage.  
There is indication from in vitro studies that nano-sized TiO2 but not micro-
sized TiO2 is genotoxic, and that the genotoxic response is caused by oxida-
tive stress, assuming a thresholded mechanism.  
The genotoxic effect of in vitro of TiO2 has been confirmed in two in vivo 
studies, which also indicate that genotoxicity is due to inflammation and oxi-
dative stress.  
Although the genotoxic effect observed after oral exposure might be thresh-
olded, concern is raised due to its carcinogenic potential following chronic 
exposure (Heinrich et al., 1995), and because of the potential to induce ge-
netic disorders in the offspring as indicated by Trouiller et al. (2009). 
The inflammogenic, oxidative and indirect genotoxic effects of nano-sized 
TiO2 are considered to be inherently linked.  
Future needs for research 
Although nano-sized TiO2 is one of the most well investigated nano sub-
stances, several data gaps still exist in relation to toxicological evaluation.  
None of the studies performed and reviewed in this survey is in accordance 
with the requirements in international accepted guidelines for toxicity testing 
accepted for regulatory purposes. The responses observed within a few stud-
ies were measured following relatively high exposure doses.  In order to clarify 
whether the observed effects, e.g. carcinogenicity, is of biological relevance, 
further studies following international accepted guidelines are needed. This is 
especially important because nano-sized TiO2 has shown genotoxic potential 
in vivo in different organs and even in the fetus after exposure of the mother. 
Therefore relevant reproductive studies are also needed. 
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For the TiO2 samples, variations in crystalline structure suggest that it might 
be difficult to compare across studies and to generate an overall conclusion. 
Clearer characterisation of the particles used is required within studies in or-
der to identify the attributes of TiO2 that are most influential in driving toxic-
ity.  
It can also be suggested that systemic responses following pulmonary expo-
sure are possible. However, this would require further investigations, which 
could also focus on determining the factors responsible for such a response, if 
the particles cannot directly access the circulation. In addition, the neuronal 
transport of nanoparticles has been demonstrated, which offers a potential 
route for nanoparticle distribution within the body, and enables them to by-
pass the blood brain barrier, and thereby access the brain. Further studies for 
examining the consequences of this exposure route are needed to put these 
potential CNS effects in a risk assessment perspective.  
Studies have mainly focused on dermal and pulmonary toxicity of particles, 
but there is an absence of data on the consequences of exposure to dam-
aged/diseased skin, and few data are available on toxicity after oral exposure. 
Thus further data is needed. Studies on other relevant target organs include 
the liver, kidney, cardiovascular system and brain which are necessary due to 
the fact that nanoparticles are likely to become systemically or neuronally 
available. The liver could be highlighted as a priority due to the propensity of 
particles to accumulate in this organ. 
 
4.6 Exposure scenarios 
For consumers the highest direct exposure to nano-scale TiO2 is expected to 
be through the use of sunscreens and dermal contact is the most likely route of 
exposure unless the products are applied as sprays. For sunscreens containing 
2% nano-scale TiO2, Hansen et al. (2008) estimated a worst-case exposure of 
57 µg/kg bw/d for a 2-year old child. 
TiO2 is also used in paints, varnishes and inks and coatings/surfaces to which 
consumers can be exposed either via the dermal or inhalation route (sprays). 
The only consumer exposure data available, reported very low exposure (22 
particles/m3, 55 nm) for release from coatings due to wear and tear, which will 
probably not constitute a risk.  
TiO2 is used in spray applications, but no exposure data for consumers are 
available. Based on modelling of application of a spray-on sunscreen, a maxi-
mum value of 3.5 g/m3 for short term exposure is estimated.  
In addition humans are also exposed to high amounts of TiO2 via food, and 
an unknown part of this will be on nanoform. It has been estimated that in 
UK the dietary intake of TiO2 is 5 mg/person pr day (Powell et al., 2010). 
This may raise concern because nano-sized TiO2 has a genotoxic potential 
after oral exposure, but presumably by a non-linear (thresholded) mechanism. 
The widespread uses of TiO2 in consumer products like sunscreens, surface 
treatment and paints allow for emissions of TiO2 nanoparticles to the envi-
ronment during and after application e.g. via wastewater or leaching of 
nanoparticles from treated surfaces.  
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In the study by Kaegi et al. (2008) it was found that TiO2 nanoparticles 
leached from painted house facades resulting in a concentration of 8 µg/L in 
urban runoff. Using modelling approaches, Müller and Nowack (2008) calcu-
lated PEC-values between 0.7 and 16 µg/L in water and Boxall et al. (2008) 
estimated environmental concentrations of 24.5 µg/L TiO2 nanoparticles in 
water. Both of these modelling attempts are based on assumptions that cannot 
be validated, however, it should be noted that they give results in the same 
order of magnitude. 
 
4.7 Risk profile 
4.7.1 Environment 
The ecotoxicity of bulk TiO2 (particles >100 nm, typically with a size around 
300 nm) is at present very poorly documented. Thus, reliable comparisons 
between nano-sized and bulk TiO2 are difficult at present. Only a few of the 
ecotoxicity studies have reported the results in terms of the endpoints and 
values listed in Information Requirements of REACH (ECHA, 2008). 
The lowest reported EC50 and LC50 values are in the range 1-10 mg/L (algae 
and crustaceans). Detailed studies on fish indicate that other endpoints than 
the traditionally used ones may be relevant and focus should be directed to-
wards gills, brain, and intestines. 
Bioaccumulation of TiO2NP has been shown in aquatic species, however, 
more research is needed to quantify this in terms of reliable BCF values. TiO2 
particles (both bulk and NP) can be regarded as persistent in the sense that 
the particles will remain TiO2-particles upon release to the environment. 
TiO2 nanoparticles have been found to be released to the environment from 
the different uses, e.g. outdoor paints and personal care products. Upon con-
tact with water, uncoated TiO2 nanoparticles tend to aggregate and settle, 
however the presence of natural organic matter may have a stabilizing effect. 
In Stone et al. (2010) a PNEC of 5.8 µg/L for freshwater has been estimated 
using an assessment factor of 1000. Based on comparisons with modelled 
PEC-values, the risk quotient for TiO2 nanoparticles (PEC/PNEC) assumes 
values from 0.1-4.2, indicating that TiO2 may give rise to toxicity in the 
aquatic environment. However, very large uncertainties exist not only with 
respect to obtaining valid ecotoxicological results for TiO2 nanoparticles 
(Hartmann et al., 2010), but also for estimating environmental concentrations 
and for taking bioavailability into account when estimating e.g. PNEC. The 
lack of information on production volumes, amounts of TiO2 nanoparticles in 
products, and market penetration makes all estimates of PEC very uncertain.  
4.7.2 Human health 
TiO2 nanoparticles were shown to be absorbed following oral exposure, and 
the main target organ seems to be the liver. There is however too few data to 
perform a risk characterisation for oral exposure.  
There is substantial evidence that nano-TiO2 does not pass through healthy 
skin, and it can be concluded that healthy skin is most likely not a risk, but it 
might be a risk for damaged skin.  
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No DNEL can be derived for short term and chronic oral and dermal expo-
sure.  
There is substantial evidence that following inhalation nano-TiO2 is more 
toxic than microsized TiO2, and the effect is dose dependant. There seems to 
be difference in sensitivity between species, with the rat being most sensitive. 
The crystalline form seems also to influence toxicity, with the anatase form 
being more toxic than the rutile form.  
Based on a NOAEC of 0.5 mg/m3 from a 13 week repeated dose toxicity 
study (Bermudez et al, 2004) a DNEL = 17 µg/m3 for chronic inhalation 
(workers 8 h a day, 21 nm particles) was calculated based on corrections fac-
tors in the REACH guidance (ECHA 2008). 
There is no data available to derive a DNEL for acute inhalation exposure.  
In general, some data are available for dermal exposure but no indication of 
direct adverse effects are observed. More information is needed to complete 
the picture regarding absorption and to allow robust risk assessment. How-
ever, there are indications that the risk from exposure to healthy skin is low 
due to a probable negligible uptake. Phototoxicity cannot be excluded for cer-
tain TiO2 qualities. Documentation is available with regard to toxicity and ad-
verse effects as a result of inhalation but in general TiO2 is likely to be associ-
ated with low risk from exposure via consumer products unless applied as air-
borne particles. 
Few toxicity data are available after oral exposure. Although it is assumed that 
the genotoxic effect observed in in vivo is thresholded, a NOAEL has not 
been derived. Long term oral toxicity studies are needed in order to perform a 
risk assessment. 
 
4.8 Summary sheet for TiO2 
Nanomaterial characteristics  
Name Titanium dioxide 
CAS number 13463-47-7 
Chemical composition TiO2 
Appearance White powder 
 
Source: wikipedia 
Manufacturing proc-
esses 
 
Manufacturing processes include precipitation, thermal hydrolysis and 
flame hydrolysis using titanium tetrachloride or titanylsulfate as starting 
material. For the ultrafine grade, the crystal may be further processed 
involving milling, then coating and milling again.  
Nanomaterial description  
Titanium dioxide is the naturally occurring oxide of titanium. Often a distinction is made by TiO2 
manufacturers between pigmentary grade and ultrafine grade. The primary crystal size typically 
ranges from 150 to 300 nm for TiO2 of a pigmentary grade. The ultrafine grade typically has a pri-
mary crystal size from 10 to 150 nm. The pigmentary TiO2 has a white color and is therefore widely 
used in paints etc. The ultrafine TiO2 including nano-sized TiO2 is transparent.  The rutile and ana-
tase crystal forms of TiO2 are the most important in relation to the use of TiO2 in consumer prod-
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ucts.  
In contrast to the bulk TiO2 (>100 nm) that is considered chemically inert, nano-scale TiO2 and in 
particular the anatase form can act as a photo-catalyst that can generate reactive oxygen species 
upon illumination. Both UV-light and visible light can induce the catalytic activity of TiO2 and the 
anatase crystal form is a more efficient photocatalyst than the rutile form. Although normally con-
sidered to be insoluble material can be made water dispersible by applying certain surface treat-
ments. In dry form, TiO2 nanomaterials will tend to agglomerate due to interaction of the particle 
surfaces, but the degree of agglomeration is depended on the specific surface treatment, relative 
humidity, sample aging, etc. Both fine and ultrafine TiO2 may be surface treated to increase their 
applicability in products, e.g. to ensure a uniform distribution in sunscreens or to optimize UV-
absorption properties. 
Applications   
A wide range of applications exists for TiO2 nanomaterials exploiting the various properties of TiO2 
nanomaterials. Pigmentary TiO2 is widely used as a pigment in paints, whereas nano-scale TiO2 is 
widely used in sunscreens and cosmetics due to the UV-absorption of the material. In paints and 
for water treatment nano-scale TiO2 is used as a photo-catalyst producing reactive oxygen that may 
degrade organic contaminants. Finally, a number of other and very diverse set of applications ex-
ists such as ointments, toothpaste, catalysts, catalyst supports, adsorbents, delustrants, semi-
conductors, etc. In some consumer products, e.g. sunscreens, the percentage of nano TiO2 may 
constitute several percent of the product. TiO2 rank as one of the most used chemicals world-wide 
(mainly as a pigment), but the tonnages of nano-scale TiO2 used nationally, in the EU or world-
wide can at present not be estimated. Given the range of possible applications of nano-scale TiO2, 
the use is anticipated to increase significantly in the near future.  
Human health risk profile   
The bulk (microsized) form of TiO2 is generally regarded as relatively inert, with a low toxic poten-
tial. However, in several studies there is clear evidence that nano-sized TiO2 is more toxic than 
micro-sized TiO2. First of all, nano-sized TiO2 is absorbed from the gastrointestinal tract and dis-
tributed to secondary target organs, whereas microsized TiO2 is not absorbed via this exposure 
route. It has been consistent within a wide range of investigations, that the acute toxicity increases 
as particle size decreases.  In addition the toxicity is dependent on the structure of the particles, 
with the anatase form being most toxic. The toxicity of TiO2 nano-particles has been demonstrated 
to be inflammation, induction of oxidative stress, and histological changes in the target organs. 
The primary target organ after inhalation is the lung. It is assumed (Stone et al., 2010) that the 
NOAEC is somewhere between 0.5 to 2 mg/m3. A few studies indicate the liver is the primary tar-
get organ after oral exposure, and that TiO2 exposure also may be related to cardiac damage.  
There is indication from in vitro and in vivo studies that nano-sized TiO2 but not micro-sized TiO2 
is genotoxic, and that the genotoxic response is caused by oxidative stress, assuming a thresh-
olded mechanism.  
The inflammogenic, oxidative and indirect genotoxic effects of nano-sized TiO2 are considered to 
be inherently linked.  
Environmental risk profile   
The bulk (microsized) form of TiO2 is generally regarded as relatively inert, with a low environ-
mental risk. For nano TiO2 the lowest reported EC50 and LC50 values are in the range 1-10 mg/L 
(algae and crustaceans). Detailed studies on fish indicate that other endpoints than the tradition-
ally used ones may be relevant and focus should be directed towards gills, brain, and intestines. 
Bioaccumulation of TiO2NP has been shown in aquatic species, however, more research is needed 
to quantify this in terms of reliable BCF values. TiO2 particles (both bulk and NP) can be regarded 
as persistent in the sense that the particles will remain TiO2-particles upon release to the environ-
ment. 
TiO2 nanoparticles have been found to be released to the environment from the different uses, e.g. 
outdoor paints and personal care products. Upon contact with water, uncoated TiO2 nanoparticles 
tend to aggregate and settle, however, the presence of natural organic matter may have a stabiliz-
ing effect. 
In Stone et al. (2010) a PNEC of 5.8 µg/L for freshwater has been estimated using an assessment 
factor of 1000. Based on comparisons with modelled PEC-values, the risk quotient for TiO2 
nanoparticles (PEC/PNEC) assumes values from 0.1-4.2, indicating that TiO2 may give rise to risk 
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in the aquatic environment. However, very large uncertainties exist not only with respect to obtain-
ing valid ecotoxicological results for TiO2 nanoparticles, but also for estimating environmental 
concentrations. The lack of information on production volumes, amounts of TiO2 nanoparticles in 
products, and market penetration makes all estimates of PEC very uncertain. 
 
 
58 
 
 
59
5 Zero valent iron - nZVI 
5.1 General characteristics 
Nano-scale zero-valent iron is the nanoform of zero valent iron. In its most 
basic form it consists of spherical iron (Fe0) nanoparticles with individual par-
ticle dimensions less than 100 nm. Substantial variations exist in the proper-
ties of nZVI in regard to average particle size, particle size distribution, spe-
cific surface area, surface charge and the presence of trace metals. nZVI may 
furthermore often be coated in order to prevent agglomeration and better con-
trol their reactivity and mobility. Polymers, polyelectrolytes, and surfactants 
are among the main types of coatings used for nZVI, including starch, 
poly(acrylic acid) (PAA) , poly(styrene sulfonate), etc. The lifetime of these 
coatings is generally unknown (Grieger et al., 2010). 
 
5.2 Manufacturing processes 
A number of different synthesis methods exist including the Sol-gel methods 
or chemical solution deposition methods where the solution acts as the pre-
cursor for an integrated network or gel as described by Chang et al. (2005), 
and the method of ferric iron reduction with sodium borohydride as described 
by Sun et al. (2006) and Li et al. (2006) (Grieger et al., 2010). 
 
5.3 Uses 
5.3.1 Main applications 
Not many applications of nZVI are known to us at this point and no con-
sumer products have been identified to be commercialized on the Danish 
market. In the nanoform, ZVI have significantly increased available reactive 
surface areas which have been found to subsequently enhance contaminant 
degradation reactions. This has been studied in pilot studies in in situ soil 
remediation at contaminated sites (PCBs, chlorinated organic solvents and 
organochlorine pesticides) not easily accessed by other treatment methods 
(Grieger et al., 2010). To the best of our knowledge no field scale applications 
of nZVI has been undertaken in Denmark. Some medical applications have 
also been reported, but it is the use in soil and groundwater remediation that is 
anticipated to be the major use of nZVI in the future. 
5.3.2 Results from industry survey 
No further information about nZVI has been available. 
 
5.4 Eco-toxicological profile 
For the following overview of the ecotoxicological profile of nano-scale zero-
valent iron it should be stressed that only a few ecotoxicological studies exist 
and only one of these is aimed at the base-set organisms (fish, crustacean and 
algae) required for doing effects assessment according to REACH. 
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In a study with bacteria (E. coli), it was found that nZVI is bactericidal under 
anoxic conditions and that the toxicity was significantly lower under oxygen 
saturated conditions (Lee et al., 2008). It was suggested that Fe(II) released 
from nZVI contributes to toxicity and that the toxic mechanism is oxidative 
stress induced by reactive oxygen. nZVI was found to cause a significant 
physical disruption of cell membranes.  
Based on extensive literature searches in ISI Web of Science it is found that 
no studies have been published in peer reviewed journals (until 22 October 
2010) on the ecotoxicity of nZVI to algae and crustaceans. Only one peer-
reviewed study (Li et al., 2009) has been carried out test with fish (Medaka, 
Oryzias latipes). It was found that nZVI caused disturbance in the oxidative 
defence system for embryos and adults, as well as oxidative damage in em-
bryos. Observed effects occurred at concentrations down to 0.5 mg/L. In 
adult fish a disturbance of the antioxidant balance was also observed, but the 
fish recovered after the exposure. Li et al. (2009) also reported on changes in 
gills and intestine of adult fish. Another study – not peer reviewed – report on 
attachment of nZVI particles to the outer surfaces of D. magna and indicates 
that EC50 values will be in the mg/L range (EC50, 48 hours of 55 mg/L) 
(Oberdörster et al., 2006). In the same study, it was found that exposure of 
fathead minnow to 50 mg/L nZVI did not cause any mortality (Oberdörster et 
al., 2006).  
No studies on the bioaccumulation of nZVI have been found as of 22 October 
2010. By definition metal nanoparticles are not degradable. Oxidation of Fe0 
is very likely to occur in aquatic media under normal conditions forming iron-
hydroxides. Therefore, nZVI particles cannot be regarded as persistent in the 
sense that the particles will remain as the original nZVI particles entering the 
aqueous media. However, a number of environmental factors (like pH, ionic 
strength, natural organic matter) may influence the particle sizes and agglom-
erate structures in the aquatic environment (Baalousha et al., 2008; Baalou-
sha, 2009) and also nanoparticle characteristics will influence the behaviour. 
Thus, Schrick et al. (2004) showed that unsupported iron nanoparticles will 
agglomerate rapidly when added to water, but also that different coatings of 
the iron nanoparticles (e.g. anionic hydrophilic carbon, and polyacrylic acid) 
resulted in colloidal suspensions with slow settling rates (hours to days).  
 
5.5 Toxicological profile 
Only a very limited number of peer-reviewed and published studies on the 
toxicological effects of nZVI exist. However, there is evidence that nZVI may 
attach to cells and to cause histological and morphological changes (Grieger et 
al., 2010). Furthermore, some coatings have been found to decrease toxicity 
probably due to reduced adherence. The effects observed seem to be linked to 
the release of Fe(II) from nZVI followed by production of reactive oxygen 
species. This may lead to disruption of cell membranes and cell death. It has 
furthermore been found that the ageing of nZVI (i.e., oxidation of Fe0) re-
duces the toxicity of nZVI (Grieger et al., 2010). Thus, the study by Phenrat 
et al. (2009) of the neurotoxic effects of nZVI, “aged” nZVI (oxidized), mag-
netite nanoparticles, and surface-modified nZVI, found that “pristine” nZVI 
was the most toxic to rodent neuron and microglia cells. The authors found 
that this could largely be attributed to oxidative stress. Mitochondrial swell-
ings as well as apoptosis were found when the cells were exposed to nZVI. 
While the surface-modified nZVI was found to be less toxic than the “pris-
tine” nZVI, the coatings were found to potentially facilitate cytoplasmic and 
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nuclear cell entry. Keenan et al. (2009) studied the effects of nZVI on human 
bronchial epithelial cells and found that cell viability was affected negatively 
possibly due to an internal ROS production. Similar to other studies, ageing 
of the nZVI resulted in decreased cytotoxicity. 
 
5.6 Exposure scenarios 
The use nZVI involves a direct injection of nZVI nanoparticles in contami-
nated ground water through drilled bore holes. In this way clean-up of hard-
to-reach sites is made possible (Grieger et al., 2010). In the injections concen-
trations 10 g/L of nZVI are typically used (Grieger et al., 2010). The reactiv-
ity of nZVI has been estimated to last 4 - 8 weeks, but this does of course de-
pend on the specific characteristics of the particles and surrounding environ-
mental conditions (like pH, redox conditions and ionic strength).  
Environmental exposure conditions are largely unknown to day, although 
some data is emerging (Grieger et al., 2010). In general, environmental migra-
tion of uncoated nZVI has been estimated to be only a few centimeters 
(Tratnyek and Johnson, 2006; Saleh et al., 2008) as a result of aggrega-
tion/agglomeration and deposition to other surfaces in the environment 
(Lowry and Casman, 2009). Environmental organisms that may be exposed 
to nZVI include bacteria, protozoa, and fungi, as well as other unicellular or-
ganisms if nZVI migrates to surface waters. During and after injection, soil-
dwelling organisms may also be exposed to nZVI around injection sites, and 
higher plants may potentially be exposed through extensive root systems 
reaching groundwater tables (Imada et al., 2008).  Although iron occurs natu-
rally in the environment, the fate and behaviour of the engineered nZVI may 
be different from the naturally occurring iron (Grieger et al., 2010). However, 
numerous highly complex environmental interactions may occur upon release 
and most of the processes involved in estimating environmental exposures for 
nZVI are largely unknown today (Grieger et al., 2010). 
As use of nZVI is only identified in occupational settings the only very low 
exposure potential for consumers is if particles end up in drinking water. 
 
5.7 Risk profile 
5.7.1 Environment 
As the current use or zero valent iron is very much restricted to ground water 
remediation, traditional risk assessment based on toxicity to fish, algae and 
crustaceans is of less relevance for this exposure scenario. 
However, for nZVI very few ecotoxicological studies have been performed. It 
appears that the acute toxicity to aquatic organisms is relatively low, but sub-
lethal effects have been observed at concentrations less than 1 mg/L. The ef-
fects observed of nZVI in bacteria, under anoxic conditions, may be linked the 
release of Fe(II) and subsequent formation of reactive oxygen species. Under 
aerobic conditions nZVI toxicity is expected to be lower, due to a rapid oxida-
tion of Fe0 to iron hydroxides (rust). At present the database is too limited to 
justify estimation of PNEC values. 
Even though environmental exposure concentrations may be high at the site 
of injection, transformation and low transport ability seem to limit the risk of 
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exposure to surface waters. High concentrations in soil may occur as a result 
of spill during injection. For the time being PEC estimations are hampered by 
lack of knowledge on the environmental fate and behaviour of nZVI. 
5.7.2 Human health 
With the existing applications of nZVI for professional uses only and thereby 
insignificant risk of exposure of consumers, the overall risk for consumers is 
expected to be low. 
 
5.8 Summary sheet for nano-scale zero-valent iron 
Nanomaterial characteristics  
Name Nano-scale zero-valent iron 
(nZVI) 
CAS number 8053-60-9 
Chemical composi-
tion 
Fe 
Appearance Dark powder 
Source: 
US EPA 1) 
Manufacturing proc-
esses 
 
A number of different synthesis methods exist including the Sol-gel 
methods and the sodium borhydride method.   
Nanomaterial description  
nZVI is the nanoform of zero-valent iron. In its most basic form it consists of spherical iron (Fe0) 
nanoparticles with individual particle dimensions less than 100 nm. Substantial variations exist in 
the properties of nZVI in regard to average particle size, particle size distribution, specific surface 
area, surface charge and the presence of trace metals. nZVI may furthermore often be coated in 
order to prevent agglomeration and better control their reactivity and mobility. Polymers, polyelec-
trolytes, and surfactants are among the main types of coatings used for nZVI. 
Applications   
nZVI has been used as an in-situ remediation technology for contaminated sites (e.g. for degrada-
tion of PCBs, chlorinated organic solvents, and organochlorine pesticides). A few medical applica-
tions have also been reported, but it is the use in soil and groundwater remediation that is antici-
pated to be the major use of nZVI in the future. 
Human health risk profile   
Only a very limited number of peer-reviewed and published studies on the toxicological effects of 
nZVI exists, however, there is evidence that nZVI may attach to cells and to cause histological and 
morphological changes. Furthermore, some coatings have been found to decrease toxicity proba-
bly due to reduced adherence. The effects observed seem to be linked to the release of Fe(II) from 
nZVI followed by production of reactive oxygen species. This may lead to disruption of cell mem-
branes and cell death. It has furthermore been found that the aging of nZVI (i.e., oxidation of Fe0) 
reduces the toxicity of nZVI (Grieger et al., 2010).  It is anticipated that there is a very small risk of 
human exposure to nZVI used for environmental remediation purposes when personal protection 
equipment appropriate for handling powders is used. Thus, the overall risk for human health ef-
fects is expected to be very low. 
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Environmental risk profile   
For nZVI very few ecotoxicological studies have been performed. It appears that the acute toxicity 
to aquatic organisms is relatively low, but sub-lethal effects have been observed at concentrations 
less than 1 mg/L. The effects observed of nZVI in bacteria, under anoxic conditions, may be linked 
the release of Fe(II) and subsequent formation of reactive oxygen species. Under aerobic condi-
tions nZVI toxicity is expected to be lower due to a rapid oxidation of Fe0 to iron hydroxides (rust). 
At present the database is too limited to justify estimation of PNEC values. Even though environ-
mental exposure concentrations may be high at the site of injection, transformation and low 
transport ability seem to limit the risk of exposure to surface waters. High concentrations in soil 
may occur as a result of spill during injection. For the time being PEC estimations are hampered 
by lack of knowledge on the environmental fate and behavior of nZVI. 
1)Http://cfpub.epa.gov/ncer_abstracts/index.cfm/fuseaction/display.abstractDetail/abstract/2172/
report/2002 
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6 Cerium dioxide - CeO2 
6.1 General characteristics 
Cerium(IV) oxide (CeO2) is an oxide of the element cerium. The crystal form 
of CeO2 is cerianite and according to Wakefield et al. (2008) CeO2  is a ce-
ramic compound, which means that it is inorganic and non-metallic. CeO2 is 
commercially available in a number of different size ranges below 100 nm 
(Nanowerk, 2010). 
 
6.2 Manufacturing processes 
It is not clear at this point in time how the nanoform of CeO2 is manufactured, 
but industrial bulk cerium is extracted from mined minerals, primarily mona-
zite and bastnasite (Lide, 2009) whereas CeO2 are formed by thermal treat-
ment processes. 
 
6.3 Uses 
6.3.1 Main applications 
CeO2 has several uses exploiting the catalytic ability of CeO2 to adsorb and 
release oxygen (Deshpande et al., 2005) which can be used to coat the inside 
of self-cleaning ovens, in solar panels and for hydrogen production (Charvin 
et al., 2009), in fuel cells and in automobile catalysts (Lide, 2009). CeO2 has 
also been used as a fuel additive (Wakefield et al., 2008) and this use may be 
particularly important, since it may lead direct emissions during the use phase. 
CeO2 can also be used in polishing agents for glass mirrors (Prospect, 2010). 
It is not clear whether such uses are deployed in Denmark, however, no in-
formation indicating that this is the case has been found. The production and 
use of CeO2 nanoparticles (CeO2-NP) is rapidly growing, and as mentioned 
above CeO2-NP have a number of applications of which the use as a diesel 
additive in the UK is among the most prominent ones (Rothen-Rutishauser et 
al., 2009; Wakefield et al., 2008). For this application CeO2-NP is mixed 
completely with the diesel (concentration: 5-8 ppm; average particle size: 8-10 
nm) (Wakefield et al., 2008). The advantage of using CeO2-NP as a fuel cata-
lyst is the improved engine combustion efficiency that results in reduced emis-
sions of soot, CO and NOx. Furthermore, the fuel efficiency has been re-
ported to increase by 8-9 % (Wakefield et al., 2008). While Boxall et al. 
(2007) mentions that CeO2 is used as a fuel additive in countries like the Phil-
ippines, New Zealand and the UK, the amounts used are at present unknown. 
6.3.2 Results from industry survey 
The survey has been focused on the use of ceriumdioxide as additive to diesel 
oil. In this context the trade association for oil products in Denmark has been 
contacted. The association informs that ceriumdioxide is not used as additive 
in oil products by any of the oil companies operating in Denmark (EOF, 
2010). No information is available on products supplied by smaller companies 
operating on the market in Denmark. Based on the information available it is 
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not possible to quantify the use of ceriumdioxide in Denmark. However, a 
major release from fuel is not expected in Denmark. 
 
6.4 Eco-toxicological profile 
For the following overview of the ecotoxicological profile of nano-scale ceriu-
moxide (CeO2) it should be stressed that only three ecotoxicological studies 
were found and that only one of these found effects of CeO2. 
Harper et al. (2008) investigated the toxicity of various metal oxides towards 
Danio rerio embryos and among these was CeO2. However, no effects were 
reported following exposure to up to 250 mg/L for 5 days.  
Velzeboer et al. (2008) observed no measurable effects on neither the crusta-
cean Chydorus sphaericus nor the freshwater algae Pseudokirchneriella Subcapi-
tata exposed to a concentration of 100 mg/L CeO2 nanoparticles and tap wa-
ter for 48 hours. 
Van Hoecke et al. (2009) studied the toxicity of CeO2 NPs of three different 
sizes (14, 20, and 29 nm) towards green algae (Pseudokirchneriella subcapi-
tata), two crustaceans species (Daphnia magna and Thamnocephalus platyu-
rus), and zebra fish embryos (Danio rerio). They found no acute toxicity for 
the two crustaceans and fish embryos in test concentrations up to 1000, 5000, 
and 200 mg/L, respectively. For the freshwater green algae, EC10-values be-
tween 2.6 and 5.4 mg/L were observed.  
No studies on bioaccumulation of CeO2 have been found as of 22 October 
2010. 
By definition CeO2 nanoparticles are not degradable and speciation of CeO2 
(e.g. dissociation or complexation) is not likely to occur in aquatic media un-
der normal conditions. Therefore, CeO2 particles can be regarded as persis-
tent in the sense that the particles will remain CeO2-particles, however, the 
sizes of the particles and hence their bioavailability may change due to ag-
glomeration and aggregation in aquatic media. 
 
6.5 Toxicological profile 
Very few toxicological studies have been performed on nano-sized CeO2, and 
all studies performed were in vitro studies.  
6.5.1 Uptake of CeO2 into cells 
No ADME studies have been performed on cerium dioxide, but a study has 
been performed on lung epithelial cells. 
The physico-chemical properties of particles have been illustrated to influence 
CeO2 uptake and adsorption onto proteins by Patil et al. (2007). The surface 
charge of particles was observed to influence the adsorption of proteins onto 
the particle surface. Specifically, BSA adsorbed onto the surface of positively 
charged CeO2 to the greater extent, when compared to negatively charged 
CeO2. Negatively charged nanoparticles were internalised by A549 cells to a 
greater extent. Electrostatic interactions were suggested to be the main driving 
force for the protein adsorption and cellular uptake of CeO2 nanoparticles. 
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Surface charge therefore appears to be a determining factor to particle uptake 
and protein adsorption.   
In general, the uptake of metal oxides by a variety of cell types has been dem-
onstrated on numerous occasions. The consequences of particle uptake into 
the cells are assumed to be oxidative stress followed by cytotoxicity and possi-
bly genotoxicity. The physico-chemical properties of particles may influence 
their internalisation by cells; accordingly the importance of size and surface 
charge has the ability to influence particle uptake. In addition, the cell type 
under investigation has the potential to determine the mechanism of uptake 
and intracellular fate of particles. 
6.5.2 In vitro toxicity- lung models  
Pulmonary toxicity has been investigated in two different models: rat lung 
slices and a lung epithelial cell line.   
CeO2 is used as a fuel additive to reduce particulate matter emissions from 
diesel engines. Fall et al. (2007) demonstrated that the CeO2 content of diesel 
exhaust fumes was unable to impact on the toxicity of CeO2supplemented 
diesel, within rat lung slices.  On exposure of lung slices to freshly generated 
fumes, no alterations in cell viability, pro-inflammatory mediator expression 
(TNFα) and antioxidant enzyme activity (glutathione peroxidase, superoxide 
dismutase) were identified. However, it was demonstrated that the antioxidant 
enzyme catalase, and GSH were elevated, at low concentrations of CeO2, 
which is likely to derive as a defence response. Overall, it was concluded that 
CeO2could be tolerated at a high dose. In contrast, exposure of lung slices to 
non-supplemented fuel was able to moderately decrease ATP content, and 
decrease GSH levels. Therefore, it is implied that the addition of CeO2 intro-
duces a protective effect.  
Lin et al. (2006) investigated the effects of CeO2 (20 nm diameter) on the 
A549 epithelial cell line. Cells were exposed to CeO2 at concentrations of up 
to 23 µg ml-1 for up to 72 hours. A concentration and time dependent in-
crease in cytotoxicity and ROS production, antioxidant (GSH and -
tocopherol) depletion and lipid peroxidation (indicated by malondialdehyde) 
were observed. This study therefore highlighted the oxidative and cytotoxic 
behaviour of CeO2. Similarly, in a study by Park et al. (2008a) the cytotoxicity 
and oxidative potential of CeO2 nanoparticles (15, 25, 35, 40 nm) to BEAS-
2B epithelial cells was investigated, at concentrations up to 40 µg ml-1, for a 
period of up to 96 hours. CeO2 elicited a dose and time dependent decrease in 
cell viability within BEAS-2B cells, with all particle sizes eliciting a similar re-
sponse. Cytosolic caspase 3 activation and chromosome condensation were 
also observed, suggesting that an apoptotic mode of cell death was involved. 
CeO2 exposure was also associated with enhanced cellular ROS production, 
and a decrease in cellular GSH, so that the cytotoxic response was assumed to 
be driven by oxidative stress.  No cytotoxic response was observed within 
H9C2 cardiomyocyte or T98G brain fibroblast cells, indicating that some cell 
types may be more sensitive to the effects of CeO2.   
6.5.3 Dermal models 
Park et al. (2007) investigated the toxicity of nano (9 nm) and micro (320 
nm) forms of CeO2 to the skin, in vitro. The EpiDerm skin model indicated 
that both forms of CeO2 tested were skin irritants. No cytotoxicity was ob-
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served and CeO2 was not mutagenic in the Ames test. The toxicity observed 
within this study was not size dependant. 
 
6.5.4 Mechanistic studies - Oxidative stress  
Oxidative responses exhibited by metal oxide particles have been a focus of a 
number of studies, especially for TiO2, and its recurrence has prompted the 
suggestion that oxidative stress drives the inflammatory and cytotoxic re-
sponses evident.  In contrast, a number of investigations have suggested that 
cerium dioxide exhibit anti-oxidant, cytoprotective properties as shown below  
Xia et al. (2008) investigated whether ZnO (13 nm), TiO2 (11 nm) and CeO2 
(8 nm) oxidative stress development or particle dissolution contributed to 
their toxicity.  RAW 264.7 macrophages and BEAS-2B epithelial cells were 
exposed to the nanoparticle panel for up to 15 hours, at concentrations up to 
60 µg ml/L.  Only ZnO particles were capable of inducing cytotoxicity, within 
both cell types. In addition, ZnO stimulated increased ROS production, 
which in turn, increased HO-1 expression, and activated the JNK signalling 
pathway, which paralleled the release of IL-8 and TNFα. Increased calcium 
release was also mediated by ZnO, and was associated with mitochondrial 
damage. These findings therefore imply that ZnO elicits an oxidant driven 
response that was responsible for the initiation of an inflammatory and cyto-
toxic response. On the contrary, CeO2 was able to stimulate a cytoprotective 
response, whereby pre-treatment of cells with CeO2 protected against diesel 
exhaust particle mediated cell damage (which is known to be oxidant driven). 
All particle types were internalised by an endocytic mechanism, however, only 
ZnO accumulated within lysosomes, which was suggested to drive their ability 
to inflict oxidative injury, and promote particle dissolution. ZnO also induced 
ultrastructural alterations, including nuclear fragmentation, apoptotic body 
formation and mitochondrial disappearance. ZnO was therefore recognised as 
being the most toxic particle within the panel, however, this was thought to be 
accounted for, in part, by their dissolution and therefore release of Zn2+ ions. 
The ability of ZnO particles to generate ROS, oxidant injury, inflammation 
and cell death was demonstrated within this study, highlighting how these 
processes are inherently linked.  The toxicity of the metal oxide particles was 
therefore suggested to be driven by their oxidant properties, which was de-
pendent on their composition, dissolution and intracellular fate. In contrast 
CeO2 may exhibit cytoprotective response, suggesting that composition plays 
an important role in determining cellular responses to nanoparticles.  
Neurones are particularly prone to oxidative stress (Das et al., 2007). As a 
result, Das et al. (2007) investigated the ability of CeO2 particles (3-5 nm) to 
exhibit neuroprotective effects, during the culture of rat spinal cord neurones. 
The survival of neurones was promoted by the inclusion of CeO2 (10 nM) 
within the cell culture medium, and this was thought to derive from the ability 
of CeO2 to scavenge free radicals, and thereby prevent against oxidative stress. 
The antioxidant behaviour of CeO2 was also suggested by the findings that 
CeO2 treatment improved neurone viability following H2O2 exposure. How-
ever, further studies would be required to confirm this hypothesis.  
In line with these findings, Schubert et al. (2006) investigated the neuropro-
tective behaviour of CeO2 from oxidative stress mediated cell death. The 
HT22 neuronal cell line was exposed to CeO2 nanoparticles (6 and 12 nm) or 
microparticles (1 µm) for 20 hours, at concentrations up to 100 µg ml/L, and 
no detrimental impact on cell viability was observed. Pre-treatment with CeO2 
particles were able to protect against glutamate mediated cell death, which is 
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known to be driven by oxidative stress. As a consequence, it was suggested 
that CeO2 particles acted as antioxidants, and that this property was not size 
dependent. This was confirmed by the finding that glutamate mediated in-
creases in ROS production were diminished by CeO2 pre-treatment. The 
findings were also replicated using yttrium oxide particles. Therefore contrary 
to the findings that demonstrate CeO2 is toxic, this study illustrated that CeO2 
may also exhibit antioxidant, cytoprotective properties.   
6.5.5 Summary 
No in vivo studies have been identified on cerium dioxide, and therefore no 
risk characterisation can be performed on this substance.  
From in vitro studies it is evident that surface charge appears to be a deter-
mining factor to particle uptake and protein adsorption.   
There was indication from in vitro studies with rat lung slices, that cerium di-
oxide had low toxicity and even had protective effect against oxidative stress 
produced by diesel exhaust particles 
Contrary in the lung epithelial cell line A549 CeO2 induced oxidative stress 
and cytotoxicity. No cytotoxic response was observed within H9C2 cardio-
myocyte or T98G brain fibroblast cells, indicating that some cell types may be 
more sensitive to the effects of CeO2.   
 
6.6 Exposure scenarios 
The use of cerium dioxide nanoparticles as a fuel additive may lead to a direct 
exposure of the general population through inhalation. Boxall et al. (2008) 
estimated an air concentration a distance of 5 m from roads of 0.6 ng/m3 and 
Park et al. (2008) estimated worst case concentrations of 5-25 ng/m3. These 
values are considered to be low when compared to occupational exposure 
concentrations (Stone et al., 2010). For water and soil extremely low pre-
dicted environmental concentrations were estimated by Boxall et al. (2008), 
but it should be emphasised that the data and assumptions used are difficult 
to validate. 
 
6.7 Risk profile 
The only study on the ecotoxicity of CeO2 NPs showed no acute toxicity for 
crustaceans and fish embryos in test concentrations up to 1000, 5000, and 
200 mg/L, respectively. For the freshwater green algae effects were seen at 
10% inhibition CeO2 at concentrations between 2.6 and 5.4 mg/L for three 
different sizes of CeO2 NP. This indicates that CeO2 nanoparticles in the 
worst case can be classified as “Aquatic Chronic 2”, but more likely should be 
classified as “Aquatic Chronic 3”. 
No studies of bioaccumulation of CeO2 have been found as of 22 October 
2010. CeO2 particles can be regarded as persistent in the sense that the parti-
cles will remain CeO2 -particles; however, the sizes of the particles may 
change due to agglomeration and aggregation in the environment. 
With only one ecotoxicity study and very uncertain concentration estimates at 
hand, neither PNEC nor PEC can be estimated and therefore no quantitative 
risk characterisation can be carried out. 
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Current results do not indicate that CeO2 added to diesel fuel increases the 
risk associated with inhalation of diesel exhaust. 
 
 
 
 
 
 
 
6.8 Summary sheet for CeO2 
Nanomaterial characteristics  
Name Ceriumdioxide, ceriumoxide 
CAS number 1306-38-3 
Chemical composition CeO2 
Appearance Pale yellow-white powder  
Source: wikipedia 
Manufacturing proc-
esses 
Industrial bulk cerium is extracted from mined minerals, primarily 
monazite and bastnasite and CeO2 is formed by thermal treatment proc-
esses 
Nanomaterial description  
Cerium(IV)oxide (CeO2) is an oxide of the element cerium. The crystal form of CeO2 is cerianite. 
CeO2 is a ceramic compound, which means that it is inorganic and non-metal. CeO2 is commer-
cially available in a number of different size ranges below 100 nm. 
Applications   
CeO2 has several applications and due the catalytic ability of CeO2 to adsorb and release oxygen it 
is used e.g. to coat the inside of self-cleaning ovens and for hydrogen production in fuel cells. The 
most widespread use of CeO2 is as an additive to diesel. This use may be particularly important 
from an environmental point of view, since it may lead to direct emissions during the use phase. 
For this application CeO2-NP is mixed completely with the diesel (concentration: 5-8 ppm; average 
particle size: 8-10 nm). The advantage of using CeO2-NP as a fuel catalyst is the improved engine 
combustion efficiency that results in reduced emissions of soot, CO and NOx. Furthermore, the 
fuel efficiency has been reported to increase by 8-9 %. The production and use of CeO2 nanoparti-
cles (CeO2-NP) is rapidly growing and CeO2 is used as a fuel additive in countries like the Philip-
pines, New Zealand and the UK. However, the amounts produced and used are at present un-
known. 
Human health risk profile   
No in vivo studies have been identified on cerium dioxide, and therefore no risk characterisation 
can be performed on this substance.  
From in vitro studies it is evident that surface charge appears to be a determining factor to particle 
uptake and protein adsorption. There was indication from in vitro studies with rat lung slices, that 
cerium dioxide had low toxicity and even had protective effect against oxidative stress produced by 
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diesel exhaust particles. 
Contrary in the lung epithelial cell line A549 CeO2 induced oxidative stress and cytotoxicity. No 
cytotoxic response was observed within H9C2 cardiomyocyte or T98G brain fibroblast cells, indi-
cating that some cell types may be more sensitive to the effects of CeO2. 
Environmental risk profile   
The only study on the ecotoxicity of CeO2 NPs showed no acute toxicity for crustaceans and fish 
embryos in test concentrations up to 1000, 5000, and 200 mg/L, respectively. For the freshwater 
green algae effects were seen at 10% inhibition occurred at concentrations between 2.6 and 5.4 
mg/L for three different sizes of CeO2 NP. This indicates that CeO2 nanoparticles in the worst case 
can be classified as “Aquatic Chronic 2”, but more likely should be classified as “Aquatic Chronic 
3”. No studies of bioaccumulation of CeO2 have been found as of 22 October 2010. CeO2 particles 
can be regarded as persistent in the sense that the particles will remain CeO2-particles; however, 
the sizes of the particles may change due to agglomeration and aggregation in the environment. 
With only one ecotoxicity study and very uncertain concentration estimates at hand, neither PNEC 
nor PEC can be estimated and therefore no quantitative risk characterisation can be carried out. 
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7 Silver - Ag 
7.1 General characteristics 
Nanosilver is the nanoform of silver characterized by being spherical particles 
of a size ranging from 1-250 nm. Nanosilver is commercialized as powder, 
flakes, grains, ingots, etc., and is sold in suspension (in water, alcohol or sur-
factant) and as a dry powder. Nanosilver is furthermore available in prepara-
tions (e.g. as a coating agent, in alloys, etc.) and in articles (electrodomestic 
appliances, in textiles, in food packages, etc.). In its pure form nanosilver will 
aggregate and hence nanosilver is often surface modified with for instance 
dextran, citrate, polysaccharide, hydrocarbon or polyvinylpyrrolidone (PVP). 
Sometimes nanosilver is also found to be deposited on or used as a coating of 
a substrate such as plastic, silica or polymers, to give a desired adhesion, elec-
trical conductivity, etc. (Luoma et al., 2007; Nanowerk, 2010; Pronk et al., 
2009). In aqueous solutions nanosilver forms dissolved free silver ions by dis-
solution and subsequent oxidation.  
 
7.2 Manufacturing processes  
Nanosilver can be produced through a number of methods such as ultra-sonic 
precipitation and chemical vapour deposition, but also exploding wire synthe-
sis. By using silver salts as a starting material and then adding various surface 
active agents and coatings, the size, shape, surface area, etc. can be modified. 
Nanosilver sold in suspensions needs to be surface-modified or suspended 
with a chelator (e.g. citrate) to ensure the stability of the nano-silver particles 
in suspension. 
 
7.3 Uses 
7.3.1 Main applications 
The use of nanosilver is very diverse and includes therapeutic applications 
such as wound dressing, personal care products, powdered colours, varnish, 
textile, paper, interior and exterior paints, printing colours, water and air-
purification, polymer-based products and foils for antibacterial protection 
such as washing machines. The main consumer uses seems to be linked to the 
antibacterial properties of silver such as clothing for preventing odour (e.g. 
socks, underwear, sport textiles) toothpaste and self-sanitizing toothbrushes. 
Potential usage of nanosilver could be Food Contact Materials (FCM) like 
kitchenware and containers for food storage and even as food supplement. 
However, the uses of silver on nanoform for food related purposes (i.e. as 
FCM or food additives/supplements) require more data on toxicity and expo-
sure in order to get approval for such uses in Europe  
However, nanosilver can be bought on the internet as colloidal silver in food 
supplements for treating certain diseases and as allergy prophylaxis (Gulbran-
son et al., 2000; Silver, 2003). 
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Nowack et al. (2011) underlines that products containing nanosilver particles 
have been commercially available for decades in diverse applications, e.g. in 
biocides and without use of the prefix "nano". In the United States all silver 
registrations with EPA from 1970 to 1993 were for nanosilver (colloidal sil-
ver) or for silver  nanocomposites. EPA has also registered several biocidal 
additives based on elemental silver particles with particle size < 100 nm. 
Today silver is being used in many applications due to a desire to shift away 
from organic chemical agents toward additives, which can be used in much 
lower concentrations in a wider variety of products including applications re-
quiring high temperature processing which is not feasible for organic com-
pounds (Nowack et al., 2011). 
On the Danish market a total of 178 products have been identified to be 
commercially available through the internet. Of these which 111 products fall 
into the category of Health and Fitness, 17 and 16 products fall into the cate-
gory of Home & Garden and Food & Beverages, respectively. In the category 
of Health and Fitness the large majority of the products (69) fall into the cate-
gory of personal care products whereas a smaller minority of the products falls 
into the categories of Filtration (19) and Clothing (12) and Sporting goods 
(8). These numbers should be seen as indicative numbers only since a num-
ber of methodological concerns may introduce a bias in the actual numbers of 
products on the market (as described in section 2.2.1). 
In the cases of shampoo, soap and toothpaste the concentration of nanosilver 
has been reported to be 0.001-0.002 % (Boxall et al., 2008), but in general the 
scale of use of nano-silver in terms of percentages in consumer products is 
unknown at this point in time. 
7.3.2 Results from industry survey 
Regarding the use as biocide in clothes request for information has been made 
to dominant international suppliers of sports equipment. While some compa-
nies Nike (Nike, 2010; Intersport, 2010) informs that nanosilver is not used in 
sports equipment, other companies e.g. Adidas has not responded. Overall it 
can be concluded that no confirmation of the use of nanosilver particles in this 
context has been received, but indications exist that some products/brands 
may contain nanosilver. A manufacturer of nano silver yarn presents the fields 
of application as active/casual/sports/outdoor wear, underwear and home fur-
nishing and bedding (Everest, 2010).  
Quantification of the amount of nanosilver used for this purpose is not possi-
ble.  
 
7.4 Eco-toxicological profile 
A number of ecotoxicity studies on AgNP have been reported in the literature 
and it seems that the number of papers on AgNP is rapidly increasing. This is 
probably due to the inherent toxicity of the element silver and many studies 
aim to disclose the difference between nano-scale Ag and the Ag+-ion. It is 
beyond the scope of this report, to give a full review of the ecotoxicity of Ag 
or AgNP. For this the review by Ratte (1999) and Weijnhoven et al. (2009) 
give good overviews. Here the focus is on the studies that are considered to be 
relevant for e.g. hazard classification or the predicted no-effect concentration 
for AgNP. 
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For fish a 48 hour static toxicity tests on adult zebrafish (Danio rerio) revealed 
LC50, 48h, of 7.07 (6.04-8.28) mg/L (Griffitt et al., 2008) and 7.20 (5.9-8.6) 
mg/L (Smith et al., 2007). Using zebra fish embryos decreased dose-
dependent hatching rates, weak heart beats, edema and abnormal notochords 
has been reported by Yeo and Kang (2008) after 48 hours exposure of 0.01 
mg/L and 0.02 mg/L 10-20 nm Ag nanoparticles suspended in tap water. 
A number of short-term studies have been performed on Ag nanoparticles on 
pelagic crustaceans and a number of LC50, NOEC and LOEC have been de-
rived. Short-term toxicity testing on adult Daphnia pulex and Ceriodaphnia 
dubia neonates reported LC50, 48 h, to be 0.040 (0.030-0.050) mg/L and 
0.067 mg/L (Griffitt et al., 2008), respectively. In the same study an EC50 of 
0.19 mg/L after 96 hours was found for green algae (P. subcapitata). For an-
other alga species (Chlamydomonas reinhardtii) EC50 ranged from 0.355 mg/L 
± 0.062 mg/L after 1 hour, to around 0.092 ± 0.011 mg/L after 3-5 hours. 
Expressed as a function of free Ag+, EC50 was estimated to range from 3.6 ± 
0.5 ug/L after 1 hour, to 0.9 ± 0.08 ug/L after 5 hours (Navarro et al., 2008). 
This study is important because it was found that the toxicity of AgNP cannot 
solely be explained by the free ion (Ag+) (Navarro et al., 2008).  
The widespread use of AgNP as a disinfectant in consumer products raises 
the questions whether unwanted environmental side-effects can occur. In this 
respect, the effect of AgNP on the biomass in wastewater treatment plants is 
especially important. In studies of effects on nitrifying bacteria Choi and Hu 
(2008) and Choi et al. (2008) used microbial growth inhibition tests to study 
the effect of different sizes (9-21 nm) of Ag nanoparticles in concentrations of 
0.05-1 mg/L. At exposure concentrations of 1 mg/L a significant inhibition of 
86 ± 3% was observed for Ag nanoparticles compared to 42 ± 7%, and 46 ± 
4% for Ag+ ions and AgCl colloids, respectively (Choi et al. 2008). No corre-
lation between nanoparticle size and bacteria inhibition in respirometry tests. 
However, a correlation was found between inhibition and the fraction of 
nanoparticles with sizes less than 5 nm, indicating that this fraction might 
have a stronger effect on respiration than larger size fractions. Furthermore, it 
was found that, at the same total concentration of Ag, Ag nanoparticles 
caused a greater inhibition than the free Ag+.  
By definition metal and metal oxide nanoparticles are not degradable. How-
ever, changes in the silver speciation can occur depending on redox condi-
tions, salt content etc. For ionic silver the speciation is the determining factor 
for bioavailability and ecotoxicity. Though the speciation of silver most likely 
will play a major role in the ecotoxicity of AgNP (in analogy to the case of 
ionic silver), the changes in speciation of the elemental silver are poorly 
documented and no general conclusion can be made in this regard (Stone et 
al., 2010). 
 
7.5 Toxicological profile 
The toxicological studies on nano-silver described below are quoted from 
Stone et al. (2010), Christensen et al. (2010) and Wijnhoven et al. (2009). I 
addition a few recent papers from the open literature are included. 
The toxicity of silver metal (bulk) and silver compounds is not described in 
detail in this report, and only a few studies on bulk silver are available com-
pared to nano-silver and dissolved silver (Nowack et al., 2011). The toxicity 
of silver is considered to be relatively low (Wijnhoven et al., 2009), and mini-
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mal risk is expected due to clinical exposure by inhalation, ingestion, dermal 
application or through the urological or haematogenous route. Toxicity stud-
ies on silver are mainly human studies and toxic effect on humans other than 
agyria have only been observed at very high concentrations. Chronic ingestion 
or inhalation of silver preparations (especially colloidal silver) can lead to 
deposition of silver metal/silver sulphide particles in the skin (argyria), eye 
(argyrosis) and other organs. These are not life-threatening conditions but 
cosmetically undesirable and irreversible. The most dramatic symptom of ar-
gyria is that the skin becomes blue or bluish-grey colored (ASTDR). Agyria is 
mainly caused by medical use of colloidal silver. The estimated total dose re-
quired to induce argyria by ingestion is in the range of 1-30 g for soluble silver 
salts (Nordberg and Gerhardsson, 1988). Already in 1939 a threshold value 
above which argyria can be expected was set (Nowack et al., 2011). This 
value was set to 0.9 g of silver over the whole lifetime. Later (WHO / SDE / 
WSH / 03.04 / 14) a total lifetime oral intake of about 10 g of silver was con-
sidered as the human NOAEL on the basis of present epidemiological and 
pharmacokinetic knowledge. This value corresponds to a daily intake over 70 
years of 0.4 mg/person. In Denmark, the limit value for silver in drinking wa-
ter is set to 0.01 mg/L4 corresponding to 2.5% of the human NOAEL. 
7.5.1 ADME studies 
Absorption 
 
Inhalation 
After exposure to nano-silver (4-10 nm) 3 x 106 particles cm-3 equivalent to 
133 µg m-3 for 6 hours, silver was deposited in the lung. Silver was measured 
in the blood and low concentrations of silver were found in the liver, kidney, 
spleen, brain and heart. It was not clear whether the absorbed silver included 
silver nanoparticles, free silver ions (Ag+), a silver complex or a combination 
(Takenaka et al., 2001).  
In a 90 day whole body inhalation study to silver nanoparticles (18-19 nm), at 
low,  medium and high doses, deposition of silver in the lung was observed - 
as well as silver in the blood and secondary organs such as liver, olfactory 
bulb, brain and kidneys Sung et al. (2008, 2009).  Also this study did not clar-
ify whether the absorbed silver was nano-silver or free ions. A similar distribu-
tion pattern was observed in a 28 day inhalation study (Ji et al., 2007). 
Oral 
Absorption via the oral route was investigated in a 28 days study with expo-
sure to very high doses (up to 1000 mg/kg bw/day) compared to what would 
be seen in an occupational or consumer situation. Deposition of silver was 
observed in different organs (brain, liver, kidneys, lungs and testes) indicating 
transfer of silver into blood (Kim et al., 2008). 
There is also indication that silver can be transported to the skin after oral ex-
posure, where blue-grey colouring of the skin (argyria) has been observed 
(Wadhera and Fung, 2005). 
                                                          
4 (Bekendtgørelse nr 1449, 2007)  
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As for uptake via the lung, none of the above studies clarify whether the up-
take is as nano-silver, silver ions, silver complexes or a combination of the 
two. However, it must be anticipated that at least part of the silver uptake fol-
lowing oral exposure to nano-silver takes place as silver ions.  This assump-
tion is – at least partly – supported by the fact that some of the same toxic ef-
fects as seen following non-nano silver exposure are seen following nano-
silver exposure (in particular argyria).   
Dermal 
Some studies have shown that silver nanoparticles can be absorbed via the 
skin when used in wound dressings. In these studies, the wound dressings 
were applied to damaged skin every 2-4 days. Vlachou et al. (2007) showed 
that serum levels increased with increasing exposure time peaking after 9 days 
and returning to normal 6 month after exposure. 
In an in vitro diffusion cell system Larese et al. (2009) investigated the pene-
trations of polyvinylpirrolidone coated silver nanoparticles (25 nm) on intact 
and damaged human skin slices. Silver nanoparticles (70 µg cm-2, for 24 
hours) were able to pass through the skin preparations. The absorption was 
very low (0.0006% of applied dose with intact skin) but detectable and the 
penetration was 5 times greater in damaged skin. In addition, silver nanoparti-
cles could be detected by electron microscopy (TEM) in the stratum corneum 
and the outermost surface of the epidermis. 
As for uptake via the lung, it is not clear whether the uptake via the skin is as 
nano-silver, silver ions, silver complexes or a combination and the relevance 
of these in vitro findings needs to be investigated in vivo. 
Distribution  
Following absorption silver was seen in the following secondary organs: liver, 
kidney, spleen, hearth, olfactory bulb, brain, testes and skin (discoloration of 
the skin), with liver being the likely major secondary organ site of accumula-
tion. As noted above there is no clear indication whether the absorbed and 
distributed silver occurs as silver nanoparticles, silver ions, silver complexes or 
a combination.  
Metabolism 
As described earlier there is no clear indication whether it is silver nanoparti-
cles, silver ions, silver complexes or a combination that is absorbed. There is 
thus also no clear data suggesting whether and how the silver is further trans-
formed once in the body. However, one of the biological/toxic effects seen in 
some studies (argyria - being a blue-grey dis-colouring of the skin) may, at 
least partly, involve a transformation/reduction of silver ions to metallic silver 
following exposure to UV-radiation/sunlight. This could indirectly suggest 
that some of the silver in circulation occurs as silver ions. These ions will at 
least partly be detoxified as “normal” silver ions by precipitation as sulphide 
and chloride salts and binding to proteins making them less bioavailable. 
However, if nanosilver is absorbed as particles these particles may continu-
ously release silver ions within the tissue and thereby, at least partly, bypass 
the detoxification mechanism. Therefore nanosilver may be more toxic than 
the non-nanoform. 
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Elimination 
Trop et al. (2006) showed elevated silver levels in the urine following expo-
sure. No other data for nano-silver elimination has been identified.  
7.5.2 Acute toxicity 
Oral 
After a single oral dose of  nano- (15 nm) and micro-particles (2 - 3.5µm) sil-
ver, ingested directly into the stomach of mice histopathological analysis of the 
liver tissue, 3 days post-exposure, demonstrated evidence of inflammation in 
the form of lymphocyte influx for both particle sizes (greater response for the 
nanoform). This was further supported by changes in the gene expression of 
4 genes involved in inflammation (Cha et al., 2008). This dose seems to be 
relatively high in relation to what would be expected in terms of occupational 
and consumer exposure. The relevance of these findings is therefore dubious 
for the purpose of risk assessment. 
Inhalation 
No acute toxicity studies have been identified. 
Dermal 
No studies investigating the dermal acute toxicity of silver nanoparticles on 
healthy skin has been identified. However, there are signs of argyria and liver 
toxicity following treatment of burns with wound dressings. The relevance of 
this data for healthy skin at lower concentrations and longer exposure time (as 
expected in occupational and consumer settings) is uncertain. Therefore, fur-
ther investigations are needed on healthy skin with doses and exposure times 
relevant for exposures as seen in occupational and consumer settings. 
Other routes 
No studies were identified studying toxicity via other routes of exposure. 
7.5.3 Irritation and corrosion 
No studies have been identified investigating specifically the irritating behav-
iour of silver nanoparticles (to the eyes, lungs or skin).   
Silver nanoparticles are not expected to be irritating to skin based on the hu-
man findings of applying it in wound dressings. However, further information 
would be needed to draw firm conclusions. Based on the above considera-
tions, silver nanoparticles are also not assumed to be corrosive. 
7.5.4 Sensitisation 
No studies have been identified investigating the sensitising behaviour of silver 
nanoparticles. As silver nanoparticle containing wound dressings are routinely 
applied and none of the studies investigating that application have reported 
sensitisation, it appears unlikely that nano-silver is a dermal sensitiser. Regard-
ing possible sensitisation following inhalation, further proof/investigation is 
required. 
7.5.5 Repeated dose toxicity 
Oral 
In a 28 day repeated dose toxicity study in mice (OECD guideline 407) by 
Kim et al. (2008), a dose-dependent toxicity was observed in the liver (histo-
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pathology changes and inflammation), insinuating that this organ is a target 
site for silver nanoparticle toxicity. However, it should be noted that the doses 
used within this study were relatively high (up to 1000 mg/kg bw/day), which 
should be addressed if used for a risk assessment. However, due to limited 
histopathological information, no oral No Observed Adverse Effect Level 
(NOAEL) was established based on these data. 
Recently a 90 day oral study according to OECD guideline 408 and in com-
pliance with GLP has been registered under REACH (EC Regulation no 
1907/2006ref5). Nanosilver (56 nm) was investigated in male and female wis-
tar rats. The animals were dosed daily by gavage with 0, 30, 125 and 500 
mg/kg bw/day. The doses were based on the 28 days study by Kim et al. 
(2008). The study referred to in the REACH registration was performed by 
Kim et al. (2010). 
The target organ for the silver nanoparticles was found to be the liver in both 
the male and female rats after 90-day of exposure to silver nanoparticles. Sig-
nificant dose-related changes were found in alkaline phosphatase and choles-
terol levels of male and female rats at and above 125 mg/kg bw/d, indicating 
slight liver damage. Histopathology revealed slightly higher incidences of bile-
duct hyperplasia with or without necrosis, fibrosis and/or pigmentation in 
treated animals together with a dose-dependent accumulation of silver in all 
tissues examined. A NOAEL of 30 mg/kg bw/day and LOAEL of 125 mg/kg 
bw/day were established based on effect on the liver. 
There was a statistically significant (p<0.01) dose-related increase of silver 
deposition in testes, liver, kidneys, brain, lungs and blood of treated rats. - A 
two-fold higher accumulation of silver was seen in kidneys of females com-
pared to males. 
Inhalation 
In a 28 days inhalation study rats were exposed to silver nanoparticles (13 – 
15 nm) in an inhalation chamber 5 days a week and 6 h per day to 3 different 
doses (Hyun et al., 2008). It was concluded by the authors that although a 
slight effect was observed on the neutral mucins in the respiratory mucosa, no 
significant toxicological effect was observed with exposure up to 61 µg/m3.  
In another 28 days inhalation study (OECD guideline 412) in rats by Ji et al. 
(2007) with the same exposure duration and dose levels as above some toxic-
ity (cytoplasmic vacuolation and heptatic necrosis) was observed within the 
liver, but histopathological analysis did not reveal any distinct toxicity within 
other organs.  
A 90 days whole body inhalation study was performed according to OECD 
guideline 413 (Sung et al., 2008, 2009). Rats were exposed to silver nanopar-
ticles (18-19 nm), at low (49 µg/m3, equivalent to 0.6x106 particles/cm3 and 
1.08x109 nm2/cm3), medium (133 µg/m3, equivalent to, 1.4x106 particles/cm3 
and 2.39x109 nm2/cm3) and high (515 µg/m3, equivalent to 3.0x106 particles / 
cm3 and 6.78x109 nm2/cm3) doses for 6 h/day and 5 days/week. Lungs and 
liver were the main target organs for accumulation of silver and toxicity.  
Prolonged exposure to silver nanoparticles was demonstrated to elicit an in-
flammatory response within the lung, and induced alterations in lung func-
                                                          
5 All, non-confident data is publicly available on 
http://apps.echa.europa.eu/registered/registered-sub.aspx 
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tion, at all par ticle concentrations (Sung et al. 2008), indicating that the low-
est dose (49 µg/m3) would be a lowest observed effect concentration 
(LOAEC). The silver concentration was observed to increase in the blood, 
indicating that silver nanoparticles were transferred into blood from the lung, 
after which they subsequently became distributed within the liver, olfactory 
bulb, brain and kidneys. However, the silver content within these tissues may 
derive from nanoparticle or ion presence, which warrants further investiga-
tion. In the Sung et al. (2009) study, which reported on clinical observations, 
haematology and histopathological examinations, erythrocyte aggregation and 
kidney function test, toxic effect on liver and lung was observed at the highest 
concentration, and a No-observed Adverse Effect concentration (NOAEC) of 
100 µg/m3 was suggested. However, as this dose was not an observed value, 
the middle dose of 133 µg/m3, the observed dose without significant liver ef-
fect, will be applied as the NOAEL. Because it is uncertain whether the lung 
effect is an adverse effect, both values (49 and 133 µg/m3) will be used in the 
risk characterisation.  
Dermal 
No information identified except the dermal studies reported under acute tox-
icity. 
Other routes 
No studies identified 
7.5.6 Mutagenicity 
No mutagenicity or genotoxicity studies classically used in chemical regula-
tory setting have been identified. 
A micronucleus test was performed at the end of the 28 days oral study in rats 
(described under the repeated dose oral toxicity study) (Kim et al., 2008).  
No clastogenic/aneugenic effect was observed. However, it should be noted 
that no positive control was included. 
Nano-silver may cause mutagenicity/genotoxicity via an indirect thresholded 
mechanism driven by formation of ROS.  Further testing of the possible direct 
genotoxicity of nano-silver is needed. 
7.5.7 Carcinogenicity 
No studies investigating the carcinogenicity of silver nanoparticles have been 
identified.  However, as silver nanoparticles may be genotoxic, carcinogenicity 
cannot be excluded. However, further chronic carcinogenicity studies should 
await results on mutagenicity of nanosilver.  
7.5.8 Reproductive toxicity and developmental toxicity 
Fertility 
In an in vitro study on mouse spermatogonial stem cell (SSC) Bradyich-Stolle 
et al. (2005) invetstigated the cytotoxicity of different nanoparticles (Silver 
(15 nm), molybdenum trioxide (MoO3, 30 nm), and aluminum (Al, 30 nm)) 
using the LDH and MTT assays. The cells were exposed to 10 µg/ml for 48 
hours. Findings demonstrated a concentration-dependent toxicity for all types 
of particles tested, whereas the corresponding soluble salts had no significant 
effect. Silver nanoparticles were the most toxic.  
 
81
In a later study Bradyich-Stolle et al. (2010)  investigated the cytoxicity and 
cell proliferation of Ag-NPs of different sizes (10, 25-30 and 80 nm) coated 
with either polysaccharide (Ag-PS) or hydrocarbon (Ag-HC) in the same cell 
line as in the 2005 study above. The results of the 2010 study showed that 
Ag-NPs reduced the viability and cell proliferation of SSC and that the effect 
is size and concentration dependant. It was also shown that, over time, there 
was no (protective) effect of particle coating. At low exposures decrease in cell 
proliferation was not due to ROS formation but other mechanism like interac-
tion with cell communication.  Electronmicroscopy (TEM) showed optake of 
Ag-NP.  
These results confirm that toxicity of Ag-NP increase with decreasing particle 
size in vitro. Although  it has been demonstration from in vivo inhalation stud-
ies (Sung et al., 2009) and oral studies (REACH) that nanosilver is distrib-
uted to different organs, including testes, there was no detailed analysis of 
toxic effect on testis, but the exposure concentration would have been much 
lower with a blood concentration of 4 ng/g blood, than in the in vitro studies 
with germ cells where a concentration of 10 µg/ml was used. Therefore it is 
difficult to relate the in vitro results to human exposures, and in vivo studies 
are needed to draw a conclusion. 
No data on female fertility has been identified. 
Developmental toxicity 
Developmental toxicity was investigated in two embryo fish studies and com-
pared with toxicity of gold nanoparticles (Bar-Ilan et al., 2009). It seems that 
toxicity (malformation and death) is dose dependent and that silver is consid-
erably more toxic than inert gold nanoparticles. As for fertility, further inter-
pretation requires better understanding of the toxicokinetics and possibly sub-
sequent confirmation in vivo. 
7.5.9 Biological mechanism 
A range of mainly in vitro studies have shown that the toxicity of silver and 
other metal nanoparticles appear to be mediated by the induction of inflam-
mation and oxidative stress, which can result in cytotoxicity and genotoxicity.  
 
7.5.10 Summary 
It has been shown that silver from nanoparticles can be absorbed especially 
via oral and inhalation routes of exposure. Based on in vitro data there is indi-
cation that dermal absorption occur to a lesser extent, and intact skin seems to 
be a rather effective barrier against absorption, however, in vivo data are 
needed for a firm conclusion. However, it is unclear in which form (as parti-
cles, free ions, silver ions or complexes) nanosilver is absorbed and distributed 
to target organs. At least for uptake via the oral route it is likely that at least 
some of the uptake occurs as ions. It appears that smaller particles exhibit 
higher toxicity as compared to larger particles; and if silver is absorbed as par-
ticles then the surface area is relevant.    
Should silver uptake occur solely as ions, the database for silver could be ap-
plied to assess systemic silver nanoparticle toxicity.  For that exercise, it would 
need to be considered whether and how the dramatically increased surface 
area and possibly increased solubility of silver nanoparticles would need to be 
taken into account. 
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Quite a few, mainly in vitro studies, have shown that the main mechanism of 
silver nanoparticle toxicity seems to be mediated by an increase in ROS pro-
duction (except toxicity on germ cells), stimulating inflammation and 
genotoxic events and apoptosis or necrosis. The concentration of the adminis-
tered nanoparticles is able to influence the toxicity, specifically, at low levels of 
oxidative stress a protective response is initiated which progresses to a damag-
ing response with increasing particle concentration, and therefore oxidant lev-
els. It is thus relevant to consider that the (geno)toxicity of silver nanoparticles 
is thresholded.   
 
7.6 Exposure scenarios 
Silver is one of the most widely used nanoparticles in consumer products 
(Wijnhoven et al., 2009) and especially the uses in textiles and personal care 
products may lead to human and environmental exposures. 
Nano-silver in textiles is used in all kinds of clothes from sock and shirts to 
caps, gloves and underwear. In all cases it is the antimicrobial activity of nano-
silver that is the reason for incorporating it in textiles. The environmental re-
leases from textiles have been investigated in some theoretical studies and a 
few laboratory based ones. In the study by Luoma (2008) it was estimated 
that mass release from silver containing socks in the USA would be in the 
range of 6-930 kg or 180-2790 kg assuming that 10% and 30%, respectively, 
of the population would use these kinds of socks. The release of nanosilver 
from socks upon contact with water showed that for some socks almost all sil-
ver leached to water whereas for others no leaching was detected (Benn & 
Westerhoff, 2008). In a simulation of the washing of silver-containing textiles, 
Geranio et al. (2009) found varying percentages of the total silver emitted 
during one wash, i.e. from less than 1% and up to 45%. Benn et al. (2010) 
measured the content of silver in textiles (in a shirt, a medical mask, a towel 
and a cloth), personal care products (toothpaste, shampoo), a detergent, a toy 
(teddy bear), and two humidifiers. They found silver concentrations from 1.4 
to 270,000 µg Ag g product–1. Upon wasing in tap water they estimated the 
potential release of silver into aqueous environmental matrices in quantities up 
to 45 µg Ag/g product. By electron microscopy Benn et al. (2010) were able 
to confirm that nano-silver particles were present in the products, but also in 
the wash water samples. 
In what can best be characterized as first attempt on material flow analysis 
Mueller and Nowack (2008) made some estimation of predicted environ-
mental concentrations of silver and Gottschalk et al. (2010) have further re-
fined these estimates. For surface water, Gottschalk et al. (2010) derive a PEC 
values of 0.72 ng/L and for sewage treatment plant effluents a PEC of 11.8 
ng/L.  
Human exposure to nanosilver is suspected to be highest in the working envi-
ronment. The main exposure route for occupational settings is primarily via 
inhalation and dermal contact.  
For consumer exposure no quantitative data have been identified, but it must 
be assumed that the main exposure route is dermal contact for clothes and 
paint applications, and inhalation for spray applications. Oral exposure may 
occur from toothpaste and toothbrushes containing nanosilver and if, in the 
future, nanosilver will be permitted for FCM and in food supplements (see 
5.2.1). The magnitude of exposure will depend on the concentration in the 
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consumer product, the amount released from the products, which depends on 
how strong nanosilver is bound in the solid matrix applications (e.g. in clothes 
and FCMs). 
 
7.7 Risk profile 
7.7.1 Environment 
Silver is known to be an ecotoxic metal, however, the toxicity is highly de-
pendent on the form and speciation of the metal. In the registration of silver 
under REACH (EC Regulation no 1907/2006), predicted no effect concen-
trations (PNECs) are reported to 0.04 µg/L (freshwater), 0.86 mg/L (marine 
water) and 0.025 (sewage treatment plants). Test with silver nanoparticles 
(AgNP) do also reveal very low effect concentrations. Thus, for algae EC50-
values a low a 4 µg/L has been found and also for crustaceans values far below 
1 mg/L have been reported. This ranks AgNP as "Aquatic chronic 1". It is also 
important to note that at concentrations below 1 mg/L inhibition of nitrifying 
bacteria can occur and thus the function of wastewater treatment plants may 
be affected by the presence of AgNP. For ionic silver it is known that the 
speciation in aqueous media is determining for the bioavailability and toxicity. 
This is most likely also the case for elemental silver nanoparticles, but influ-
ence of speciation on uptake, depuration, and toxicity remain to be studied in 
this case. 
The environmental concentration resulting from the use of AgNP in con-
sumer products are at present uncertain, even though a number of different 
estimates have been proposed. It is evident that even though silver nanoparti-
cles are incorporated in textiles, they can be released upon washing. Concen-
trations in the low ng/L range have been proposed and even such low concen-
trations may under very precautious assumptions6 constitute an environmental 
risk due to the high toxicity of silver. 
It is debated today whether silver nanoparticles are in fact more toxic than 
their bulk counterpart, since effects in many cases can be ascribed to the ionic 
form of silver (Ag+). Some studies have documented a higher effect of 
AgNP, but it is the widespread and dispersive use of silver in consumer prod-
ucts that poses the greatest risk to the aquatic and terrestrial environment. 
Even if AgNP are “only” as toxic as larger silver particles, silver is still a very 
ecotoxic metal. 
7.7.2 Human health 
Although nano-silver is presumably the most widely applied nanomaterial on 
the market, and relatively high exposure to workers and consumers might be 
expected, there is still a need for further data on exposure and human toxicity 
to fill out existing data gaps. Some important areas for research needs are 
mentioned below. 
 Human exposure data are very important for a risk characterisation. 
However, no or very few data on concentrations as well as data on size 
and form (e.g. aggregates, agglomerates) in consumer products exists. 
Such data are urgently needed in the future, in particular for occupa-
                                                          
6 These assumptions are using the highest assessment factor of 1000 and are assuming 
that the bioavailability of silver is not reduced due to complexation.   
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tional inhalation and consumer inhalation and dermal exposure. In 
such studies characterisation  of the silver nanoparticles in terms of 
size and agglomeration states, as well as a clear indication of duration 
and frequency of exposure is important. 
 Further investigations of the nano-silver toxicokinetics. In particular, 
to which extent the silver absorbed via different routes becomes sys-
temically available as ions, as nanoparticles and/or as silver complexes, 
and whether the size of the silver nanoparticles influences the uptake 
mechanism(s);  
 Further testing for the possible direct genotoxicity of silver nanoparti-
cles; and depending of the results of these studies carcinogenicity 
studies might be needed. 
 When more knowledge is obtained on absorption and distribution of 
different sizes of nano-silver is obtained, then effects on other organs 
than liver and lung should be investigated in (sub)chronic studies fol-
lowing different exposure routes, especially inhalation and dermal ex-
posures are relevant for consumers. 
 Further in vivo investigation of the possible reproductive and devel-
opmental toxicity of silver nanoparticles. 
However, some (limited) studies exist on which this (preliminary) risk charac-
terisation is based. 
The acute toxicity of nanosilver seems to be low for mammals. For soluble 
silver nitrate the estimated acute lethal dose is at least 10 g for humans. However, 
if absorbed as particles nanosilver may be more toxic than the non-nano form 
due to the small size and larger surface. 
In vitro genotoxicity data indicate that nanosilver may cause mutagenic-
ity/genotoxicity via a thresholded mechanism. Therefore a human NOAEL 
can be established, provided that sufficient data are available.  
Risk following inhalation 
Due to uncertainties of the genotoxic potential and the limited dataset in the 
existing studies reported so far, only human Indicative No-effect Levels 
(INELs) can be set for inhalation.  
As mentioned earlier and proposed in Stone et al. (2010) and Christensen et 
al. (2010) a human no effect level will be based on reduced lung function 
(LOAEL of 49 µg/m3) and systemic liver effect (NOAEL of 133 µg/m3). 
Using assessment factors as set out in the REACH guidance (ECHA 2008, 
chapter R.8) and explained in Stone et al. (2010) and Christensen et al. 
(2010) the following INELs were derived: 
 
 
Reduced lung function used as critical effect  
1. Scenario: using a factor 3 for extrapolation a LOAEL to a NOAEL 
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INELlung 1= 0.33 µg/m
3 equivalent to 4000 particles m-3 and 7.2 x 106 nm2/cm3 
2. Scenario: using a factor 10 for extrapolation a LOAEL to a NOAEL 
INELlung 2= 0.098 µg/m
3 equivalent to 1200 particles m-3 and 2.2 x 106 
nm2/cm3 
Systemic liver effect as critical effect 
INELliver= 0.67 µg/m
3 equivalent to 7000 particles m-3 and 1.2 x 106 nm2/cm3 
These values are much lower as compared to a DNEL value of 0.04 mg/m3 
for bulk silver for systemic effects, which has been derived by the registrant of 
silver in the REACH registration dossier on silver (ECHA web site April 
2011)7.  
The differences between the INELs and DNEL above clearly indicate that 
nano-silver might be more toxic than bulk silver after inhalation. 
It has been estimated (Christensen et al., 2010) that peak occupational expo-
sure can be at same order of magnitude or even higher as the above calculated 
INELs when expressed in particle number. However, better data (exposure 
and toxicity data) are needed.  
No quantitative risk estimation can be carried out for consumers because no 
inhalation data have been identified for consumers. However, given that 
nanosilver applications in spray have been reported, this exposure route could 
be of concern, and the identification of exposure values via inhalation should 
be prioritised.  
Based on available toxicological data it is recommended to avoid exposure via 
inhalation, because health effects like reduced lung function and toxic effect 
on the liver cannot be excluded after repeated exposure. There is also indica-
tions from in vivo inhalation studies that silver can reach the germ cells and 
toxicity to germ cells has been observed in vitro from AgNP, although at 
much higher concentrations than could be expected from consumer exposure. 
Risk following dermal exposure 
No quantitative data related to occupational and consumer dermal exposure 
has been identified. It must be assumed that especially consumers can be ex-
posed to nanosilver due to the relatively widespread use in clothes. Very few 
toxicity data for nanosilver are available, but human data have indicated toxic-
ity (agyria and liver toxiciy) after use of wound dressings containing 
nanosilver. However, consumer exposure is considered to be much lower and 
will normally be applied on healthy skin. On the other hand consumer expo-
sure is considered to last much longer than a shorter term treatment of a burn. 
Better toxicity and exposure data are needed for improved risk assessment. 
However, based on existing data, indicating that the absorption via skin is low 
even for damaged skin, it could be assumed that the health risk via this expo-
sure route would be quite low. 
                                                          
7 ECHA (2011) http://apps.echa.europa.eu/registered/data/DISS-9d92ea78-89c7-
2334-e044-00144f67d249/showdocument671a.html?treeUuid=DISS-9d92ea78-
89c7-2334-e044-00144f67d249%2FDISS-9d92ea78-89c7-2334-e044-
00144f67d249&uuid=AGGR-1d2a0e67-531a-489a-8bde-a3965db67638%2FDISS-
9d92ea78-89c7-2334-e044-00144f67d249 
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Risk following oral exposure 
Available toxicity data for oral exposure is mainly related to silver used in drug 
applications. Based on human data (agyria) a limit in drinking water is set to 
0.01 mg/L corresponding to 0.02 mg/person/day. This value corresponds to 
2.5 % of an estimated human lifetime NOAEL of 10 g (corresponding to 0.4 
mg/person/day over a 70 years period). 
This value is much lower as compared to a DNEL value of 1.2 mg/kg bw/d 
for bulk silver for systemic effects which has been derived by the registrant of 
silver in the REACH registration dossier on silver (ECHA web site April 
2011)8, again indicating that nano-silver is more toxic than bulk silver. 
No quantitative data for consumer exposure to nanosilver have been identi-
fied, and therefor no quantitative risk assessment can be performed.  
The oral route is not expected to be the most important route of exposure for 
consumers, except from intake of nano or colloidal silver as food supplement, 
where high exposure could be expected. Consumer exposure via the oral 
route could alsooccur, albeit at a relatively low level, if chewing on silver con-
taining textiles or skin to mouth contact, from cosmetics containing nano-
silver.  
However, relatively high exposures may occur from silver containing tooth 
brusches or toothpaste. If it is considered that toothpaste contain 0.002% 
nanosilver, and estimated that a person use 1 tube of toothpaste of 100g in 20 
days. As a worst case exposure estimate, assuming that 100% of the nanosilver 
is absorbed, will be 0.1 mg/person/day. This is 10 times higher than the limit 
for drinking water in Denmark and 25% of the human NOAEL for silver.   
Existing knowledge base 
Nowack et al. (2011) refers to existing knowledge from the more than 50-year 
use of nanosilver for biocidal, algicidal and disinfectant uses and use of colloi-
dal nanosilver for medical purposes. The authors conclude that the toxicity of 
silver is considered to be relatively low and that toxic effects on humans other 
than argyria are only observed at very high concentrations. Furthermore, they 
state that a significant portion of the historical toxicological research on the 
effects of silver on humans can be considered early examples of “nanotoxicol-
ogy”. 
According to Nowack et al. (2011) data about effects on nonmammalian spe-
cies for environmental risk assessment have until recently been obtained 
mostly using dissolved silver, and nano-Ag is only studied as part of more re-
cent research. The authors stress that it is questionable if data obtained using 
ionic silver should be used to derive threshold values in the environment as 
silver in natural waters typically is associated with the particulate or colloidal 
fraction and thus to some extent is naturally present as nanoparticles and 
metal-sulfide clusters. Many aquatic species are much more sensitive to silver 
compared to mammals and therefore the question whether nanosilver has a 
different toxicity compared to dissolved silver is extremely important.  
                                                          
8 ECHA (2011) http://apps.echa.europa.eu/registered/data/DISS-9d92ea78-89c7-
2334-e044-00144f67d249/showdocument671a.html?treeUuid=DISS-9d92ea78-
89c7-2334-e044-00144f67d249%2FDISS-9d92ea78-89c7-2334-e044-
00144f67d249&uuid=AGGR-1d2a0e67-531a-489a-8bde-a3965db67638%2FDISS-
9d92ea78-89c7-2334-e044-00144f67d249 
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Based on the long historical record of relatively safe use and regulation of sil-
ver including nanosilver, Nowack et al. (2011) argue that nanosilver is a mate-
rial that does not fit the paradigm of "new" chemical with new and unknown 
risks and therefore it is sufficient to apply the existing coherent risk assess-
ment framework for other silver-containing materials. 
 
7.8 Summary sheet for nano-Silver 
Nanomaterial characteristics   
Name Silver; NanoAg 
CAS number 7740-22-4 (elemental Ag) 
Chemical composition Ag 
Appearance White lustrous powder 
 
Source: 
http://www.tradevv.com/ 
Manufacturing processes 
 
Ultra-sonic precipitation, chemical vapour deposition, exploding 
wire synthesis. The size, shape, surface area, etc. can be modi-
fied by adding various surface active agents and coatings to 
syntheses involving silver salts. 
Nanomaterial description   
Nanosilver (AgNP) is the nanoform of silver characterized by being spherical particles of sizes 
ranging from 1-250 nm. AgNP is commercialized as powder, flakes, grains, ingots, etc., and is sold 
in suspension (in water, alcohol or surfactant) and as a dry powder. AgNP also available in prepa-
rations (e.g. as a coating agent, in alloys, etc.) and in articles (electrodomestic appliances, in tex-
tiles, in food packages, etc.). In its pure form AgNP will aggregate and hence nanosilver is often 
surface modified with for instance dextran, citrate, or PVP. Sometimes AgNP is also found to be 
deposited on or used as a coating of a substrate such as plastic, silica or polymers, to give a de-
sired adhesion, electrical conductivity, etc. In aqueous solutions AgNP forms dissolved free silver 
ions in aqueous by dissolution and subsequent oxidation.  
Applications   
The use of AgNP is very diverse and include therapeutic applications (diet supplement), personal 
care products, powdered colours, varnish, textile, paper, interior and exterior paints, printing col-
ours, water and air-purification, polymer-based products and foils for antibacterial protection such 
as washing machines, kitchenware and food storage. The AgNP concentrations used are unknown 
for most applications. The scale of use of AgNP is unknown at this point in time, but expected to 
increase rapidly as more and more consumer products with AgNP are entering the market. 
Human health risk profile   
It has been shown that silver nanoparticles can be absorbed via especially the oral and  inhala-
tional route, whereas intact skin is a barrier against absorption. However, it is unclear in which 
form (as particles, free ions, silver ions or complexes) nanosilver is absorbed and distributed to 
target organs.  At least for uptake via the oral route it is likely that at least some of the uptake oc-
curs as ions. It appears that smaller particles exhibit higher toxicity as compared to larger particles; 
and if silver is absorbed as particles then the surface area is relevant.    
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Should silver uptake occur solely as ions, the database for silver could be applied to assess sys-
temic silver nanoparticle toxicity.  For that exercise, it would need to be considered whether and 
how the dramatically increased surface area and possibly increased solubility of silver nanoparti-
cles would need to be taken into account. 
Quite a few, mainly in vitro studies, have shown that the main mechanism of silver nanoparticle 
toxicity seems to be mediated by an increase in ROS production, stimulating inflammation and 
genotoxic events and apoptosis or necrosis.  The concentration of the administered nanoparticles 
is able to influence the toxicity, specifically, at low levels of oxidative stress a protective response is 
initiated which progresses to a damaging response with increasing particle concentration, and 
therefore oxidant levels.  It is thus relevant to consider that the toxicity of silver nanoparticles is 
thresholded. 
No data are identified about consumer exposure to nano-silver. The most important exposure 
route for consumers is expected to be dermal exposure from textiles and cosmetics. However, 
from available data only minimal absorption is expected even on damaged skin, but further in vivo 
studies would result n more precise estimates.  
Consumer exposure via inhalation can occur from products used in spray form. Based on available 
toxicological data, it is recommended to avoid exposure via inhalation, because health effects like 
reduced lung function and toxic effect on the liver are considered to be the critical effects from 
inhalation. 
It is still unclear whether nano-silver is more toxic than bulk silver after oral exposure, especially 
after long term exposure. The toxicity of silver after oral exposure is low, however after long term 
exposure silver can accumulate in the skin and different organs, which can result in a bluish-gray 
colouring of the skin (agyria) or deposition in the eyes (agyrosis). The effect on other organs after 
long term exposure is still unknown. 
For long term (life time) exposure a limit of 0.01 mg/L is set for silver in drinking water.  
Even though the oral exposure is not expected to be the main exposure route for consumers, expo-
sure from tooth paste can occur and might be close to the exposure from drinking water. High 
exposure could be expected from intake of food supplements containing nano- (colloidal) silver, 
which are available on the internet, but not approved for use in Europe.  
Environmental risk profile   
Silver is known to be an ecotoxic metal and test with silver nanoparticles (AgNP) do also reveal 
very low effect concentrations. Thus, for algae EC50-values as low as 4 μg/L has been found and 
also for crustaceans values far below 1 mg/L has been reported. This ranks AgNP as “Aquatic 
Chronic 1”. It is also important to note that at concentrations below 1 mg/L inhibition of nitrifying 
bacteria can occur and thus the function of wastewater treatment plants may be affected by the 
presence of AgNP. For ionic silver it is known that the speciation in aqueous media is determining 
for the bioavailability and toxicity. This is most likely also the case for elemental silver nanoparti-
cles, but influence of speciation on uptake, depuration, and toxicity remain to be studied in this 
case. 
The environmental concentration resulting from the use of AgNP in consumer products are at 
present uncertain, even though a number of different estimates have been proposed. It has been 
documented that even though silver nanoparticles are incorporated in textiles, they can be re-
leased upon washing. Concentrations in the low ng/L range have been proposed and even such 
low concentrations may under very precautious assumptions9 constitute an environmental risk 
due to the high toxicity of silver. 
It is debated today whether silver nanoparticles are in fact more toxic that their bulk counterpart, 
since effects in many cases can be ascribed to the ionic form of silver (Ag+). Some studies have 
documented a higher effect of AgNP, but it is the widespread and dispersive use of silver in con-
sumer products that poses the greatest risk to the aquatic and terrestrial environment. Even if 
AgNPs are “only” as toxic as larger silver particles, silver is still a metal of high environmental con-
cern. 
                                                          
9 Using the highest assessment factor of 1000 and that the bioavailability of silver is 
not reduced due to complexation.   
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8 Nanoclay 
8.1 General characteristics 
Nanoclays are minerals which have a high aspect ratio and with at least one 
dimension of the particle in the nanometer range. The most important factor 
is the aspect ratio of the clay particle. The clays having a platy structure and a 
thickness of less than one nanometer are the clays of choice. Silica is the 
dominant constituent of clays followed by alumina. Depending on the chemi-
cal composition and nanoparticle morphology, nanoclays can be organised in 
several classes including bentonite with montmorillonite as the principle clay 
mineral consituent, kaolin and smectite.10: 
 Bentonite is the rock or ore that contains the clay mineral montmoril-
lonite.  
 Smectite is a clay mineral group characterized as an expanding clay 
mineral which includes the clay minerals vermiculite, sauconite, sapo-
nite, nontronite, hectorite and montmorillonite.  
 Montmorillonite is a clay mineral species with a 2:1 expanding crystal 
lattice whereas kaolinite is a 1:1 layer type.  
 Cloisite® Na+ is a highly refined, untreated montmorillonite sold un-
der the trademark of Cloisite® nanoclay by Southern Clay Products.  
The terms Montmorillonite, Smectite and Bentonite are sometimes used in-
terchangeably. 
Montmorillonite clays are the most commonly used nanoclays. Montmorillo-
nite nano clays are unique clays having a platy structure with a unit thickness 
of one nanometer or less but the surface dimension is generally 300 to more 
than 600 nm. The aspect ratio is in the 1000:1 range (Suresh et al., 2010).  
Organically-modified nanoclays (organoclays) constitute a class of hybrid or-
ganic-inorganic nanomaterials with potential uses in polymer nanocomposites, 
as rheological modifiers, gas absorbents and drug delivery carriers. 
 
8.2 Manufacturing processes 
Clays are mined and purified and then milled into the desired size.  
Because montmorillonite clay is hydrophilic, it is not compatible with most 
polymers and must be chemically modified to make its surface more hydro-
phobic. The most widely used surface treatments are ammonium cations, 
which can be exchanged for existing cations already on the surface of the clay. 
A lot of research is going into surface modication of nanoclay (e.g. onuim ion 
modification) in order to make nanoclay dispersed evenly in polymers which 
                                                          
10 From: http://www.nanoclay.com/faqs.asp 
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are generally organophilic (Nanocor, 2010; Vejen-Henriksen et al., 2009; 
Briel, 2010). 
 
8.3 Uses 
8.3.1 Main applications 
The organically modified platelets have been proven to reinforce thermoplas-
tics by enhancing flexural and tensile modulus while lowering CLTE (The 
Coefficient of Linear Thermal Expansion). They are also effective at improv-
ing gas barrier properties of thermoplastic systems. The surface char forma-
tion and flame retardance of thermoplastic systems have also been improved 
by incorporating the nanoclay particles into the structure. Other unique appli-
cation areas have been shown to include improvement of the properties of in-
jection molded pieces for the automotive industry, of flexible and rigid pack-
aging such as films, bottles, trays, and blister packs, and also of electronics 
plastics such as wire and cable coatings. 
Nanoclay has also been shown to improve the mechanical properties of ce-
ment and result in higher compressive strength and tensile strength of cement 
mortars compared to plain cement with the same water-binder ratio (Morsy et 
al., 2010). 
The main application of nanoclay seems to be food packaging where they may 
also substitute materials based on petrochemical polymers. The platelet mor-
phology of nanoclays forces gases to follow a complicated path through the 
polymer, which slows down their transmission. The nano-layer structure 
thereby increases the path of diffusion that penetrating molecules of gases or 
other substances must take and significantly improves the polymer's barrier 
properties. Examples of pacgaging materials include beer bottles (PEN 2010). 
Often the nanoclay is embedded in a polypropylene layer that is itself placed 
between external and internal polyethylene layers (Taylor, 2008). No con-
sumer products have been identified in the database to entail nanoclay on the 
Danish market.  
The nanoclay concentrations used in food packaging have not been identified 
and the scale of use is not known at this point in time.  
Other reported uses of nanoclays include the use as synergist flame retardant 
to substitute the halogen-containing flame retardants. Organoclays are not 
flame retardant agents as such, but they show synergistic effects with a broad 
range of conventional flame retardants like aluminium hydroxide, magnesium 
hydroxide as well as halogen- and phosphor-based flame retardants. By add-
ing low concentrations of organoclay to thermoplastics the amount of conven-
tional flame retardants can be reduced significantly (Pirngadi and Richter, 
2005). 
8.3.2 Results from industry survey 
The finest clay minerals (e.g the mineral smectite) are in reality nanomateri-
als. Nanoclay is the main component of bentonite, which is defined as a clay 
material dominated by smectite. Bentonit is among other places extracted in 
Denmark (at Tåsinge) (Lindgreen, 2010). 
In Denmark nanoclay is e.g. utilised for production of leca (insulation material 
based on clay), drilling mud, and for tightening of drillings holes etc. Nano-
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clay is known to be used in other countries as additive for lacquers etc. and 
probably also plastic materials. From other countries also patents on the use of 
nanoclay in cement exist. (Lindgreen, 2010). 
Use of nanoclay in cement has also been tried in Denmark, but only as an ex-
periment that now has been stopped (Damtoft, 2010).   
No information on import of nanoclay in finished products to Denmark could 
be obtained.  
The extraction of nanoclay in Denmark is anticipated to exceed 30.000 
tons/year (Dantonit, 2010). 
Information about use in food packaging was not obtained during the survey. 
 
8.4 Eco-toxicological profile 
No ecotoxicological studies of nanoclay have been identified as of 30 Novem-
ber 2010. Since clay is a naturally occurring material for which environmental 
organisms have adapted throughout evolution, the inherent toxicity is ex-
pected to be low, however, issues related to small particle sizes may occur.  
 
8.5 Toxicological profile 
Today few studies are available and there is limited knowledge about the tox-
icity of nanoclays and the chemical derivatives that may be generated during 
production and processing of polymer nanoclay composites. However, in 
general nanoclay is not considered to pose a major health risk although a pos-
sible content of crystalline quartz may constitute a risk. Furthermore, func-
tionalised nanoclays containing quaternary ammonium or phosphonium func-
tional groups on the surface are described as potentially problematic, as am-
monium and phosphonium ions in their pure form can cause asthma symp-
toms (NFA, 2010).  
8.5.1 In vivo studies 
Li et al. (2010) investigated the acute toxicity of nanoclay fed to Sprague-
Dawley rats and found LD50 to be greater than 5700 mg/kg bw for both male 
and female rats.  
Warheit et al. (2010) compared the pulmonary and extrapulmonary systemic 
impacts in rats of intratracheally instilled Sepiolite nanoclay samples with 
quartz or ultrafine titanium dioxide particle-types at doses of 1 mg/kg or 5 
mg/kg. Dedicated groups were evaluated by bronchoalveolar lavage, lung cell 
proliferation, macrophage functional assays and full body histopathology at 
selected times postexposure (pe). Bronchoalveolar lavage results demon-
strated that quartz particles produced persistent, dose-dependent lung in-
flammatory responses measured from 24 h through 3 months pe. Exposures 
to Sepiolite samples produced transient neutrophilic responses at 24-h pe; 
however, unlike the other particle-types, Sepiolite exposures produced 
macrophage-agglomerates or multinucleate giant cells at 1 week, 5 weeks and 
3 months pe. Lung parenchymal cell proliferation rates were increased in rats 
exposed to quartz but not Sepiolite. Histopathological evaluation of lung tis-
sues revealed that pulmonary exposures to Sepiolite nanoclay or quartz sam-
ples produced inflammation in centriacinar regions at 24 hours pe but the ef-
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fects decreased in severity over time for Sepiolite and increased for quartz-
exposed rats. The quartz-induced lesions were progressive. In the Sepiolite 
nanoclay group, the finding of multinucleated giant cell accumulation associ-
ated with minor collagen deposition in acinar regions was rarely observed. Full 
body histopathology studies were conducted at 24 h and 3 months post parti-
cle exposures. Histopathological evaluations revealed minor particle accumu-
lations in some mediastinal or thoracic lymph nodes. No extrapulmonary tar-
get organ effects were observed in any of the particle-exposed groups at 3 
months post exposure. 
8.5.2 In vitro studies 
Lordan et al. (2011) evaluated the cytotoxic effects induced by unmodified 
(Cloisite Na+ ®) and organically modified (Cloisite 93A®) nanoclays in the 
human hepatic HepG2 cell line. Following 24 h exposure the nanoclays sig-
nificantly decreased cell viability. Cloisite Na+ induced intracellular reactive 
oxygen species (ROS) formation which coincided with increased cell mem-
brane damage, whilst ROS generation did not play a role in Cloisite 93A-
induced cell death. Neither of the nanoclays induced caspase-3/7 activation. 
Moreover, in the cell culture medium the nanoclays aggregated differently and 
this appeared to have an effect on their mechanisms of toxicity. Based on re-
sults from the study the authors concluded that nanoclays are highly cytotoxic 
and as a result pose a possible risk to human health. 
Li et al. (2010) evaluated the in vitro cytotoxicity and genotoxicity of exfoli-
ated silicate nanoclay using the Comet assay in Chinese Hamster Ovary 
(CHO) cells, a micronucleus test and the Salmonella gene mutation assay on 
strain TA98, TA100, TA102, TA1535 and TA1537. The Comet assay 
showed no DNA damage after 24 h of incubation with NSP of 1000 g/mL. 
No significant micronucleus induction was observed in the CHO cells at the 
concentrations tested, and no of mutations were found in the five Salmonellea 
strains. Furthermore, cytotoxicity of the same material was assayed, showing a 
low cytotoxicity on CHO cells below 1000 µg/mL after 12 h incubation period 
and a dose-dependent effect after 24 h incubation.  
Sharma et al. (2010) investigated the potential of filtered and unfiltered water 
suspensions of the natural clay mineral montmorillonite (Cloisite® Na+) and 
an organo-modified montmorillonite (Cloisite®30B) in the Salmo-
nella/microsome assay at concentrations up to 141 g/ml of the crude clay, 
using the tester strains TA98 and TA100. Both clays did not induce muta-
tions in this assay. Filtered and unfiltered Cloisite®Na+ suspensions in cul-
ture medium did not induce DNA strand-breaks in Caco-2 cells after 24 h of 
exposure, as tested in the alkaline comet assay. However, both the filtered and 
the unfiltered samples of Cloisite®30B induced DNA strand-breaks in a con-
centration-dependent manner and the two highest test concentrations pro-
duced statistically significantly different results from those seen with control 
samples. When tested in the same concentration range as used in the Comet 
assay, none of the clays produced ROS in a cell-free test system (the DCFH-
DA assay). Inductively coupled plasma mass-spectrometry indicated that clay 
particles were absent in the filtered samples, which was independently con-
firmed by dynamic light-scattering measurements. Detection and identifica-
tion of free quaternary ammonium modifier in the filtered sample was carried 
out by HPLC-Q-TOF/MS and revealed a total concentration of a mixture of 
quaternary ammonium analogues of 1.57 mu g/ml. These findings suggest 
that the genotoxicity of organo-modified montmorillonite was caused by the 
organo-modifier. The detected organo-modifier mixture was synthesized and 
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Comet assay results showed that the genotoxic potency of this synthesized 
organo-modifier was in the same order of magnitude at equimolar concentra-
tions of organo-modifier in filtrated Cloisite (R) 30B suspensions, and could 
therefore at least partly explain the genotoxic effect of Cloisite (R) 30B. 
8.5.3 Summary  
The acute toxicity of nanoclay is low based on the results of a rat study. Tran-
sient inflammatory reactions were observed in rats after intratracheal instilla-
tion of Sepiolite nanoclay but no extrapulmonary target organ effects were 
observed following the exposure. 
No consistent picture regarding cytotoxicity and genotoxicity of nanoclays 
can be drawn based on the available studies. 
 
8.6 Exposure scenarios 
There is so far not much information about exposure to nanoclays. The use of 
nanoclay embedded in polymers is in general not considered to give rise to a 
risk of exposure neither to humans nor in the environment during the use 
phase of the products, although some experiments indicate that nanoclay can 
be released from polymer nanocomposite (PNC) film (NFA, 2010). Nano-
clays are typically used in concentrations up to 5% in polymer materials (En-
vironmental Project No. 1206, 2007). 
When used for other applications e.g. insulation materials or in conncetion 
with other construction work a potential for dermal and inhalational exposure 
should be considered. 
After disposal of the products, nanoclay may be released, but since nothing is 
known today about release of nanomaterials during waste management opera-
tions (e.g. recycling, landfilling, or incineration), exposure estimations cannot 
be made. 
 
8.7 Risk profile 
8.7.1 Environment 
No ecotoxicological studies of nanoclay have been identified as of 30 Novem-
ber 2010. Since clay is a naturally occurring material for which environmental 
organisms have adapted throughout evolution, the inherent risk may be ex-
pected to be low, however, issues related to small particle sizes may occur.  
8.7.2 Human health 
Nanoclay has low acute toxicity in animal experiments and is normally not 
considered to constitute a significant health hazard except for the possible ef-
fects on the lungs from inhaling dust. For assessing risk in relation to con-
struction applications and dermal and inhalational exposure there are no spe-
cific data available related to the nanoform of the clay, so it is uncertain to 
which extent nanoclay have another toxicological profile compared to clay 
particles in general. A possible content of crytalline quartz (up to 0.5 %) may 
add to the risk from inhalation of the material. Likewise a possible content of 
quaternary ammonium or phosphonium functional groups on the surface may 
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potentially be problematic, as ammonium and phosphonium ions in their pure 
form can cause asthma symptoms (NFA, 2010).  
In general the risk in relation to nanoclay is related to the inhalation of mineral 
dust which should always be minimised independent of the the size and form 
of the particles. 
 
8.8 Summary sheet for nanoclay 
Nanomaterial characteristics   
Name Nano-clay 
CAS number Not applicable 
Chemical composition Silica/alumina containing 
mineral 
Appearance Fine powder 
 
Source: 
http://www.nanocor.com 
Manufacturing processes Clay is mined and purified and then milled into the desired size. 
Nanomaterial description   
As it is the case for clay, nano-clay consists of finely grained alumina silicate minerals like mont-
morillonite, which is a 2-to-1 layered smectite clay mineral.  Individual platelets are just about one 
nanometer thick, but surface dimension are generally 300 to more than 600 nm. Natural mont-
morillonite is hydrophilic and a lot of research is going into surface modication of nanoclay (e.g. 
onuim ion modification) in order to make nanoclay dispersed evenly in polymers which are gener-
ally organophilic. 
Applications   
Main application of nanoclay seems to be food packaging e.g. in beer bottles. Often the nanoclay 
is embedded in a polypropylene layer that is itself placed between external and internal polyethyl-
ene layers. The nanocaly concentrations used in food packaging are unknown and so is the scale of 
use at this point in time.  
Human health risk profile   
Nanoclay has low acute toxicity in animal experiments and is normally not considered to constitute 
a significant health hazard except for the possible effects on the lungs from inhaling dust. A possi-
ble content of crytalline quartz (up to 0.5 %) may add to the risk from inhalation of the material. 
Likewise a possible content of quaternary ammonium or phosphonium functional groups on the 
surface has been discussed as potentially problematic as ammonium and phosphonium ions in 
their pure form can cause asthma symptoms. No dose-response relationships are established. 
Environmental risk profile   
No ecotoxicological studies of nano-clay have been identified as of 30 November 2010. Since clay 
is a naturally occurring material for which environmental organisms have adapted throughout 
evolution, the inherent toxicity can be expected to be low, however, issues related to small particle 
sizes may occur. 
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9 Silicium dioxide SiO2  
9.1 General characteristics 
Silica or silicon dioxide (SiO2) is an abundant mineral commonly found in 
nature in the form of sand or quartz as well as in cell walls of diatoms. SiO2 
has a number of distinct crystalline forms (rhombohedral, hexagonal, ortho-
rhombic) in addition to amorphous forms e.g. α-quartz, β-quartz. Amorphous 
nanoSilica particles can be produced in all sizes e.g. one manufacturer has 
nanosilica particles available in the size of 9, 15, 30 and 55 nm with a specific 
surface area of 300, 200, 100 and 50 m2/g (Bayercoatings, 2010). The shape 
of nanosilica is normally spherical, but other forms exsist as well such as for 
instance springs and nanosilica can also vary in regard to their porousity. 
Nanosilica can furthermore be functionalized with for instance organogroups 
as well as other metals (mknano, 2010). 
 
9.2 Manufacturing processes 
Several methods can be used to produce nanoparticles. NanoSilica can be 
produced via the sol-gel method where silica monomers are allowed to con-
dense to colloidal particles, which again can form aggregates and age. Another 
method is high-temperature hydrolysis in a hydrogen oxygen flame. The term 
pyrogenic silica refers to highly dispersed silicas formed from the gas phase at 
high temperature. The vapor-liquid-solid method can be used to produce sil-
ica nanospring (Lidong et al., 2006). Silica nanoparticles are often used in 
formulation or as components of other nanoparticles as e.g. a surface silaniza-
tion may result in less cytotoxic nanoparticles suited for bio-applications.  
 
9.3 Uses 
9.3.1 Main applications 
Silica nanoparticles have numerous applications such as ingredients in ce-
ment, paints, solid lubricants, shampoos, cosmetics, face creams and food 
(spices) (Wiesner, 2005; Environmental Project No. 1206, 2007; Winter et 
al., 2010; PEN, 2010). Bioelectrocemistry, curing, oil recovering applications 
and in formulation of other particles are furthermore potential applications 
(Sun et al., 2009; Makimura et al., 2010). Organo-silica has also been re-
ported to be used as scratch resistant coatings (Boxall et al., 2008). No prod-
ucts were identified using silica nanoparticles on the Danish marked, but a 
total of 14 products were identified that use the non-oxidized form of silica, 
namely silicon (Si). Of these products nine products were in the category 
Health and Fitness.  
Very little information is available about the SiO2 concentrations used in the 
various products. Concentrations of 0.1% and 15% have been reported for 
paints, whereas organo-silica used in concentrations of 10% in scratch resis-
tant coatings are reported. Very little is furthermore known about the scale of 
use, but one Danish company has been reported to handle 1-10 ton silica per 
year (Environmental Project No. 1206, 2007, Boxall et al., 2008). 
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9.3.2 Results from industry survey 
Microsilica is a residual from manufacturing of ferrosilicium with a size of 1-
10 nm. Microsilica may be used in concrete as well as in paint etc.  The sur-
vey on the use of microsilica has been focused on concrete assumed to be a 
dominant field of application. 
In concrete, microsilica has been used since the 1980'es. Use of microsilica 
prevents alkali-silica reactions that may cause concrete to be torn apart. Mi-
crosilica furthermore has a puzzulane effect and may increase the tightness 
and thereby the strength of concrete. Previously microsilica was widely used 
for manufacturing of concrete in Denmark. Today the use has been signifi-
cantly reduced, primarily because of strong price increases due to heavy de-
mand from the Middle East. (Eriksen, 2010). According to Environmental 
Project No. 1206 (2007), the commercially available silica nanoparticles (Mi-
crosilica) with a grain size of 100-200 nm are used in the production of con-
crete. In dry form the used silica nanoparticles are aggregated with an aggre-
gate size above 100 nm. When dispersed in water the aggregates break up into 
primary particles smaller than 100 nm. 
The content of microsilica used in concrete will correspond to 4-6 % (weight-
based) of the amount of cement (Eriksen, 2010). 
The present consumption of microsilica in concrete in Denmark may be 
roughly estimated to at least 3. - 4.000 tonnes/year (Jensen, 2010). 
 
9.4 Eco-toxicological profile 
For the following overview of the ecotoxicological profile of nano-scale silica 
(SiO2) it should be stressed that only a few ecotoxicological studies exist and 
only a part of these are aimed at the base-set organisms (fish, crustacean and 
algae) required for doing effects assessment according to REACH. Even 
fewer studies report the results in terms of the endpoints and values listed in 
Information Requirements of the REACH (e.g., LC50, EC50, NOEC, LOEC) 
(ECHA, 2008).  
For zebrafish embryos (Danio rerio) significant incidences of jaw malforma-
tions was noticed at the concentration of 250 mg/L, but other effects were not 
reported as result of the SiO2/AlO2 nanoparticles (Harper et al., 2008). Silica 
nanowires of 200 nm and 50 nm) with aspect ratios (i.e. ratio between length 
and diameter) greater than 1 has been found to cause zebrafish embryo de-
formities, but particles with aspect ratio of 1 did not exhibit any toxic or tera-
togenic activities at the same concentrations (Nelson et al., 2010).  
A study by Fent et al. (2010) assessed the uptake and embryo toxicity of fluo-
rescent silica nanoparticles in zebrafish (Danio rerio). Two different size fluo-
rescent silica nanoparticles (~200nm and ~60nm) were used. Zebrafish em-
bryos were exposed to concentrations of 0.0025-200 mg/L.  No significant 
changes were observed in the survival time, hatching time, the morphology of 
embryos or larvae or development of zebrafish eggs.  
For the freshwater crustacean, Daphnia magna, it was found that SiO2 concen-
trations of 10 mg/L caused 70% mortality (Adams et al., 2006).  
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Growth inhibition tests using the algae Chlorella kessleri showed that the size 
of cells increased as a result of exposure with the 5 nm SiO2 particles and that 
these had a greater effect than the 26 and 78 nm particles (Fujiwara et al., 
2008). Growth rate inhibition of the green algae Pseudokirchneriella subcapitata 
(72 h incubation) was observed after exposure to 12.5 nm and 27 nm silica 
NPs by van Hoecke et al. (2008). EC10, 72h were found to be 10.9 ± 4.4 mg/L 
and 15.0 ± 4.3 mg/L, and NOEC and LOEC were observed to be 4.6 and 
10.0 mg/L for 12.5nm and 27 nm SiO2 NPs, respectively. Taking the specific 
surface area of the silica particles into account, van Hoecke et al. (2008) also 
expresse EC10-values as EC10, 72h in units of m2/l yielding values of 2.6 ± 1.0 
and 2.0 ± 0.6 m2/L 12.5nm and 27 nm SiO2 NPs respectively. The toxicity of 
silica nanoparticles (10-20 nm) and the bulk particles (5-10μm) towards the 
green algae Scenedesmus obliquus revealed EC20 values of 388.1 mg/L (72 h) 
and 216.5 mg/L (96 h) (Wei et al. 2010).  
No studies on the bioaccumulation of SiO2 have been found as of 22 October 
2010. By definition metal oxide nanoparticles are not degradable and speci-
ation of SiO2 (e.g. dissociation or complexation) is not likely to occur in 
aquatic media under normal conditions. Therefore, SiO2 particles can be re-
garded as persistent in the sense that the particles will remain as SiO2-
particles, however the sizes of the particles may change due to agglomeration 
and aggregation in aquatic media.  
 
9.5 Toxicological profile 
Most of the available toxicological research into bulk silica has focussed on 
coarse or fine crystalline silica particles of 0.5 to 10 m. Crystalline silica in 
the form of quartz is an IARC classified human carcinogen and is involved in 
the pathogenesis of silicosis. However, the mechanisms of crystalline silica 
toxicity at the cellular or molecular levels are still unclear. It is also not known 
if any single mechanism underlies the observed effects although severe in-
flammation appears to be a common initiating step. The role of reactive oxy-
gen species in the inflammatory, fibrogenic and carcinogenic activity of quartz 
is well established. Oxidative membrane and DNA damage are considered the 
most important mechanisms involved in the health effects of microsized crys-
talline silica (Napierska et al., 2010). A large body of experimental work has 
shown that particle surface reactivity and the form of silica seem to govern the 
hazardous nature of crystalline silica and that cytotoxicity appears to be di-
rectly related to the form of the particles and the extent of the exposed sur-
face. 
Amorphous silica and the naturally occurring amorphous silica such as diato-
maceous earth are in general considered less harmful than its crystalline coun-
terpart. With regard to the cytotoxic activity of different forms of amorphous 
silica, it has been shown not to depend on a crystalline silica component but 
rather on the surface charges and morphologic features of particles (Napier-
ska et al., 2010). 
For the silica nanoparticles (SNPs) the origin/synthesis of the particles plays 
an important role in determining the physico-chemical properties and conse-
quently their potential interactions with biological systems. Relevant parame-
ters are surface area, surface morphology, surface energy, dissolution layer 
properties, adsorption and aggregation properties (Napierska et al., 2010). 
Nanosilica occurs mainly in the amorphous form, and the potential hazard 
cannot be simply related to studies of micron-sized crystalline materials. 
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9.5.1 ADME studies 
No studies investigating the absorption from the site of exposure into the 
blood have been identified. One in vivo study investigating the impact of size 
on tissue distribution and elimination of SNPs has been identified. In this 
study nanosilica (50, 100, and 200 nm diameter) injected intravenously into 
mice was observed in macrophages of the liver and spleen for four weeks after 
a single injection. The study also showed that the smaller particles were 
cleared via urine and bile more rapidly than larger particles (Cho et al., 2009). 
Kumar et al. (2010) studied biodistribution of multimodal organically modi-
fied SNPs intravenously administered to nude mice and found a greater ac-
cumulation of nanoparticles in liver, spleen, and stomach than in kidney, 
heart, and lungs. Almost 100% of the injected nanoparticles were effectively 
cleared out of the animals over a period of 15 days via the hepatobiliary excre-
tion. No signs of organs toxicity were observed. 
In an in vitro study in human mesenchymal stem and 3T3-L1 cells the effect 
of surface charge on cellular uptake of mesoporous nanosilica (porous silicates 
with very big surface areas) was evaluated. The results showed that the uptake 
could be regulated by a threshold of positive surface charge and also imply 
that the modulation of surface charge is cell specific (Chung et al., 2007). 
9.5.2 Short term toxicity 
Inhalation 
Six in vivo studies, one involving inhalation and five involving intratracheal 
installation of a single dose of different forms of silica in rats and mice have 
been identified.  
Sayes et al. (2010) exposed rats by inhalation to freshly generated, aerosolised 
amorphous silica NP for 1 or 3-days. Neither exposure period produced any 
significant pulmonary inflammatory, or adverse lung histopathological effects 
in rats exposed to very high particle numbers corresponding to a range of 
mass concentrations (1.8 or 86 mg/m3). It was also concluded that there was 
no genotoxic effects from the exposure. 
In a study with intratracheal instillation of different sizes of nanoquartz and 
mined quartz particles in rats the theory that nanoparticles are more toxic than 
fine-sized particles of similar chemistry was contradicted. Well-characterized 
samples were tested for surface activity and hemolytic potential. In addition, 
groups of rats were instilled with either doses of 1 or 5 mg/kg of carbonyl iron 
(CI) or various alpha-quartz particle types in phosphate-buffered saline solu-
tion and subsequently assessed using bronchoalveolar lavage fluid biomarkers, 
cell proliferation, and histopathological evaluation of lung tissue at 24 h, 1 
week, 1 month, and 3 months postexposure. Exposures to the various alpha-
quartz particles produced differential degrees of pulmonary inflammation and 
cytotoxicity, which were not always consistent with particle size but correlated 
with surface activity, particularly hemolytic potential. The results demonstrate 
that the pulmonary toxicities of alpha-quartz particles appear to correlate bet-
ter with surface activity than particle size and surface area (Warheit et al., 
2005). 
Another study with intratracheal instillation of colloidal silica in rats revealed 
that the effect of fibrogenesis of nanosized SiO2 might be milder than that of 
microsized SiO2 in rats, potentially resulting from nanoparticles tending to be 
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diffused and easily translocated due to their ultrafine particle size compared to 
microsized particles (Chen et al., 2004). 
Kaewamatawong et al. (2006) compared acute pulmonary toxicity from expo-
sure to ultrafine colloidal silica particles (UFCSs) and fine colloidal silica par-
ticles (FCSs) in mice intratracheally instilled with 3 mg of 14 nm UFCSs and 
230 nm FCSs revealed for both sizes bronchiolar degeneration, necrosis, neu-
trophilic inflammation, alveolar type II cell swelling and alveolar macrophage 
accumulation. UFCs induced extensive alveolar hemorrhage, a more severe 
bronchiolar epithelial cell necrosis and neutrophil influx in alveoli compared 
to FCSs. Electron microscopy demonstrated UFCSs and FCSs on bronchio-
lar and alveolar wall surface as well as in the cytoplasm of alveolar epithelial 
cells, alveolar macrophages and neutrophils. Type I alveolar epithelial cell ero-
sion with basement membrane damage in UFCSs treated animals was more 
severe than those in FCSs-treated animals. These findings suggest that 
UFCSs have greater ability to induce lung inflammation and tissue damages 
than FCSs. 
Acute and subacute lung toxicity of low dose of UFCSs was further studied in 
mice intratracheally instilled with 0, 0.3, 3, 10, 30 or 100 g of UFCSs (Kae-
wamatawong et al., 2006). Cellular and biochemical parameters in bronchoal-
veolar lavage fluid (BALF), histological alteration and the body weight were 
determined at 3 days after instillation and in addition the time response was 
investigated. UFCSs induced moderate pulmonary inflammation and tran-
sient injury on BALF indices. UFCSs-treated animals showed a significant 
increase of the apoptotic index in lung parenchyma at all observation times. 
Findings from the study suggest that instillation of a small dose of UFCSs 
causes transient acute moderate lung inflammation and tissue damage. Oxida-
tive stress and apoptosis may underlie the lung tissue injury induction. 
Cho et al. (2007) studied the pulmonary effects and inflammatory mecha-
nisms of ultrafine amorphous silica particles (UFASs) intratracheally adminis-
tered to A/J mice at doses of 0, 2, 10 and 50mg/kg (n=5 per group). Bron-
choalveolar lavage fluid analysis, histopathological examination, quantitative 
real-time PCR and immunohistochemistry of the lung tissues were assessed. 
UFASs significantly increased the lung weights and total BAL cells following 
exposures. The histopathological examination revealed that UFASs induced 
transient but severe lung inflammation, with neutrophils, at an early stage and 
chronic granulomatous inflammation at the later stage. Cytokines (IL-1beta, 
IL-6, IL-8 and TNF-alpha) and chemokines (MCP-1 and MIP-2) were iden-
tified as playing important roles in the inflammation induced by the intratra-
cheal instillation of UFASs. 
Dermal 
No in vivo dermal studies investigating short term toxicity have been identi-
fied.  
In a study designed to determine whether nanosilica has the potential to cause 
acute cutaneous toxicity, using cultured HaCaT keratinocytes (CHK) Park et 
al. (2010) evaluated cytotoxicity of two nanosilicas of particle size 7 and 10-
20 nm. HaCaT cell viabilities were determined after exposure to the two 
nanosilicas at different concentrations for 48 h. Both particle sizes dose-
dependently reduced cell viabilities (P < 0.001). No differences were found 
for the two particle sizes. 
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Oral 
No short term oral studies have been identified. 
Intravenous, intraperitoneal, subcutaneous 
Hudson et al. (2008) studied the biocompatibility of mesoporous silicates and 
found that when particles were injected subcutaneously in rats, the amount of 
residual material decreased progressively over 3 months, with good biocom-
patibility on histology at all time points. In contrast, intra-peritoneal and intra-
venous injections in mice resulted in death or euthanasia. No toxicity was seen 
with subcutaneous injection of the same particles in mice. Microscopic analy-
sis of the lung tissue of the mice indicated that death may be due to thrombo-
sis. Although local tissue reaction to mesoporous silicates was benign, they 
caused severe systemic toxicity.  
Nishimori et al. (2009) investigated the relationship between particle size and 
toxicity using silica particles with diameters of 70, 300 and 1000 nm (SP70, 
SP300, and SP1000) as a model material. Silica particles were administered 
intravenously to mice and to evaluate acute toxicity, histological analysis was 
performed for liver, spleen, kidney and lung. SP70-induced liver injury at 30 
mg/kg body weight, while SP300 or 1000 had no effect even at 100 mg/kg. 
Administration of SP70 dose-dependently increased serum markers of liver 
injury, serum aminotransferase and inflammatory cytokines. Repeated ad-
ministration of SP70 twice a week for 4 weeks, even at 10mg/kg, caused he-
patic fibrosis. These findings indicate that nano-size materials may be hepato-
toxic. 
Park and Park (2009) investigated oxidative stress and proinflammatory re-
sponses induced by silica nanoparticles in vivo and in vitro. A single treatment 
of SNPs (50 mg/kg) administered intravenously to mice led to the activation 
of peritoneal macrophages, increased cytokines, and increased level of nitric 
oxide released from the peritoneal macrophages. mRNA expressions of in-
flammation-related genes were also elevated in the cultured peritoneal macro-
phages harvested from the treated mice. Viability of splenocytes from the 
mice treated with silica nanoparticles was significantly decreased in the higher 
dose-treated groups (100 mg/kg, 200 mg/kg i.p.). However, cell proliferation 
without cytotoxicity was shown in the group treated with the low dose of 50 
mg/kg i.p.  
To elucidate the pro-inflammatory mechanism of silica nanoparticles in vivo, 
in vitro study using RAW 264.7 cell line which is derived from mouse perito-
neal macrophage was carried out. Treatment of silica nanoparticles to the cul-
tured RAW264.7 cells led to the reactive oxygen species (ROS) generation 
with a decreased intracellular GSH. In accordance with ROS generation, silica 
nanoparticles increased the level of nitric oxide released from the cultured 
macrophage cell line. These results suggested that silica nanoparticles gener-
ate ROS and the generated ROS may trigger the pro-inflammatory responses 
both in vivo and in vitro (Park and Park, 2009). 
9.5.3 Irritation and corrosion 
Park et al. (2010) studied dermal irritation in a Draize test according to Korea 
Food and drug Administration guideline. Nanosilicas (7 and 10-20 nm) were 
applied to the shaved back of rabbits. No erythema or edema was observed 
after exposure for 24 or 72 hours and the results suggest that nanosilica does 
not induce acute cutaneous irritation.  
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In the same study Park et al. (2010) also carried out a skin irritation study us-
ing a human skin equivalent model, EpiDerm. Models were treated with 500 
g/ml of either nanosilica type for 5 and 18 h. Use of the model revealed no 
irritation potential at 500 g/ml nanosilica. 
9.5.4 Skin and respiratory sensitization (in vitro and in vivo) 
No studies addressing sensitisation in relation to nanosilica have been identi-
fied. 
9.5.5 Repeated dose toxicity, short term, sub-chronic and long term 
Repeated dose: inhalation 
Two studies have investigated the pulmonary responses in rats after up to 4 
weeks inhalation of Ludox colloidal silica. Warheit et al. (1991) exposed CD 
rats (nose-only) for 2 or 4 weeks at concentrations of 0, 10, 50, and 150 
mg/m3 Ludox (dried SiO2). Additional groups of rats exposed for 4 weeks 
were given a 3-month recovery period. Following exposure and/or recovery, 
fluids and cells were recovered from the lungs by bronchoalveolar lavage 
(BAL) and measured for cellular and biochemical parameters. Results showed 
that exposures to 150 mg/m3 Ludox for 2 or 4 weeks produced pulmonary 
inflammation along with increases in BAL protein, LDH, and alkaline phos-
phatase values (p less than 0.05) and reduced macrophage phagocytosis. 
Autoradiographic studies demonstrated that the labelling indices of terminal 
bronchiolar and lung parenchymal cells were generally increased in the 50 and 
150 mg/m3 groups after 2 and 4 weeks of exposure but, with one exception, 
returned to normal levels following a 3-month post exposure period. No sig-
nificant alterations in any measured parameters were detected in rats exposed 
to 10 mg/m3 Ludox at any time postexposure. The no-observable-effect level 
(NOEL) was determined at 10 mg/m3 which was consistent with results ob-
tained by conventional toxicology methods.  
Lee and Kelly (1992) exposed rats for 4 weeks at concentrations of 0, 10, 50, 
and 150 mg/m3 to Ludox colloidal silica. Rats were killed after 4 weeks of ex-
posure and 10 days or 3 months after exposure. No effects were seen at the 
lowest concentration. After 4 weeks exposure, lung weights were increased 
significantly in the two highest dose groups but they were similar to the con-
trols after 3 months. A dose dependent alveolar macrophage response, poly-
morphonuclear leukocytic infiltration, and Type II pneumocyte hyperplasia in 
alveolar duct regions was reported. Lung-deposited nanosilica cleared rapidly 
from the lungs with half-times of approximately 40 and 50 days for the 50 
and 150 mg/m3 groups, respectively. The lungs did not show fibrotic scar tis-
sue formation or alveolar bronchiolarization. 
Chen et al. (2008) investigated age-related differences in pulmonary and car-
diovascular responses to SiO2 nanoparticle in a study with young, adult, and 
old rats exposed toair containing aerosol of manufactured SiO2 nanoparticles 
(24.1 mg/m3; 40 min/day) for four weeks. Inhalation of SiO2 nanoparticles 
under identical conditions caused pulmonary and cardiovascular alterations in 
old rats, and less change in young and adult rats, including pulmonary in-
flammation, myocardial ischemic damage, atrio-ventricular blockage, and in-
crease in fibrinogen concentration and blood viscosity. Old individuals were 
more sensitive to nanoparticle exposure than the young and adult rats. The 
risk of causing pulmonary damages was: old > young > adult and the risk of 
cardiovascular disorder was observed only in old age. The results suggest that 
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different ages may require different biomarkers for identifying pulmonary tox-
icity during inhalation of nanoparticles. 
Repeated dose: dermal 
No dermal in vivo studies with exposure to nanosilica have been identified. 
Repeated dose: oral 
So et al. (2008) studied the effect of micro/nanoparticle silica fed to Balb/c 
and C57BL/6J mice for 10 weeks. The size of the nano and micron sized silica 
were approximately 30 nm and approximately 30 microm, respectively.Blood 
was tested biochemically and hematologically. There was no difference be-
tween the groups in the tested items except ALT (Alanine Aminotransferase). 
The nano sized silica particle dieted group showed higher value of ALT than 
normal and micron sized silica dieted groups. H&E staining of the liver of the 
nano sized particle dieted group indicated some fatty liver pattern while the 
contents of Si in the livers of the groups were almost the same. From the re-
sults, it was suggested that the nanosized silica particle had a toxic effect on 
the liver even though there was no significant difference in the health of mice 
fed amount of 140 g silica/kg mouse. 
9.5.6 Mutagenicity/genotoxicity 
Lison et al. (2009) investigated the genotoxic potential of SNP with the in vi-
tro cytochalasin-B micronucleus (CBMN) test. This test was selected because 
it allows the detection of two types of chromosomal damage, i.e. clastogenic 
events or chromosome breaks and aneugenic events or chromosome loss. The 
CBMN assay was applied in A549 cells treated with different concentrations 
of 3 types of Stöber silica nanoparticles (16, 60 and 101 nm SNPs). A statisti-
cally significant increase of micronuclei in binucleated cells was detected after 
treatment but only with the smallest SNPs, indicative of a size dependent 
genotoxic effect. However, results showed no dose-dependent effect. 
Barnes et al. (2008) reported no significant genotoxicity of commercial colloi-
dal and laboratory-synthesized silica nanoparticles tested using the single cell 
gel electrophoresis or Comet assay. Comet assays were performed on 3T3-L1 
fibroblasts with 3, 6, and 24 h incubations and 4 or 40 μg/ml of silica 
nanoparticles. Results were independently validated in two separate laborato-
ries. 
In a review document discussing adaptations of the in vitro MN (micronu-
cleus) assay for the genotioxicity assessment of nanomaterials, Gonzales et al. 
(2011) report on genotoxic effects of SiO2 nanoparticles investigated in two 
studies. Wang et al. (2007 as cited by Gonzales) demonstrated that crystalline 
7.21 nm SiO2 nanoparticles induce MN. In contrast, no statistically significant 
induction of MN was found by amorphous SiO2 nanoparticles of 16, 60 and 
104 nm. In this study, MN frequencies were expressed in function of mass 
dose, number of particles and surface area and this when taking into account 
both the nominal and cellular dose. They showed that there was a statistically 
significant positive correlation between the fold increase of MN and the parti-
cle number or surface area, considering both nominal and cellular dose. No 
significant correlation was found between the fold increase of MN and mass 
dose. 
Park et al. (2010) investigated the potential of four well-characterized amor-
phous silica nanoparticles to induce chromosomal aberrations and gene muta-
tions using the micronucleus and the plasmid lacZ gene mutation assay. The 
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80 (34) nm silica nanoparticles induced chromosomal aberrations in the mi-
cronucleus assay using 3T3-L1 mouse fibroblasts and the 30 (34) and 80 
(34) nm silica nanoparticles induced gene mutations in mouse embryonic fi-
broblasts carrying the lacZ reporter gene. TEM imaging demonstrated that 
the majority of nanoparticles were localized in vacuoles and not in the nucleus 
of 3T3-L1 cells, indicating that the observed DNA damage was most likely a 
result of indirect mechanisms. The authors concluded that further studies are 
needed to reveal these mechanisms and to determine the biological relevance 
of the effects of these particular silica nanoparticles in vivo.  
9.5.7 Carcinogenicity 
No carcinogenicity studies involving SNPs have been identified. 
9.5.8 Reproductive toxicity, developmental toxicity and teratogenicity 
No reproductive toxicity, developmental toxicity and teratogenicity studies 
involving SNPs have been identified. 
9.5.9 In vitro studies 
Most studies carried out for mainly amorphous NSPs are in vitro studies in 
different cell types. As summarised by Napierska et al. (2019), most of these 
in vitro studies involving different SNPs documented the cytotoxic effects of 
these nanomaterials. The determinants of the observed cytotoxicity seem to 
be complex and vary with the particles used and cell type tested. Unfortu-
nately, for many published studies, adequate material characterization is still 
missing. 
Singh et al. (2009) also summarises results from in vitro studies: Silica has 
been shown to induce inflammatory and oxidative stress responses in vitro 
and also in vivo, but cytotoxicity is largely only observed at high concentra-
tions. Additionally, silica nanoparticles have been shown to enter the cell nu-
cleus where they could potentially bind to the DNA phosphate backbone. 
Since the silica nanoparticles can result in increased ROS (reactive oxygen 
species) levels and given that the hydroxyl radical is a highly reactive molecule 
the generation of OH close to the DNA could readily lead to the induction of 
DNA strand breaks and oxidised bases which could have important implica-
tions in the development of cancer. 
Singh et al. (2009) further summarises: Silica nanoparticles also have an im-
pact on nuclear integrity by forming intranuclear protein aggregates that can 
lead to inhibition of replication, transcription, and cell proliferation. Addition-
ally, they have been shown to reduce replication activity down to 67% and 
60% after 6 and 24 h respectively and transcriptional activity down to 82% 
after 4 h, thus resulting in decreased cell proliferation after 24 h (88%) and 48 
h (65%). This study underscores the importance of nanoparticles sizing since 
particles >200 nm fail to penetrate the nucleus, do not alter nuclear structure 
and function, and also do not interfere with gene expression. 
There seems to be conflicting results as regards the genotoxicity of SNPs. On 
the one hand, there is limited evidence to suggest silica nanoparticles are 
genotoxic and some recent studies utilizing the comet assay have demon-
strated that silica nanoparticles ranging in size from 20 to 400 nm do not exert 
significant genotoxicity (Singh et al., 2009). In contrast, one investigation 
based on the micronucleus assay found that these nanoparticles do indeed in-
 
104 
duce chromosomal damage. Thus, to get a clear indication of genotoxic po-
tential a battery of standardised tests that quantify different types of genetic 
aberrations are required to cover all potential forms of DNA damage that may 
be induced following exposure to nanoparticles. 
9.5.10 Summary  
For nano-silica particles there are relatively few studies of the toxicity available 
compared to what is available for titanium dioxide. Most studies are in vitro 
studies in different cell types. A few short-term and no chronic in vivo studies 
are available.  
Results of available in vitro studies indicate that the particle surface area may 
play a crucial role in the toxicity of silica. The cytotoxic activity of silica parti-
cles can be related to their surface interfacing with the biological milieu rather 
than to particle size or shape (Napierska et al., 2010). The effect related to 
other physico-chemical properties of SNPs are less well studied and no defi-
nite conclusions can be made. 
Results from in vivo studies indicate that the toxicity of SNPs can depend on 
not only the material itself but also the administration route, as was shown by 
Hudson et al. (2008). In this study subcutaneous injection presented good 
biocompatibility, whereas intraperitoneal and intravenous injection led to fatal 
outcomes. 
Currently available data do not clarify whether amorphous SNPs - showing 
augmented cytotoxicity and presumably processing oxidative DNA damaging 
potential – are less or more harmful as compared with micron-sized silica 
(Napierska et al., 2010). 
In most in vivo studies on acute or sub-acute health effects of SNPs the ani-
mals have been exposed via inhalation or intratracheal instillation. Other ex-
posure routes should therefore also be checked (e.g. blood, skin, gastrointesti-
nal tract). In addition chronic studies are needed to supplement and verify the 
existing data.  
Determining the association of results from in vitro and in vivo toxicity as-
sessments is difficult; however, as concluded by Napierska et al. (2010) the 
common feature seems to be cytotoxicity and inflammatory response after 
exposure to SNPs. 
Information is so far not sufficient to clearly identify and characterize the 
health hazards of SNPs related to the different physic-chemical characteris-
tics. 
 
9.6 Exposure scenarios 
Apart from exposure through food containing silicium dioxide, consumers' 
direct exposure to nano-scale SiO2 is expected to be through the use of tooth-
paste and cosmetic products. Oral and dermal contact are therefore the most 
likely routes of exposure unless the cosmetic products are applied as sprays. 
Dermal exposure to paints and inhalation of dust from grinding painted sur-
faces are other potential exposures to NSPs.  
Furthermore, it must be expected that the nanoscale fraction of microsilica in 
concrete (up to 6 % w/w) will give rise to both exposure of humans by inhala-
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tion and of the environment. However, this is not a new situation, as mi-
crosilica is a naturally occurring substance, which has been used in concrete 
since the 1980'es. 
The widespread uses of SiO2 in consumer products like sunscreens, surface 
treatment and paints allow for emissions of SiO2 nanoparticles to the envi-
ronment during and after application e.g. via wastewater or leaching of 
nanoparticles from treated surfaces.  
 
9.7 Risk profile 
9.7.1 Environment 
In short-term ecotoxicity tests, silica nanoparticles has been found to exhibit 
the following effects in aquatic organisms: in zebrafish there was an incidence 
of jaw malformations and embryo deformities; in different algal species, cell 
coagulation, membrane damage, arrested growth and decrease in chlorophyll 
was found; an increased mortality was observed for Daphnia magna. For 
daphnids, SiO2 concentrations of 10 mg/L caused 70% mortality (Adams et 
al., 2006) and for algae EC10, 72h values in the range of 11-15 mg/L were 
found for two different sizes of SiO2 (van Hoecke et al., 2008). Not many 
studies have analyzed dose-response relationships, thus making it difficult to 
perform an effects assessment following the guidelines of ECHA (2008). 
9.7.2 Human health 
Acute toxicity from oral exposure is low. There is little information available 
with regard to toxicity from other exposure routes. In vitro studies give some 
indication of a genotoxic potential although the results from different studies 
were not consistent and therefore more standardized tets are required to pro-
vide firm conclusions.With regard to the human health risk there is little in-
formation available with regard to the specific amounts of nano SiO2 used in 
different product types and thereby the extent of the exposure.  
Silica used in cosmetics and personal care products is in the amorphous form. 
In cosmetics for skin use, the silica is expected to present little, if any risk to 
people. For products that might be inhaled (such as a facial powder), silica 
particles are finely ground down and may be inhaled as such. However, as-
suming that no crystalline silica is present, the exposure to silica and the re-
lated risk is considered low even though the inhaled particles are associated 
with respiratory toxicity. 
For products where silica is integrated in a matrix as in the case with sporting 
goods like tennis rackets and fishing rods, no risk is identified. 
Conclusions from recent research into the "nanosilica hazard" states that, until 
now, the health effects of SNPs have mainly been studied in terms of expo-
sure via the respiratory tract, after acute or sub-acute exposure. Therefore 
other exposure routes should be checked (e.g. blood, skin, gastrointestinal 
tract) in order to clarify if the SNP's have specific properties compared to 
their bulk counterparts. It is also stated that chronic studies are needed to 
supplement and verify the existing data. (Napierska et al., 2010) 
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9.8 Summary sheet for SiO2 
Nanomaterial characteristics   
Name Silicium dioxide, silicon 
dioxide, silica 
CAS number 7631-86-9 
Chemical composition SiO2 
Appearance White powder 
 
Source:alibaba.com 
Manufacturing processes 
 
NanoSilica can be produced via for instance the sol-gel method 
or high-temperature hydrolysis in a hydrogen oxygen flame. The 
vapor-liquid-solid method can be used to produce silica 
nanospring (Lidong et al., 2006). Several methods can be used to 
produce nanoparticles. Silica nanoparticles are often used in for-
mulation or as components of other nanoparticles. as e.g. a sur-
face silanization may result in less cytotoxic nanoparticles suited 
for bio-applications. 
Nanomaterial description   
Silica or silicon dioxide (SiO2) is an abundant mineral commonly found in nature in the form of 
sand or quartz as well as in cell walls of diatoms. SiO2 has a number of distinct crystalline forms 
(rhombohedral, hexagonal, orthorhombic) in addition to amorphous forms e.g. α-quartz, β-quartz. 
Amorphous nanoSilica particles can be produced in all sizes e.g. one manufacturer has nanosilica 
particles available in the size of 9, 15, 30 and 55 nm. The shape of nanosiliica is normally spherical, 
but other forms exsits as well such as for instance springs and nanosilica can also vary in regard to 
their porousity. Nanosilica can furthermore be functionalized with instance organogroups as well 
as other metals. 
Applications   
Silica nanoparticles have numerous applications such as ingredients in cement, paints, solid lubri-
cants, shampoos, cosmetics, face creams and food (spices). Bioelectrocemistry, curing, oil recov-
ering applications and in formulation of other particles are furthermore potential application. Or-
gano-silica has also been reported to be used as scratch resistant coatings. Very little information 
is available about the SiO2 content in the various products. Concentrations of 0.1% and 15% have 
been reported for paints, whereas organo-silica is used in concentrations of 10% in scratch resis-
tant coatings. Very little is known about the scale of use of nanosilica. 
Human health risk profile   
Only few in vivo studies are identified for silica nanoparticles. Acute toxicity from oral exposure is 
low. There is little information available with regard to toxicity from other exposure routes and no 
dose-response relationships are established. In vitro studies give some indication of a genotoxic 
potential although the results from different studies were not consistent and therefore more stan-
dardized tets are required to provide firm conclusions. With regard to the human health risk there 
is little information available with regard to the amounts of nano SiO2 used in different product 
types and thereby the extent of the exposure. 
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Environmental risk profile   
In short-term ecotoxicity tests, silica nanoparticles has been found to exhibit the following effects 
in aquatic organisms: in zebrafish there was an incidence of jaw malformations and embryo de-
formities; in different algal species, cell coagulation, membrane damage, arrested growth and de-
crease in chlorophyll was found; an increased mortality was observed for Daphnia magna. For 
daphnids, SiO2 concentrations of 10 mg/L caused 70% mortality and for algae EC10, 72h values in 
the range of 11-15 mg/L were found for two different sizes of SiO2. These values indicate that 
nanosilica has low toxicity towards aquatic organisms. Only very few studies have analyzed dose-
response relationships and estimated environmental concentrations are lacking. Therefore, no 
quantitative risk characterization can be made at this point in time.  
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10 Exposure and risk potential 
Bulk versus nano? 
A key question in relation to risk and safety assessment of nanomaterials, is to 
which extent the existing knowledge base about toxicity and risk related to the 
bulk counterparts can be used in the evaluation of the nanomaterials and sim-
ply be scaled based on the size and knowledge about possible nano-specific 
behaviour and effects. 
As discussed in the ENHRES study (Stone et al., 2010), and under the as-
sumption that 'chemistry' is a key driver for toxicity, this would at least require 
that the chemistry should be similar for the bulk form and the nano-form of 
the material. This is, however, not always the case, e.g. for carbonbased 
nanomaterials like fullerenes, where specific surface modifications are intro-
duced in order to obtain the required properties. In addition the impact of ag-
glomeration and aggregation needs to be considered. For the more chemically 
inert particles like TiO2 and SiO2, the possibility of scaling toxicity and risk 
information from bulk to nano, seems to be more of an option, although it will 
require further investigations before firm conclusions can be made. However, 
for materials like TiO2, SiO2 and to some extent nanoclay, where naturally oc-
curring, unmodified nanoscale particles have been part of some of the 'con-
ventional' materials, the existing knowledge base is likely to cover some of the 
nanospecific properties and effects for these materials.  
In relation to the present survey, it is important to note that all the reviewed 
studies are dealing with the core-particles, whereas most real-world uses of 
engineered nanoparticles require a surface functionalisation. How these func-
tionalisations/coatings affect the bioavailability, uptake / distribution / metabo-
lism / excretion, and toxicity nanoparticles is at present unknown.  
Ecotoxicity and toxicity of nanomaterials? 
The bulk counterparts of the seleted nanomaterials are generally not perceived 
as very hazardous chemicals, although some of them do have hazardous prop-
erties that may constitute a risk in relation to certain exposure situations.  
The overall picture in relation to the reviewed nanomaterials is that the range 
of toxicological and ecotoxicological studies available is not sufficient to allow 
firm conclusions with regard to the toxicity of the nanoparticles compared to 
theit bulk counterparts. This is also due to the fact that principles for physico-
chemical characterization, which is a critical factor for any toxicity evaluation, 
still need to be further developed. 
The issue of characterization in the media where the nanomaterials are tested, 
is a frequently discussed topic in the nano (eco)toxicological literature. In the 
newest studies, characterisation of the nanoparticles that are tested is most 
often carried out in terms of chemical composition, sizes, and surface area. 
However, it still remains a scientific challenge to characterize the test materials 
in the actual test media, and hence to control the exposure. Therefore more 
research is needed before a link between specific properties, or combinations 
of properties, and observed effects can be made. 
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While reviewing the literature on environmental effects of the selected nano-
materials, a lack of studies addressing degradability and accumulation became 
evident – as also described by Stone et al. (2010). These two properties are as 
important as toxicity for determining the hazard profile of a material, and it is 
therefore recommended that more research efforts are directed towards bioac-
cumulation and degradability of engineered nanomaterials. 
In addition, the concentrations that are used in the ecotoxicological studies are 
mostly much higher than the concentrations expected to be environmentally 
realistic.  
Another issue is that the majority of the reviewed studies have focussed on 
short-term effects of the nanomaterials whereas little information is available 
with regard to long-term exposures to lower concentrations aimed at chronic 
endpoints.  
Furthermore, only part of the tests performed for environmental toxicity as-
sessment are aimed at the base-set organisms and the endpoints required for 
doing effects assessment according to REACH as mentioned in the case of 
fullerenes.  
For those substances that have been registered under REACH in 2010 (e.g. 
C60, Ag and TiO2) environmental data are now available for the test species in 
the base set for risk assessment in REACH (i.e., fish, crustacean, algae), al-
though some of these data still need replication to improve quantification of 
exposure. 
With regard to the evaluation of toxicological effects of the nanomaterials, an 
issue is that most studies are in vitro studies and only few studies are available 
in vivo. However, based on available studies there are indications that a com-
mon mechanism of toxicity is that exposure to nanoparticles can generate an 
oxidative stress response and lead to pulmonary and cardiovascular inflamma-
tion. Whether other mechanisms of toxicity are of importance needs to be de-
termined. However, as not all nanoparticles induce toxicity, the mechanism 
behind the differences also needs clarification. 
Main applications and exposure? 
Although it may seem straight forward to determine the number of products 
containing nanomaterials, this is far from the case. Available databases con-
taining information about nanomaterials are typically biased towards what is 
sold on the internet and not necessarily what is available on the market as a 
whole. Nanomaterials are used in a range of products and articles not defined 
as “nano-based” since the nanomaterials may only constitute part of the func-
tionality of the product or article e.g. suntan lotions, car catalysts or laptop 
computers.  
The results of the present survey indicate that titaniumdioxide, nanoclay and 
siliciumdioxide are the nanomaterials used in highest volumes in products that 
are also used by consumers, whereas use of cerium oxide and zero valent iron 
in product for consumers in Denmark has not been confirmed.  
Nanosilver is likely to be found in many consumer products on the Danish 
market in addition to those that are commercially available on the internet and 
listed in the Woodrow Wilson database. It was not possible to quantify the 
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possible use in textiles in Denmark as part of the small industry survey, due to 
lack of response. 
In Table 4 the main consumer applications mentioned in the reviewed litera-
ture for the selected nanomaterials are shown together with an indication of 
the level of environmental and consumer exposure related to their applica-
tions. Applications in food and medicine are not included. The table shows 
the areas of application which are considered relevant for consumers in Den-
mark as well as the results from the small industry survey. It should be 
stressed that since this survey did not cover all potential areas of application it 
does not provide a complete picture of the current products on the market 
containing the selected nanomaterials. Based on a primarily qualitative estima-
tion, the levels of potential environmental and consumer exposure are indi-
cated as: 
Low: Fixed particles in a matrix or low concentration of nanoparti-
cles in the products 
Medium: Free particles or direct contact/release in low or moderate con-
centrations 
High: Free particles, liquid or direct contact/release in high or mod-
erate concentrations 
Table 4 Main applications and exposure of the selected nanomaterials 
Nanomaterial Main applications (consumer) Industry survey1) Potential environ-
mental exposure 
Potential con-
sumer exposure
Fullerenes - C60  Sportsgear 
 Cosmetics and personal care 
 Lubricants (motor oil) (~0.01 %) 
No information  Low (disposal) 
 High 
 High 
 Low 
 High 
 High 
Titanium diox-
ide - TiO2 
 Cosmetics and personal care 
(including sun screens) 
 Paints 
 Pigment in mortar and cement 
Pigment  High 
 
 Medium 
 Medium 
 High 
 
 Medium 
 Medium 
Zero valent iron 
- nZVI 
 Therapeutic No information No information No information 
Cerium dioxide 
- CeO2 
 Self-cleaning ovens 
 Diesel fuel additive 
Not used as fuel 
additive in DK 
No information No information 
Silver - Ag  Personal care 
 Textiles 
 Sportsgear 
 Home and garden 
No confirmed use  High 
 Medium 
 Low (disposal) 
 Medium 
 High 
 Medium 
 Low 
 Low 
Nanoclay  Food packaging 
 Electronics (wires and cables) 
 Cement 
Leca  Low (disposal) 
 Low 
 Medium 
 Low  
 Low 
 Medium 
Silicium dioxide 
- SiO2 
 Cosmetics and personal care 
(including sun screens) 
 Paints 
 Lubricants 
Concrete  High 
 
 Medium 
 Medium 
 High 
 
 Medium 
 Medium 
1) Based on the limited industry survey carried out under the present project 
The table show the estimated exposure but does not consider the actual ab-
sorption by consumers through dermal exposure.  
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Risk? 
The question regarding the possibility of scaling of the risk from the bulk sub-
stances to the nanoform, is as mentioned not yet clarified for the many differ-
ent nanomaterials and will require further research. The question is further 
complicated by the fact than many nanomaterials have surface modifications 
deliberately added to give them specific properties.  
For the more chemically 'inert' particles, it is more likely that behavior and ef-
fects can be scaled based on knowledge about the larger particles to the nano-
scale materials.  
With regard to human health, there are indications that some of the toxic ef-
fects of nanosized TiO2 can be scaled based on surface area considerations 
from the toxicity of the micro-sized TiO2 (Stone et al., 2010). This may also 
be the case for SiO2 and to some extent nanoclay. For silver, more research is 
required, although products containing nanosilver particles are likely to have 
been commercially available for more than 100 years and are thereby included 
in some of the already existing toxicity test results. In addition there are some 
indications that the toxicity of silver is related the Ag+ ions but overall it is too 
early for firm scientific conclusions. 
Fullerenes in contrast are more likely to be associated with specific nano-
toxicological properties, because of the very different surface characteristics 
compared to the bulk material.  
In order to determine whether the nanomaterials give rise to new risks com-
pared to the bulk materials, it is necessary to have adequate risk assessment 
methodologies that are agreed and that information is available to allow com-
parison of the results from different studies across different physico-chemical 
characteristics.  
The future? 
In order to answer the many questions regarding nanomaterials and risk more 
information and research is required in the future. Some of the gaps can be 
summarized as follows: 
 Characteristics sufficient for toxicity testing 
 Fate, behavior and kinetics of different nanoparticles 
 Agreement regarding risk assessment methodologies to comply with 
regulatory regimes 
 More information on chronic effects of nanomaterials 
 Effect of surface functionalisation on toxicity of the nanomaterials 
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Annex 1 Nano terminology and ac-
ronyms 
Nanoterminology 
The terms explained below are primarily included to support the reader of 
this report. Several of these terms are currently under discussion and may be 
adjustded as part of the process of developing regulations and standards in the 
nanotechnology field. 
Agglomerate: Collection of loosely bound particles or aggregates or 
mixtures of the two where the resulting external surface 
area is similar to the sum of the surface areas of the indi-
vidual components. (Particles are held together by rela-
tively weak forces, including Van der Waals forces, elec-
trostatic forces and surface tension.) 
Aggregate: Particle comprising strongly bonded or fused particles 
where the resulting external surface area may be signifi-
cantly smaller than the sum of calculated surface areas of 
the individual components. (The forces holding an ag-
gregate together are strong forces, e.g. covalent bonds.) 
Coating: A covering that is applied to the surface of an object to 
alter or improve surface properties. 
Derivatisation: Transforming a chemical compound into another com-
pound (derivate) of similar structure. 
Doping: Addition of controlled impurities to a semiconductor 
material to change its electrical properties. 
Functionalisation: Addition of functional groups to the surface of the mate-
rial in order to achieve specific surface properties.  
Mesoporous: Possessing pores with at least one dimension between 2 
nm to 50 nm. 
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Nanomaterial11: Material having one or more external dimensions in the 
nanoscale or which is nanostructured. 
Nanoobject: Discrete piece of material with one or more external di-
mensions in the nanoscale. 
Nanoparticles: Nano-object with all three external dimensions in the 
nanoscale. (If the lengths of the longest and the shortest 
axes of the nano-object differ significantly (typically by 
more than three times) the terms nanorod or nanoplate 
are intended to be used instead of the term nanoparti-
cle.)  
Nanoscale: Size range from approximately 1 nm to 100 nm. 
Nanostructured: Possessing a structure comprising contiguous elements 
with one or more dimensions in the nanoscale but ex-
cluding any primary atomic or molecular structure.  
Acronyms 
ADME Absorption Distribution Metabolism Excretion 
BAL BronchoAlveolar Lavage 
BCF Bioconcentration Factor 
CA Chromosomal Aberrations 
CHL/IL Chinese Hamster Lung / Interleukin 
CMC-Na Methylcellulose sodium 
CNT Carbon NanoTubes 
DNA Deoxyribonukleinsyre 
DNEL Derived no Effect level 
EC50 Effective Concentration 50% 
FCM Food Contact Materials 
                                                          
11 A formally accepted definition of the term "nanomaterial"is not yet accepted. The 
European Commission has proposed the following definition to be used as the over-
arching, broadly applicable reference term for any European Union communication 
or legislation addressing nanomaterials, but this may to subject to change in the fu-
ture: 
Nanomaterial: means a material  that meets at least one of the following criteria: 
– consists of particles, with one or more external dimensions in the size range 1 nm 
- 100 nm for more than 1 % of their number size distribution; 
– has internal or surface structures in one or more dimensions in the size range 1 
nm – 100 nm; 
– has a specific surface area by volume greater than 60 m2/cm3, excluding materi-
als consisting of particles with a size lower than 1 nm. 
 Annex 1 
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FPG Formamido-pyrimidine-DNA-glycosylase 
INEL Indicative Effect level 
LC50 Lethal Concentration 50%  
LD50 Lethal Dose 50%  
LDH Lactate DeHydrogenase 
LOAEC Lowest Observed Adverse Effect Concentration 
LOEC Lowest Observed Effect Concentration 
MMC Mitomycin C 
MN Micronucleus 
NOAEL No Observed Adverse Effect Level 
NOAEC No Observed Adverse Effect Concentration 
NOEC No Observed Effect Concentration 
NOAEL No Observed Adverse Effect Level 
NOEL No Observed Effect level 
NP Nanoparticles 
NSP Nano-Sized Particle 
PEC Predicted Environmental Concentration  
PNEC Predicted No-Effect Concentration 
REACH Registration, Evaluation, Authorisation of Chemicals 
ROS Reactive Oxygen Species 
SNP Silica NanoParticle 
TEM Transmission Electron Microscopy 
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Annex 2 Companies that commer-
cialise nanotechnology 
and / or nano materials in 
Denmark 
Companies that commercialize nanotechnology and/or nanomaterials 
in Denmark 
Recently, the Nanowerk published an online Company & Labs directory with 
4,196 links to labs, associations, networks and companies. This directory in-
cludes only companies and labs that work with and/or commercialise 
nanotechnology and/or nanomaterials and does not include entities that only 
have “nano” in their name.  
According to Nanowerk there are 18 companies in Denmark involved in vari-
ous fields of technology commercially.  
1. AQUAporin: The company is committed to revolutionizing water pu-
rification through bionanotechnology with the development of a highly 
water-selective membrane. 
2. Cantion: Provides nanomechanical products such as nanonanofluidic 
dispensers and nanomechanical cantilevers for label free detection and 
analysis of molecules. 
3. Capres - Copenhagen Applied Research: CAPRES develops new 
technology for direct nano- and micro-scale electrical characterization 
of materials. 
4. DME Danish Micro Engineering: Develops and manufactures Scan-
ning Probe Microscopes. 
5. Haldor Topsoe: Topsoe specialises in the production of heterogene-
ous catalysts and the design of process plants based on catalytic proc-
esses. Focus areas include the fertiliser industry, the chemical and pet-
rochemical industries, and the energy sector (refineries and power 
plants). Topsoe has for many years dedicated large research efforts to 
nanoscience and nanotechnology. The efforts range from the devel-
opment of novel preparation methods to theoretical and experimental 
investigations. 
6. Image Metrology: Nanoscale image processing software and 3D visu-
alization. 
7. InMold Biosystems: InMold Biosystems proprietary technology offers 
a radical new approach to increase the functionality of plasticware. 
Biomolecules, like proteins, may be transferred to flat or structured 
surfaces in a pattern with nanometer sized details by micro contact 
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printing. 
8. LiPlasome Pharma: The combination of a protected blood transport-
ing nanocarrier system and a tumor specific activation technology 
makes LiPlasome Pharma very competitive in a commercially attrac-
tive and dynamic anticancer market, where drug delivery systems will 
gain increasing importance over the coming years. 
9. NanoCover: NanoCover specialises in the production, distribution, 
sales and development of NanoCover, a series of surface treatment 
products. NanoCover is developed and produced using the newest 
and most advanced nanotechnologies. 
10. Nanofiber: Develops protocols for growth and transfer of morphologi-
cally and optically controlled organic nanofibers. 
11. Nanon: Specializes in the nanoscale manipulation of 'difficult' poly-
mers, such as silicone, with the goal of optimizing performance - with-
out compromising the properties of the base material. 
12. NanoWorld I/S: NanoWorld I/S specializes on research, test and dis-
tribution of nano-based surface sealants. The company offers a wide 
range of nano sealing products for private and professional use. 
13. NIL Technologies: The company sells stamps for nanoimprint lithog-
raphy (NIL), provides imprint service, production by NIL, consul-
tancy and enters into joint development of novel applications benefit-
ing from nano-scale structures. 
14. Noliac: Designs, develops and manufactures the total range of piezo-
electric products - from powders to mono- and multilayer components 
and all the way to finished plug-and-play applications. 
15. Proxeon: Proxeon develops state-of-the-art solutions to solve many of 
the scientific and technical challenges that are faced by those working 
in the field of proteomics. The company's core competencies are in 
the areas of mass spectrometry, protein analysis, hardware and soft-
ware design for proteome analysis. 
16. QuantumWise: QuantumWise produces software for atomic-scale 
modeling of nanoelectronic devices, wrapped in a platform with a 
graphical user interface and a scripting language interface. The com-
pany is unique in offering a commercial code that can do transport 
calculations using first-principles methods, and at the same time the 
back-end provides state-of-the-art simulation capacity for large-scale 
systems, allowing for systems with over 1,000 atoms to be simulated 
on a single workstation. 
17. SCF Technologies: SCF Technologies A/S develops and commercial-
izes technologies, such as nanostructure materials, that are used to re-
fine products, enhance processes and produce intelligent materials. 
18. SunFlake: SunFlake is developing a new generation of solar cells based 
on a novel shape of semiconductor nanostructures (NanoFlakes). The 
nanostructures can eliminate the need for a lattice-matched substrate 
as well as the need for a clean solar grade substrate (Nanowerk 2010). 
 
 
